US20210077134A1 - Devices and methods for removal of acute blockages from blood vessels - Google Patents

Devices and methods for removal of acute blockages from blood vessels Download PDF

Info

Publication number
US20210077134A1
US20210077134A1 US17/038,301 US202017038301A US2021077134A1 US 20210077134 A1 US20210077134 A1 US 20210077134A1 US 202017038301 A US202017038301 A US 202017038301A US 2021077134 A1 US2021077134 A1 US 2021077134A1
Authority
US
United States
Prior art keywords
catheter
clot
distal
tip
proximal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US17/038,301
Inventor
David Vale
Brendan Casey
Michael Gilvarry
Kevin McArdle
Maeve HOLIAN
David HARDIMAN
Alan KEANE
Daniel King
Jacqueline O'Gorman
Eamon Brady
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuravi Ltd
Original Assignee
Neuravi Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/737,249 external-priority patent/US10441301B2/en
Application filed by Neuravi Ltd filed Critical Neuravi Ltd
Priority to US17/038,301 priority Critical patent/US20210077134A1/en
Assigned to NEURAVI LIMITED reassignment NEURAVI LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KING, DANIEL, KEANE, Alan, MCARDLE, KEVIN, CASEY, BRENDAN, GILVARRY, MICHAEL, HARDIMAN, David, HOLIAN, Maeve, O'GORMAN, JACQUELINE, BRADY, EAMON, VALE, DAVID
Publication of US20210077134A1 publication Critical patent/US20210077134A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22031Gripping instruments, e.g. forceps, for removing or smashing calculi
    • A61B17/22032Gripping instruments, e.g. forceps, for removing or smashing calculi having inflatable gripping elements
    • A61M1/008
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84Drainage tubes; Aspiration tips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/32056Surgical snare instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/00234Surgical instruments, devices or methods for minimally invasive surgery
    • A61B2017/00349Needle-like instruments having hook or barb-like gripping means, e.g. for grasping suture or tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/00234Surgical instruments, devices or methods for minimally invasive surgery
    • A61B2017/00358Snares for grasping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00778Operations on blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22065Functions of balloons
    • A61B2017/22067Blocking; Occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22079Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with suction of debris
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/22Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • A61B2017/2215Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having an open distal end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • A61B2017/3435Cannulas using everted sleeves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2217/00General characteristics of surgical instruments
    • A61B2217/002Auxiliary appliance
    • A61B2217/005Auxiliary appliance with suction drainage system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/32General characteristics of the apparatus with radio-opaque indicia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/12Blood circulatory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/005Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
    • A61M25/0052Localized reinforcement, e.g. where only a specific part of the catheter is reinforced, for rapid exchange guidewire port
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0119Eversible catheters

Definitions

  • This invention relates to devices intended for removing acute blockages from blood vessels.
  • Acute obstructions may include clot, misplaced devices, migrated devices, large emboli and the like.
  • Thromboembolism occurs when part or all of a thrombus breaks away from the blood vessel wall. This clot (now called an embolus) is then carried in the direction of blood flow.
  • An ischemic stroke may result if the clot lodges in the cerebral vasculature.
  • a pulmonary embolism may result if the clot originates in the venous system or in the right side of the heart and lodges in a pulmonary artery or branch thereof.
  • Clots may also develop and block vessels locally without being released in the form of an embolus—this mechanism is common in the formation of coronary blockages.
  • the invention is particularly suited to removing clot from cerebral arteries in patients suffering acute ischemic stroke (AIS), from coronary native or graft vessels in patients suffering from myocardial infarction (MI), and from pulmonary arteries in patients suffering from pulmonary embolism (PE) and from other peripheral arterial and venous vessels in which clot is causing an occlusion.
  • AIS acute ischemic stroke
  • MI myocardial infarction
  • PE pulmonary embolism
  • a catheter having an expansile distal tip, the catheter tip having a constricted delivery configuration and an expanded deployed configuration, and having a support frame and an elastic sleeve extending over the frame, the sleeve being expandable in the deployed configuration to define an enlarged distal tip.
  • the sleeve is partially folded in the delivery configuration. In one case at least a portion of the support frame is configured to expand radially outwardly from the deployed configuration. In one embodiment the support frame comprises a flexible region just proximal of the distal tip. The support frame may be cut from a tube and the cut pattern defines ring members and axially extending connections between the ring members. At least a distal region of the support frame may comprise a radiopaque material. In one embodiment the sleeve comprises a polymeric membrane. The membrane may have an internal and/or external low friction coating.
  • the invention also provides a clot retrieval system having a first catheter of the invention; and an access catheter.
  • the self expanding distal tip of the first catheter being collapsible to a diameter less than or equal to that of the access catheter for delivery through the lumen of the access catheter, and being expandable to a diameter which is greater than that of the access catheter lumen in an unconstrained state.
  • the invention further provides a system having a clot retrieval catheter having a self expanding distal tip which is expansile from a radially retracted delivery configuration to a radially expanded configuration for reception of a clot; and an access catheter.
  • the self expanding distal tip being collapsible to a diameter less than or equal to that of the access catheter for delivery through the lumen of the access catheter, and being expandable to a diameter greater than that of the access catheter lumen in an unconstrained state.
  • the invention also provides a system having a clot retrieval catheter having a distal tip which is expansile from a radially retracted delivery configuration to a radially expanded configuration for reception of a clot; and a self expanding element having a retracted delivery configuration and an expanded configuration, the self expanding element being axially movable within the catheter from an axially retracted configuration proximal of the distal tip to an axially extended configuration to expand the distal tip of the catheter.
  • the self expanding element may be mounted to a proximally extending control element.
  • the control element may comprise a control wire extending from the self expanding element.
  • the self expanding element may comprise a super elastic material such as Nitinol.
  • the invention provides a system having a catheter selected from an aspiration catheter and an intermediate catheter; and a clot gripper which is adapted for gripping clot.
  • the clot gripper may be a separate element which is movable relative to the catheter.
  • the clot gripper may comprise a shaft having clot gripping means at the distal end of the shaft.
  • the clot gripper comprises a barbed tipped shaft for gripping clot.
  • the clot gripping means is movable from a delivery configuration to an expanded clot gripping configuration.
  • the clot gripping means may comprise two or more jaws for gripping clot.
  • the clot gripper is integrated with the catheter.
  • the clot gripper comprises a snare.
  • the clot gripper comprises a distal loop which is movable from an inactive position at the distal end of the catheter to an active configuration and an actuator for activating the loop.
  • the loop may be retained in the inactive position within receivers at the distal end of the catheter and the activator is adapted to remove the loop from the receivers.
  • the catheter may comprise an expansile distal tip.
  • the invention provided a catheter having an expandable distal tip and having an integral actuator for expanding and contracting the distal tip.
  • the distal tip may comprise a support material to provide lateral strength, and an expansile material to maintain a closed wall at the tip on expansion and contraction of the tip.
  • the actuator comprises a wire which extends around the distal tip.
  • the wire may extend around a guide lumen at the distal tip of the catheter.
  • the wire may be fixed at a fixation location within the guide lumen.
  • the wire extends through a lumen in the catheter which extends along the length of the catheter.
  • the invention also provides a catheter having a distal tip and having internal grip features on the internal surface of the distal tip.
  • the grip features may be unidirectional grip features.
  • the distal tip may be an expansile distal tip.
  • An atraumatic element may be provided for location at the distal tip to cover the grip features during advancement of the catheter.
  • the atraumatic element is mounted on an elongate control element.
  • the atraumatic element may comprise a lumen.
  • the invention provides an aspiration catheter having an open distal end, a secondary hole in the wall of the catheter adjacent to the distal end and a closure element which is movable from a closed position normally closing the secondary hole to an open position in which the secondary hole is exposed.
  • the closure element comprises a hinged tab.
  • the closure element may be movable in response to blockage of the distal end of a catheter.
  • a catheter having an inner sleeve, an outer sleeve and a flexible element interconnecting the sleeves at the distal end of the catheter, the inner and/or the outer sleeves being movable relative to one other.
  • the length of the flexible element in some cases is from 2 mm to 30 mm, from 5 mm to 15 mm.
  • the flexible element may comprise a polymeric material such as polyurethane.
  • the flexible element may comprise a braid of superelastic material such as Nitinol.
  • the invention further provides a clot retrieval system having an outer access catheter and an inner rapid exchange clot retrieval catheter which is adapted to be advanced through the outer catheter wherein the system comprises a narrowed region which forms a seal between at least a portion of the inner wall of the outer access catheter and at least a portion of an outer region of the inner clot retrieval catheter.
  • the outer catheter comprises a narrowed region which forms a seal between the inner wall of the outer access catheter and the outer wall of the inner clot retrieval catheter.
  • a catheter having a self expandable distal tip and having a narrowed section of reduced diameter adapted to provide enhanced flexibility and trackability.
  • the reduced diameter section may have a length of from 20 mm to 200 mm, in one case approximately 100 mm. In one case the diameter of the reduced diameter section is from 50% to 60% of the diameter of the main body of the catheter.
  • a catheter having a distal tip and a neck-down region just proximal of the distal tip. In one case the transition from the neck down region to the distal tip defines a flare.
  • the invention also provides a method of retrieving an obstructive thrombus from a patient's blood vessel, the method having the steps of advancing a microcatheter across the thrombus; advancing a clot retrieval device through the microcatheter; partially retracting the microcatheter to deploy at least a portion of the clot retrieval device distal of the thrombus; advancing a clot retrieval catheter to a position adjacent the proximal face of the thrombus; aspirating through the clot retrieval catheter to urge at least a portion of the thrombus into the distal mouth of said catheter; and removing the clot retrieval catheter and at least a portion of the thrombus from the patient.
  • portion of the clot retrieval device remains constrained within the microcatheter during at least part of the aspiration step.
  • portion of the clot retrieval device distal of the thrombus comprises a fragment capture basket.
  • the method includes the additional step of further retracting the microcatheter to deploy an additional portion of the clot retrieval device within the clot prior to removal of the clot retrieval catheter.
  • the method includes the additional step of retracting the clot retrieval device at least partially into the mouth of the clot retrieval catheter.
  • the clot retrieval device is removed from the patient simultaneously with the clot retrieval catheter.
  • a clot retrieval system having an outer access catheter, an inner rapid exchange clot retrieval catheter, and a clot capture device.
  • the rapid exchange clot retrieval catheter having a proximal elongate shaft and a distal tubular member.
  • the clot capture device having a proximal elongate shaft and a distal expandable portion.
  • the system having a restriction to effect a seal between at least a portion of the inner wall of the outer access catheter and at least a portion of the distal tubular member of the inner clot retrieval catheter.
  • the invention also provides a method of retrieving an obstructive thrombus from a patient's blood vessel using the clot retrieval system of the invention, the method having the steps of advancing the access catheter into the vasculature of the patient; advancing a clot capture device up to and across the thrombus; deploying at least a portion of the clot capture device distal of the thrombus; advancing the rapid exchange clot retrieval catheter through the access catheter to a position adjacent the proximal face of the thrombus; applying an aspiration force to the proximal end of the access catheter to effect aspiration through the rapid exchange clot retrieval catheter to urge clot into the catheter mouth; and withdrawing the rapid exchange clot retrieval catheter through the access catheter and out of the patient.
  • the method may further comprise the step of retracting the clot capture device and any captured thrombus through the access catheter and out of the patient.
  • the method may comprise the step of retracting the clot capture device and the rapid exchange clot retrieval catheter and captured thrombus simultaneously through the access catheter and out of the patient.
  • the method includes the step of partially retracting the clot capture device into the distal mouth of the rapid exchange clot retrieval catheter and then removing the clot capture device and rapid exchange clot retrieval catheter and any captured thrombus simultaneously through the access catheter and out of the patient.
  • a method of retrieving an obstructive thrombus from a patient's blood vessel using the clot retrieval system of the invention having the steps of a) advancing the access catheter into the vasculature of the patient; b) advancing a clot capture device up to and across the thrombus; c) deploying at least a portion of the clot capture device distal of the thrombus; d) advancing the rapid exchange clot retrieval catheter through the access catheter to a position adjacent the proximal face of the thrombus; e) applying an aspiration force to the proximal end of the access catheter to effect aspiration through the rapid exchange clot retrieval catheter and urge at least a portion of the thrombus into the mouth of the catheter; f) withdrawing the rapid exchange clot retrieval catheter through the access catheter and out of the patient; g) re-advancing the rapid exchange clot retrieval catheter over the shaft of the clot capture device and up
  • the method may comprise the step of injecting contrast media through the access catheter and thus on through the distal tubular member of the rapid exchange clot retrieval catheter to assess the degree of obstruction remaining in the vessel prior to further treatment steps.
  • the method includes the step of injecting contrast media through the access catheter after step f to assess the degree of obstruction remaining in the vessel, and then removing the clot capture device if adequate revascularisation of the target vessel is observed.
  • a catheter for assisting in the retrieval of a clot from a vessel having a distal end and a proximal end, a distal segment and a proximal segment and a lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment and a flow restrictor located on the outer surface of the catheter distal of the transfer port.
  • the catheter is an aspiration catheter for aspirating a clot.
  • the flow restrictor is actuatable between engaged and disengaged configuration.
  • the catheter may comprise an actuator for selectively engaging and/or disengaging the flow restrictor.
  • the flow restrictor includes a framework and a membrane coupled to the framework, the framework being movable by the actuator between an expanded configuration and a retracted configuration.
  • the aspiration catheter may comprise a proximal flow restrictor proximate the proximal end of the distal segment and a distal flow restrictor spaced distally from the proximal flow restrictor.
  • the distal end of the catheter includes a mouth for reception of clot.
  • the mouth may be defined by an expansile tip.
  • the distal segment includes a hinge adjacent to the distal mouth.
  • the hinge may be defined by a region of the distal segment which is configured to have lateral flexibility.
  • the mouth has an expanded configuration and a retracted configuration.
  • the catheter may comprise a control member for controlling the movement of the mouth between the expanded and retracted configurations.
  • the mouth includes a number of segments and the control member is configured to move at least some of the segments.
  • the control member may comprise a draw string or the like.
  • the invention provides a catheter for aspirating a clot in a vessel having a distal end and a proximal end, a distal segment and a proximal segment and a lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment wherein the distal end of the catheter includes a mouth for reception of clot.
  • the mouth may be defined by an expansile tip.
  • the catheter has a flow restrictor located on the outer surface of the catheter distal of the transfer port.
  • a system for treating an occlusion in a vessel having a first catheter and a second catheter; the first catheter having a proximal end, a distal end and a lumen extending between the proximal end and the distal end, the lumen of the first catheter further having a proximal segment and a distal segment; the second catheter having a distal end and a proximal end, a distal segment and a proximal segment, and a lumen, said lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment; the first catheter being configured to facilitate aspiration through the lumen; the transfer port being configured to transmit aspiration in the proximal lumen of the first catheter into the lumen of the distal segment of the second catheter and the distal end of the second catheter being configured to receive clot into at least a portion of the lumen of the second catheter.
  • system further includes a flow restrictor between the first catheter and the distal segment of the second catheter, distal of the transfer port.
  • the flow restrictor may be located on the inner surface of the first catheter. Alternatively or additionally the flow restrictor is located on the outer surface of the second catheter.
  • proximal flow restrictor proximate the proximal end of the distal segment of the second catheter and a distal flow restrictor spaced distally from the proximal flow restrictor.
  • the distal end of the second catheter includes a mouth for reception of clot.
  • the mouth may be defined by an expansile tip.
  • the transfer port includes a rapid exchange port.
  • the first catheter is a guide catheter.
  • the second catheter may be an intermediate catheter.
  • the system may also include a microcatheter which is adapted to be advanced through the first catheter and the second catheter.
  • the system may further comprise a clot engaging device for delivery from the microcatheter.
  • Also provided is a method of removing a clot from a vessel having the steps of providing a guide catheter and an intermediate catheter, the intermediate catheter having a distal mouth and being configured such that it is advanceable within the lumen of the guide catheter; inserting the guide catheter into a first vessel proximal of an occlusion; advancing the intermediate catheter through the lumen of the guide catheter until the tip of the intermediate catheter extends distal of the guide catheter into a second vessel adjacent to the occlusion; applying aspiration to the proximal end of the guide catheter; and the intermediate catheter being configured to direct said aspiration through the distal lumen of the intermediate catheter to aspirate the clot into the mouth of said intermediate catheter.
  • the aspiration catheter may comprise a distal end, a proximal end, a distal segment, a proximal segment and a lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment.
  • the method includes restricting flow between the outside surface of the intermediate catheter and the inside surface of the guide catheter.
  • the method includes the step, before or after aspiration, of delivering a microcatheter to the occlusion and deploying a clot capture device from the microcatheter.
  • the method may comprise advancing the microcatheter to the clot, deploying a clot capture device from the microcatheter, retracting the microcatheter to a location proximal of a transport port at the proximal end of a distal segment of the aspiration catheter.
  • the invention provides method of removing an occlusion from a vessel having the steps of providing a first aspiration catheter and a second aspiration catheter, the second aspiration catheter extending distal of the first aspiration catheter and further having a transfer lumen proximal of the distal end of the first aspiration catheter; inserting the first catheter into a first vessel proximal of the occlusion; advancing the second catheter through the lumen of the first catheter until the tip of the second catheter extends distal of the first catheter into a second vessel and is substantially opposing the occlusion; and aspirating through the proximal lumen of the first catheter so as to urge the clot into the distal lumen of the second catheter.
  • the method may comprise restricting flow between the outside surface of the second catheter and the inside surface of the first catheter.
  • the method may comprise the step, before or after aspiration, of delivering a microcatheter to the occlusion and deploying a clot capture device from the microcatheter.
  • the method as includes the step, prior to aspiration, of retracting the microcatheter to a location proximal of the transfer port.
  • the first aspiration catheter is a guide catheter.
  • the second aspiration catheter is an intermediate catheter.
  • the invention provides a clot receptor device.
  • the device is a catheter which may include rapid exchange features.
  • the device provides a self-expanding aspiration catheter with flow-arrest.
  • the aspiration assist device has a distal end which expands to seal against the vessel proximal of the clot and provides a large open mouth to receive clot easily without risk of dislodging the clot from the thrombectomy device (if used).
  • the inner rapid exchange expandable device is delivered through an outer catheter, which may be a conventional intermediate or aspiration catheter or a distal access catheter (DAC).
  • an outer catheter which may be a conventional intermediate or aspiration catheter or a distal access catheter (DAC).
  • DAC distal access catheter
  • it is a tailored catheter with an extremely trackable distal section for ease of access. This outer catheter trackability is possible because the distal section does not require much axial stiffness, as neither clot not thrombectomy device are retracted directly into it.
  • the rapid exchange (RX) expanding device may be supplied within the outer catheter (about 15 cm proximal of the distal end) and both are delivered together over a microcatheter (or wire) until the outer catheter tip approaches the clot.
  • the inner RX expanding device is advanced to the distal end of the outer, and the outer is then retracted to deploy the self expanding RX device.
  • the Rx device seals against the vessel wall and against the inner lumen of the outer catheter to allow highly effective aspiration, and its distal end expands to provide a large opening and reception space to receive the target clot and thrombectomy device (if used).
  • the self expanding aspiration catheter has a full length tubular proximal shaft, rather than a rapid exchange shaft, so that it does not require a proximal seal and aspiration can be applied by applying a vacuum force to its proximal hub.
  • the invention also provides a rapid exchange aspiration catheter.
  • the catheter provides a proximal seal against guide catheter inner lumen so that aspiration may be applied through the guide taking advantage of the large proximal lumen.
  • the catheter having deliverability advantages of minimal frictional engagement with guide or microcatheter proximal of exit port.
  • a removable microcatheter hub that enables physician to advance a DAC over the microcatheter after the microcatheter (and thrombectomy device) are already in position (as bail, out for example).
  • FIGS. 1 and 2 a - 2 f illustrate a clot receptor device and system according to the invention
  • FIGS. 3 to 5, 6 a , 6 b , 7 a , 7 b , 8 a , 8 b , and 9 illustrate various alternative clot receptors
  • FIGS. 10 and 11 a - 11 d illustrate a rapid exchange aspiration catheter according to the invention
  • FIGS. 12 a , 12 b , and 13 a -13 l illustrate various proximal and distal seals
  • FIGS. 14 to 21, 22 a , 22 b , 23 a - 23 d , 24 - 33 , 34 a , 34 b , 35 , 36 a , 36 b , 37 a , and 37 b illustrate various alternative distal ends and expansile tips of a clot collector device of the invention
  • FIG. 38 illustrates an alternative rapid exchange configuration
  • FIGS. 39 to 46 illustrate a removable microcatheter hub according to the invention
  • FIGS. 47 to 51 illustrate the creation of the distal segment with a continuous and smooth stiffness profile
  • FIGS. 52 to 55 illustrate a dual lumen aspiration catheter according to the invention
  • FIGS. 56 to 59 illustrate a clot receptor device and system according to the invention
  • FIG. 60 illustrates a clot receptor device according to the invention
  • FIGS. 61 a -61 c illustrate a clot receptor device and system according to the invention
  • FIG. 62 illustrates a portion of a clot receptor device and system according to the invention
  • FIGS. 64 a -64 d illustrates an expansile tip of a clot collector device of the invention
  • FIG. 65 illustrates a rapid exchange aspiration catheter according to the invention
  • FIGS. 66 a -66 e illustrate a clot retrieval catheter with expansile radiopaque tip according to the invention
  • FIGS. 67 a -67 c illustrate a rapid exchange clot retrieval catheter according to the invention
  • FIGS. 68 a and 68 b illustrate aspiration catheter clot receptor devices and associated systems according to the invention
  • FIGS. 69 a -69 d illustrate a rapid exchange catheter device and system according to the invention
  • FIGS. 70 a -70 c illustrate an actuated expansile tip catheter device and system according to the invention
  • FIGS. 71 a and 71 b illustrate an expansile tip aspiration catheter with inner tip features according to the invention
  • FIGS. 72 a and 72 b illustrate a multi-point aspiration catheter according to the invention
  • FIGS. 73 a and 73 b illustrate a clot receptor device and system according to the invention
  • FIGS. 74 a and 74 b illustrate a dual extrusion expansile tip catheter according to the invention
  • FIGS. 75 a -75 d illustrate a method of use combining a mechanical thrombectomy device and aspiration catheter according to the invention
  • FIG. 77 is an illustration of an intermediate catheter according to the invention.
  • FIGS. 78 a and 78 b illustrate the distal tip of another catheter according to the invention.
  • FIG. 1 illustrates a clot receptor device 2 of this invention being used in the retrieval of a clot 1 from the blood vessel of a patient.
  • the clot receptor device 2 includes an elongate proximal shaft 13 and a tubular expansile distal section 4 .
  • the proximal end 5 of the expansile distal section 4 is configured to seal against the inner lumen of a distal section 6 of a catheter 7 through which it is advanced, while the distal end 8 of the expansile distal section is configured to seal against the wall of the blood vessel.
  • the proximal seal against the lumen of the intermediate catheter 7 enables an aspiration force (such as a vacuum or a negative pressure differential, as may be induced by retracting a syringe plunger or through a vacuum pump) to be transmitted through the intermediate catheter 7 to the clot receptor device 2 and thus to the clot.
  • the low profile proximal shaft 13 of the clot receptor device 2 minimizes the space occupied within the intermediate catheter 7 , maximizing the effectiveness of the transmission of this vacuum/aspiration force to and trough the clot receptor 2 .
  • the seal at the proximal end of the clot receptor 2 may be provided by the expansile body of the clot receptor 2 opposing the lumen of the intermediate catheter 7 .
  • Other embodiments of this seal include a soft cuff of a foam or fibre construction, or polymer leaves or leaflets, or a balloon cuff, or a stent-like construction with a membrane cover, or combinations of these or other designs
  • the distal end 8 of the expansile distal section 4 is configured to open to a larger diameter than the proximal end, typically at least 50% larger, and in some embodiments up to 500% larger or more, depending on the relative size of the target blood vessel and the lumen of the catheter 7 through which the device is advanced.
  • the large open mouth of the distal end 8 of the clot receptor 2 provides an easy path for retraction of clot into its interior space, and once within this space the clot can be safely retrieved from the patient.
  • the inner lumen of the clot receptor device 2 has a profiled surface (like a sharkskin, or backward facing teeth) which allows clot to slide easily into the device, but resist the clot from escaping back out of the device.
  • FIGS. 2 a to 2 f illustrate a typical method of use of such a device and system.
  • the method may include at least some of the following steps: Accessing an arterial blood vessel of a patient using conventional means such as an introducer 10 and guide catheter or sheath 11 , advancing a microcatheter 12 up to and across a target occlusive clot with the aid of a guidewire 17 , removing the guidewire 17 and advancing a mechanical thrombectomy device 15 such as a stent-retriever through the microcatheter 12 to the target clot 1 , retracting the microcatheter 12 at least a few cm to deploy a mechanical thrombectomy device 15 within the clot 1 , advancing an intermediate catheter 7 containing the clot receptor device 2 up to a position just proximal of the clot 1 (or within the clot, or considerably proximal of the clot if vessel disease or tortuosity makes access difficult), advancing the clot receptor device
  • clot 1 and mechanical thrombectomy device 15 may be desirable to withdraw the clot 1 and mechanical thrombectomy device 15 through the clot receptor 2 , intermediate catheter 7 and guide 11 and out of the patient while leaving the intermediate catheter 7 and clot receptor 2 in place.
  • This allows the physician to retain a protective seal in the vessel to prevent the escape of any clot particles that may be dislodged, and also preserves a means of quick and easy access back to the target site with a microcatheter and thrombectomy device in case additional passes are needed to completely clear the vessel.
  • Another method variant involves removing the clot receptor device 2 and thrombectomy device together through the intermediate catheter 7 , leaving the intermediate catheter 7 in place for easy re-access to the target site.
  • Yet another method variant involves using the clot receptor device 2 as the primary clot retrieval tool, without the aid of a mechanical thrombectomy device such as a stent-retriever.
  • the clot receptor 2 is configured to expand and seal against the vessel wall adjacent the proximal end of the clot, thus aspirating through the intermediate catheter 7 and clot receptor 2 provides a highly effective suction force to draw the clot into the clot receptor 2 . If the clot passes through the clot receptor 2 and into the intermediate catheter 7 it may be aspirated through the intermediate catheter 7 and right out of the patient. If the clot is too large or too firm to pass through the clot receptor 2 then the clot receptor 2 may be withdrawn into the intermediate catheter 7 . Because the clot receptor 2 has a smooth and funnel shaped exterior it can be easily retracted into the intermediate catheter 7 even when containing a bulky and/or firm clot.
  • the distal end 8 of the clot receptor device 2 is intended to open up upon exiting the catheter through which it is delivered to provide a large open mouth approximately equal in size to the inner diameter of the vessel in which it is located and provide a seal against this vessel or significant flow restriction such that when a suction force is applied through the clot receptor 2 this force causes blood and clot distal of the receptor 2 to flow into the receptor 2 rather than blood proximal of the receptor 2 .
  • This flow occurs because the pressure inside the clot receptor 2 is lower than that outside (distal and proximal) of the clot receptor 2 . If the seal were not present two flow paths into the clot receptor 2 would exist and the less restricted proximal flow path would dominate, reducing the effectiveness of the clot retraction.
  • the clot receptor 2 In order to adequately seal against the vessel wall the clot receptor 2 should have either a) a high radial force or hoop strength so that the pressure gradient created by the application of suction/aspiration does not collapse the clot receptor or create a flow path past it or b) a seal construction such that the presence of a pressure gradient across the clot receptor 2 serves to tighten the seal rather than reduce it.
  • the geometry and construction of the clot receptor sealing end should be such that it can conform well to the vessel wall, which may be not be effectively circular (such as when close to bifurcations for example, or when inclined at an angle to the vessel wall).
  • the distal portion of a clot receptor may comprise a self-expanding frame with a relatively non-porous cover, such that the cover prevents any significant passage of blood through the wall of the clot receptor, and the self-expanding frame has sufficient radial or hoop strength to resist the pressure gradient created by the application of suction/aspiration.
  • the cover may be a polymeric membrane, or may be a woven or braided or knitted structure.
  • the membrane is a polymer membrane, preferably with a high elastic strain limit and a low modulus to permit its expansion by a low radial force frame structure.
  • a preferred membrane is a polyurethane membrane, which might be extruded or blow moulded or ideally dip coated directly onto the frame.
  • the membrane may be coated with a low friction coating such as a hydrophobic silicone or a hydrophilic material.
  • the membrane is a hydrophilic material itself, having a hydrogel with sufficient thickness and modulus to retain its structure under the force of aspiration.
  • suitable materials for this cover include PTFE, ETFE and PFA. Materials such as PET, UHMWPE, PET and PEN would be particularly suitable for use in the making of a cover that is woven, braided, knitted or otherwise formed from fibres
  • distal portion of a clot receptor may comprise a combination of a self-expanding frame with a relatively non-porous membrane cover, and a plurality of flexible leaflets or vanes disposed around its outer circumference in a manner similar to that of a leaflet valve.
  • additional seal provided by these flexible leaflets is instead provided by an outer cuff, and this outer cuff may comprise a compressible material such as a foam or a hydrogel or a fibre bundle or a shaped polymer.
  • the expansion of the distal end of the clot receptor may be actuatable by the user, by retraction of a pull wire within the device shaft for example, or by inflation of a balloon cuff.
  • FIGS. 3 to 9 Some of the various embodiments of the distal end of the clot receptor are illustrated in FIGS. 3 to 9 .
  • FIG. 3 depicts one embodiment of the distal end of the clot receptor having a stent-like self-expanding frame 25 with an outer membrane covering 27 .
  • a proximal shaft 21 is connected to the frame and membrane at a proximal entry port 20 .
  • the proximal end 24 of the expansile section is configured to gently appose the wall of a catheter through which it is delivered, while the distal end 23 is configured to expand and appose the vessel wall, creating a large opening 22 into the internal reception space.
  • FIGS. 4 and 5 depict a typical embodiment of the distal end of the clot receptor.
  • FIG. 4 shows a clot receptor 30 housed in an outer intermediate catheter 31 , positioned in a vessel 32 .
  • the distal end 35 of the clot receptor is folded to wrap it into a suitable profile to fit into the lumen of the intermediate catheter 31 .
  • FIG. 5 shows the deployed clot receptor upon retraction of the intermediate catheter 31 , such that distal end 35 has expanded and is contacting the vessel wall 32 , and proximal end 34 is sealing against the inner lumen of the intermediate catheter 31 .
  • the distal end 35 expands to a smaller diameter than that of the vessel, but a larger diameter than that of the intermediate catheter.
  • the intermediate catheter inner lumen may be as small as 0.75 mm or as large as 2.0 mm, but is preferably between 1.0 mm and 1.7 mm.
  • the clot receptor distal end may be configured to expand to a diameter equal to or slightly larger than the target vessel in order to provide a seal, or to a diameter slightly smaller than the target vessel in cases where a low profile, deliverable device is a higher priority than a perfect seal.
  • the clot receptor distal end is configured to expand to a diameter of between 2 mm and 4 mm.
  • the clot receptor distal end is configured to expand to a diameter of between 4 mm and 7 mm.
  • FIGS. 6 a and 6 b illustrate the collapsed (for delivery) and expanded forms of the distal end of a clot receptor 40 of this invention.
  • the mechanism of collapse for delivery through an intermediate catheter is a creasing and folding mechanism, similar to that used to wrap angioplasty balloons.
  • the material of the distal expansile end 42 is configured into pleats or folds 41 to wrap it efficiently into delivery form.
  • FIGS. 7 a and 7 b illustrate the collapsed (for delivery) and expanded forms of the distal end of a clot receptor 50 of this invention.
  • the mechanism of collapse for delivery through an intermediate catheter is a rolling mechanism, with an unrolling mechanism taking place for expansion.
  • the distal expansile end 52 exists in its minimum strain state when fully expanded as shown in FIG. 7 b . It is configured with a seam 51 running from its distal most end to a point distal of its proximal end. The seam allows the self-expanding clot receptor to be rolled up like a cigarette paper to assume a lower profile shape for delivery.
  • FIGS. 8 a and 8 b illustrate the collapsed (for delivery) and expanded forms of a frame 60 of the distal end of a clot receptor of this invention.
  • This frame may be formed from Nitinol or another material with a sufficient elastic strain limit such that this limit is not exceeded when the device is collapsed for delivery through an intermediate catheter.
  • the frame is laser cut from a Nitinol tube or sheet, and includes struts 61 connected at crowns 62 .
  • the distal end of the frame includes terminal crowns 63 , which may be formed with atraumatic ends of a higher radius of curvature than that used for the more proximal crowns.
  • the frame may be covered with a polymeric membrane as described earlier.
  • FIG. 9 illustrates the expanded form of a frame 70 of the distal end of a clot receptor of this invention, which is similar to frame 60 of FIG. 8 but is formed from wires 73 rather than cut from a tube or sheet.
  • a frame 70 of the distal end of a clot receptor of this invention which is similar to frame 60 of FIG. 8 but is formed from wires 73 rather than cut from a tube or sheet.
  • non superelastic materials such as SS, MP35N or other materials commonly used in the manufacture of balloon expandable stents
  • the wires form crowns 71 of a large and gentle radius at the distal end of the frame, rendering the tip of the device atraumatic to a blood vessel.
  • FIGS. 10 and 11 there is illustrated an aspiration catheter 101 according to the invention.
  • the aspiration catheter 101 is illustrated as part of a clot retrieval system for retrieval of a clot 110 .
  • the clot retrieval system further includes a clot engaging device 100 , a microcatheter 109 through which the clot engaging device is delivered and a guide catheter 108 through which the aspiration catheter 100 and microcatheter 109 are delivered.
  • the aspiration catheter 101 includes a distal segment 90 and a proximal segment 91 .
  • the distal segment 90 includes a distal end provided with a distal tip 112 and a proximal end provided by a transfer port 105 .
  • a lumen of the distal segment 90 extends proximal of the distal end 112 and terminates at the transfer port 105 .
  • the proximal segment 91 extends from the distal segment 90 and in this case is provided by a proximal shaft 106 .
  • a flow restrictor 102 is located on the outer surface of the aspiration catheter 101 distal of the transfer port 105 .
  • the aspiration catheter 101 provides a proximal seal 102 against a guide catheter inner lumen 103 so that aspiration may be applied through the guide catheter 108 and thus take advantage of a large proximal lumen.
  • FIG. 10 shows a simplified view of a distal region of the system, illustrating more clearly how the aspiration catheter flow restrictor 102 interacts with the inner lumen of the guide catheter 108 .
  • the guide catheter 108 may also have a flow restrictor component such as the inflatable balloon portion 104 shown in this illustration.
  • the aspiration catheter 101 is a rapid exchange (RX) catheter in which the exit port 105 defines a transfer port for aspiration and provides a deliverability advantage of minimal frictional engagement with the guide catheter 108 proximal of the exit port 105 .
  • RX rapid exchange
  • a microcatheter 109 may be provided through which a clot capture device 100 is delivered. Retracting the microcatheter 109 just proximal of the exit port 105 (rather than completely removing it) creates large aspiration advantage.
  • microcatheter 109 and the Rx aspiration catheter 101 are introduced together into the guide catheter 108 .
  • the guide wire and microcatheter 109 are then advanced across the clot 110 .
  • the guidewire can be removed and a clot retrieval device such as a stent retriever device 100 is introduced.
  • the Rx aspiration catheter 101 can be forwarded to a position proximal to the clot 110 by pushing the proximal shaft 106 or handle into the guide catheter 108 .
  • the stentriever device 100 can be deployed by retracting the micro catheter 109 .
  • the Rx aspiration catheter 101 can then be forwarded to contact the clot 110 or be positioned just proximal to or at the proximal face of the clot 110 .
  • the microcatheter 109 can then be retracted sufficiently to be proximal of the Rx port 105 of the Rx aspiration catheter 101 . This facilitates an increased lumen for aspiration without the necessity of removing the microcatheter 109 fully from the intermediate/aspiration catheter.
  • Aspiration can be applied to the lumen of the guide catheter 108 with a manual syringe 111 or vacuum pump.
  • This aspiration is directed to and effective at the distal tip 12 of the Rx aspiration catheter 101 due to the presence of the flow restrictor or seal 102 between the outer surface of the Rx aspiration catheter 101 and the inner guide catheter 108 .
  • This seal seals the lumen between the outside of the Rx aspiration catheter 101 and the inner lumen 103 of the guide catheter 108 and prevents backflow of blood into the tip of the guide catheter 108 which would reduce the effectiveness of the aspiration.
  • the seal 102 may not need to stop flow in the lumen completely but needs to restrict flow sufficiently so as not to have a significant effect on aspiration performance.
  • This seal 102 can be generated in a number of ways such as those described in FIGS. 12 to 131 . In some cases the seal 102 is located on the inside surface of the guide catheter 108 and/or on the outside surface of the aspiration catheter 101
  • the Rx aspiration catheter 101 is constructed of a proximal handle (not shown) to facilitate grip and a proximal shaft 106 constructed from a wire or tube formed preferably from Nitinol, stainless steel, PEEK or some other similar material.
  • An additional seal may be provided on a proximal haemostasis valve to assist in sealing against the proximal shaft 106 .
  • the material of the shaft 106 has high compressive and tensile strength and may have a low friction coating or jacket to minimise insertion and retraction forces.
  • the low friction coating or jacket could be formed from PTFE, HDPE or a similar material.
  • the Rx exit port 105 on the aspiration catheter 101 can facilitate forwarding a microcatheter 109 through the port 105 and through the distal section 90 of the Rx catheter 101 prior to insertion into the guide catheter 108 .
  • the Rx exit port 105 may be formed in a funnel shape to make it easier to forward a microcatheter 109 into the port even in position in the guide catheter 108 .
  • the port 105 may be formed from a moulded component or from the tubing of the distal section 90 of the catheter 101 .
  • the distal section of the Rx aspiration catheter 101 has good push and trackability characteristics to allow it to be forwarded to the target location. Therefore it may be constructed of one or more materials to give a reducing stiffness profile along the length. A braided wire or coil wire construction or combination of both may be used to improve compressive strength and track ability. Linear wire supports running parallel to the tube axis may also be used.
  • a top layer of low friction material may be applied to the distal section of the catheter 101 or alternatively a hydrophilic coating or silicon oil coating may be applied to the surface.
  • the inner lining of the distal section of the catheter 101 consists of PTFE or similar low friction material to minimise insertion and retraction forces.
  • the seal 102 on the outer surface of the Rx aspiration catheter 101 distal section 90 prevents or significantly reduces blood flow travelling from the guide catheter distal tip 113 to the Rx port 105 of the Rx aspiration catheter 101 as shown in FIG. 12 a .
  • Various embodiments of proximal seals 102 are illustrated in FIGS. 12 to 131 .
  • an additional seal 114 is provided on the distal end of the catheter 101 to seal between the Rx catheter and the target vessel.
  • This seal 114 is spaced distally from the proximal flow restrictor 102 and occludes blood flow in the vessel and improves aspiration effectiveness without the need for a balloon guide catheter.
  • the seal 114 can be constructed in a similar manner to those shown in FIGS. 12 a to 131 .
  • the seal 102 can be formed from an outer sleeve on the catheter which may be smooth or have a grooved or profiled surface 116 as shown in FIG. 13 a .
  • FIG. 13 j shows a profiled surface with a spiral groove 125 .
  • the seal could also be formed from one or more moulded rings with a sealing lip or “0” ring profile 117 as shown in FIG. 13 b . It could also be formed from an inflatable balloon 115 which is inflated by injecting saline through a lumen in the shaft and catheter as shown in FIGS. 12 a , 12 b and 13 g.
  • the seal 102 can be constructed of fibres in a brush/bristle configuration 119 or from a fibre mesh 123 formed of PET fibres or similar material as shown in FIG. 13 h .
  • the seal could be formed of a sponge material 121 which is compressed when inserted into the lumen of the guide catheter 108 as shown in FIG. 13 f.
  • the seal 102 could be provided by a body 124 formed from a hydrophilic 124 or similar material which swells and increases in diameter when in contact with saline or blood.
  • the seal 102 may also be formed by having a close tolerance clearance fit between the outer diameter of the distal end of the Rx aspiration catheter 101 and the inner diameter of the guide catheter 103 .
  • the seal 102 is formed from a lip 118 or membrane 120 which restricts flow particularly in one direction as shown in FIGS. 13 c and 13 e.
  • the occlusion between the Rx aspiration catheter 101 and the guide catheter 108 is achieved through longitudinal compression of the aspiration catheter 101 .
  • This can be achieved by having an expansile section 127 which increases in diameter when the catheter is under compression.
  • the compression can be a result of retrieving clot 110 and the stentriever device 100 into the tip 112 or may be manually actuated through a pull wire 126 .
  • This pull wire 126 may run through a separate lumen from the proximal end of the device as shown in the cross sectional view A-A in FIG. 13 l.
  • the clot 110 and stentriever type device 100 can be fully or partially retrieved into the Rx aspiration catheter 101 as controlled by the physician and depending on the resistance felt by the user or clot obstruction of the lumen as indicated by an increase in vacuum/loss of suction.
  • the expansile tip 112 of the Rx aspiration catheter 101 facilitates aspiration and retrieval of the clot 110 and stentriever device 100 by expanding under load to reduce the retraction force and lessen the risk of scraping clot off the surface of the stentriever device 100 .
  • the expansile tip 112 can also partially or fully occlude the vessel providing flow arrest improving aspiration effectiveness.
  • the expansile tip 112 can be formed in a number of ways and various embodiments are shown in FIGS. 14 to 37 .
  • the expansile tip 112 can be formed from a co-extrusion of materials with different properties such as a soft expansile polymer 131 co-extruded with a higher modulus polymer 130 to provide longitudinal support. A fully expansile ring 132 could then be connected to this tip as shown in FIG. 14 .
  • the tip 112 may also include one or multiple metallic wire supports 133 as shown in FIGS. 15 and 24 .
  • the tip has a skived profile to increase contact area with the clot during retrieval or aspiration.
  • the tip may be formed with holes 134 or perforations 137 to allow it to split and change shape when a device 100 and clot 110 is retracted into the tip as shown in FIGS. 16 and 17 .
  • These support materials may be embedded within the wall of the tubing or may be on the inner or outer surface. They may also be formed in a spline, coil, stripe, “U” shape or other configuration to provide longitudinal support to the expansile material to prevent it collapsing or buckling under compressive load, such as occurs during retrieval of a clot or stentriever device, or during insertion through a guide or access catheter.
  • FIG. 19 shows another embodiment where multiple holes 139 produce a lattice or framework in the tip.
  • Single or multiple protrusions or “teeth” 141 may also be applied to the inner surface 142 at the distal tip to improve grip on the clot as shown in FIG. 20 .
  • the expansile tip may be pre shaped to form a flared profile ( FIG. 22 a ) or a tapered profile as shown in FIG. 22 b .
  • the tip shape may be a combination of these profiles such as bulbous or ‘pear’ shaped as shown in FIGS. 23 a to 23 d .
  • the tip 160 has an increased diameter larger than the proximal catheter diameter 161 which then tapers to a reduced diameter 162 for ease of insertion.
  • the tip 166 has an increased diameter larger than the proximal catheter diameter 161 which then tapers to a reduced diameter 167 , however the reduced diameter 167 is still larger than the proximal catheter diameter 161 .
  • This tip configuration provides benefits of improved aspiration effectiveness and reduced retrieval force but also low insertion force and trackability benefits due to the distal tip radius or taper 167 .
  • the tip radius 167 also prevents the tip snagging on a bifurcation on insertion, such as at the ostium of the ophthalmic artery in the internal carotid artery.
  • FIG. 23 c shows how the tip 160 elongates during insertion through a guide or access catheter 108
  • FIG. 23 d shows the tip 160 expanding to accommodate the retrieval of a clot 110 and stentriever device 100 .
  • the profiled tips can also be constructed using multiple materials of varying durometer and expansile characteristics.
  • the expansile tip 112 could also be profiled and contain one or more slot cuts 170 to facilitate expansion as shown in FIGS. 26, 29 and 30 .
  • Other embodiments of profiled tips to facilitate expansion and retrieval of the clot 110 and stentriever device 100 are shown in FIGS. 27 and 28 .
  • the distal end of the tip has a collar 171 which tracks closely over the guidewire. This helps direct the catheter over the guidewire to the target location reducing the risk of snagging.
  • the tip configuration shown in FIG. 32 has a flattened section 173 which contains a large number of aspiration pores 174 , and aspiration windows 172 . This design potentially increases the contact area with the clot improving grip where the catheter is used without a stentriever device.
  • FIG. 33 shows an end view of FIG. 32 with the arrows indicating the direction of blood flow.
  • the tip 184 is constructed so that it can invert as the stentriever device 100 and clot 110 are retrieved into the catheter. This can reduce the retraction force and constrain the clot so fragments are not released during the retrieval process.
  • FIG. 36 b shows the tip after inversion.
  • FIGS. 37 a and 37 b there is illustrated a clot retrieval catheter with a self-expanding distal tip 190 that is constrained by a tapered cap 191 for ease of deliver and atraumatic access to a target site.
  • the cap component 191 can be retracted to allow the catheter mouth 192 to expand, creating a large opening to accept clot or other material into its lumen.
  • the cap component 191 has a distal end whose outer diameter is ideally lower than that of the catheter shaft immediately proximal of the cap, and an inner lumen sized to enable the device to be advanced over a thrombectomy device shaft and microcatheter.
  • the cap component 191 may also comprise a guide tube 193 to aid the device in moving smoothly over a thrombectomy device shaft or microcatheter.
  • the distal section of the catheter 194 is shortened so that distance X is typically between 5 and 50 mm long.
  • This device can be forwarded over the shaft of the stentriever device 100 to the target location to facilitate partial or full retrieval of the stentriever 100 into the expansile tip 112 .
  • the distal section 194 is forwarded out of the guide catheter 108 and does not translate aspiration to the distal tip 112 , but has improved trackability and access performance to reach the target vessels due to reduced friction and pushability of the wire shaft.
  • the short length distal section 194 and tip 112 are connected to a shaft 106 constructed from a wire or tube formed preferably from Nitinol, stainless steel, PEEK or some other similar material.
  • the shaft material has high compressive and tensile strength and has a low friction coating or jacket to minimise insertion and retraction forces.
  • the expansile tip 112 can be constructed in a similar manner to those shown in FIGS. 14 to 37 .
  • the Rx aspiration catheter 101 , microcatheter 109 , stentriever device 100 and clot 110 can be retracted as a unit back to the tip of the guide catheter 113 and then fully into the guide catheter 108 .
  • the guide or access catheter 108 may also have an expansile tip 113 to facilitate retraction of the devices and clot, with a reduced force and lower risk of dislodging the clot from the devices.
  • This expansile tip 113 on the guide catheter may be constructed in a similar manner to those shown in FIGS. 14 to 37 .
  • the expansile tip 112 construction and seal 102 construction shown in FIGS. 12 to 37 may also be applied to a standard length intermediate or aspiration catheter.
  • the Rx aspiration catheter 101 , microcatheter 109 , stentriever device 100 and clot 110 can then be retrieved from the guide catheter 108 and removed fully from the patient.
  • FIGS. 39 to 46 there is illustrated a removable microcatheter hub according to the invention.
  • the removable hub enables a physician to advance an intermediate or access catheter over the microcatheter after the microcatheter (and thrombectomy device) are already in position (as bail out for example). It is not possible with a standard microcatheter to forward an intermediate or access catheter over the proximal end as the fixed hub is in the way, therefore the standard microcatheter has to be removed to introduce an intermediate catheter.
  • microcatheter with a removable hub that facilitates the use of an extension wire facilitates improved control on the microcatheter position as the intermediate catheter is introduced.
  • FIGS. 39 to 46 the following numerals are used:
  • FIG. 39 shows the microcatheter hub 300 assembled with the microcatheter shaft 301 .
  • FIG. 40 shows the microcatheter shaft after detachment and
  • FIG. 41 shows the mating end of the extendable shaft 305 .
  • FIG. 42 illustrates the construction of the microcatheter connector 307 and detachable hub 300 .
  • the detachable hub 300 can be screwed onto the microcatheter connector 307 due to thread 309 on the connector and the mating thread 306 on the hub. ‘0’ ring 308 prevents any blood loss or air ingress between the connector 307 and the hub 300 when tightened.
  • FIG. 43 shows a section view of an embodiment of the extendable shaft 305 which utilises an extension wire 313 a and extension wire hub 313 b .
  • the extension wire 313 a and hub 313 b are shown screwed onto the microcatheter shaft 301 and connector 307 .
  • FIGS. 44 to 46 show another embodiment of a detachable hub where the microcatheter shaft 301 is connected to the detachable hub 317 by a compressible ‘0’ ring 316 .
  • the ‘0’ ring 316 sits in a groove on the moulded hub 320 which is connected to the microcatheter shaft 301 .
  • the ‘0’ ring is compressed by rotating part of the housing 321 on the detachable hub 317 .
  • the extension tube 318 can be pushed over the moulded hub 320 on the microcatheter shaft 301 after the hub 317 has been removed.
  • the extension tube 318 is then held in position by the spring clip 319 engaging with the groove on the moulded hub 320 .
  • FIGS. 47 to 50 illustrate a method of manufacture of a large diameter aspiration catheter.
  • the aspiration catheter is highly trackable so that it can be navigated to tortuous/distal cerebrovascular location.
  • FIG. 47 is a graph of lateral stiffness with distance from the tip.
  • FIG. 48 illustrated a conventional diagram in which different tubular segments 200 , 201 , 202 , 203 , 204 are of different materials.
  • the segments are used to create a stepped material stiffness profile (gradually increasing modulus/share hardness).
  • FIG. 49 illustrates a distal segment according to the invention in which a smooth stiffness profile is created by blending elements 205 , 206 of different modulus.
  • tapered tubes 205 , 206 FIGS. 50, 51
  • the resultant tube may then be applied to a threaded or spiral wire or unreinforced base, or use as a stand-alone catheter.
  • FIGS. 52 to 55 there is illustrated a dual lumen aspiration catheter to aid with aspiration and prevent the lumen of the catheter getting blocked with clot.
  • Lumen A small diameter lumen can be used to retrieve the device into and cause the clot to shear off.
  • the distal end of Lumen A could be flush with or recessed from the distal tip of Lumen B.
  • Lumen B the larger lumen would have aspiration constantly applied to it, to aspirate the clot that is sheared off the device when it is retrieved into the smaller lumen (Lumen A).
  • the smaller lumen A may have an inner diameter to facilitate the introduction of a microcatheter through the lumen.
  • the microcatheter can then be inserted through this lumen and across the clot as per standard procedure.
  • the stentriever device can then be deployed across the clot. Retrieving the stentriever and clot into the catheter causes the clot to be sheared off the stentriever within the aspiration catheter. This configuration prevents the clot snagging on the struts of the stentriever device and blocking the aspiration lumen.
  • the larger diameter lumen may have a diameter of about 0.058 inch and may have aspiration applied to it to aspirate the clot as the device is being retrieved into the smaller diameter lumen.
  • the clot receptor tip is expanded by means of a balloon, which may be attached to the shaft of a thrombectomy device, or to a microcatheter, or may be integral to the clot receptor catheter itself.
  • the device includes a thrombectomy device 400 with an inflation lumen 402 extending from the proximal end of the shaft to a balloon 401 at the distal end of the shaft, and a clot receptor catheter 404 with a flexible expandable distal section 405 .
  • the thrombectomy device 400 is expanded in the clot 403 . Either the thrombectomy device and clot are then retrieved towards the clot receptor catheter 404 or the clot receptor catheter is advanced towards the thrombectomy device.
  • the balloon 401 at the distal end of the device is positioned so that the distal end is in line with the distal end of an intermediate catheter.
  • the balloon is expanded to plastically deform 406 the distal end of the clot receptor catheter and then deflated.
  • the resultant open mouth 407 of the clot receptor catheter allows the entire device and clot to be retrieved into the intermediate catheter. This prevents loss of clot on retrieval into a small lumen of a conventional intermediate catheter.
  • the expansile distal portion 405 of the clot receptor catheter may be formed of a polymeric material with a low modulus and a high elongation strain to break of greater than 100%, and ideally greater than 300%. It may also comprise a support structure of a metallic material such as stainless steel which can be plastically deformed by the balloon and can then retain its deformed shape with sufficient integrity to accept the thrombectomy device and clot.
  • the balloon expandable tip of the invention can be applied to any catheter—standard or rapid exchange, and can be used with or without a thrombectomy device to aid in the aspiration and/or retrieval of clot from blood vessels.
  • FIG. 60 illustrates an RX clot removal catheter 500 .
  • This device 500 is very similar in design and in use to that shown in FIGS. 11 a - d , except that the element 504 is an actuatable flow restrictor or seal, which can be selectively engaged or disengaged by the operator.
  • the catheter 500 includes a proximal elongate shaft 501 and a distal generally tubular portion 502 .
  • the distal portion 502 includes reinforcement member 507 and a polymeric cover member 510 , and extends from an entry/exit port 517 to a distal clot reception tip 503 .
  • the cover member 510 may comprise multiple layers and segments.
  • a low friction inner layer may be employed as a lining for the lumen of the tubular section, a highly compliant membrane 506 may be employed to cover the actuatable flow restrictor/seal region, and a low modulus polymer may be employed to cover the main tubular body.
  • the distal end or tip 503 may comprise any of the designs shown elsewhere in this document.
  • the tip 503 is connected to the distal end of the tubular portion 502 by a hinge element 511 .
  • This hinge element may simply be a short region of the tubular section configured to have a high degree of lateral flexibility relative to the rest of the tubular section. This flexibility may be achieved by having a short region of the tubular section without any reinforcement element 507 , or alternatively the reinforcement at that region could be a highly flexible reinforcement such as a generally spiral metallic coil.
  • the actuatable flow restrictor or seal 504 includes a framework 508 , with a membrane covering 506 .
  • the framework 508 is at least partially collapsible by retraction of actuation member 512 , which runs through proximal elongate shaft 501 and is connected at its proximal end to slider element 514 , which is in turn slidably constrained within handle 513 , and coupled to spring element 515 .
  • Proximal elongate shaft 501 may comprise a tube of stainless steel, Nitinol or other metallic or high modulus polymeric material, and may contain a liner in order to provide a low friction internal surface against which the actuation member 512 may slide.
  • the shaft 501 may be tapered or may be slotted in order to provide a smooth transition in stiffness over its length.
  • a portion of the shaft material has been removed from the distal portion 516 of shaft 501 in order to provide an exit port for actuation member 512 and to provide a connection member to the proximal end of tubular portion 502 .
  • This distal portion 516 may also be flattened, which may assist in creating a similar curvature to that of the tubular portion 502 so that the two portions can be smoothly joined together by welding, soldering, bonding or other appropriate method of fixation.
  • the main body of the shaft may also have an oval or somewhat flattened profile, as this may be beneficial in allowing the user to seal a hemostasis valve around the shaft and a microcatheter when the two are side by side in the guide/sheath as shown previously in FIG. 11 a.
  • the reinforcement member 507 may be formed from a metal (such as stainless steel or Nitinol or MP35N or other suitable alloy) or from a high modulus polymer material.
  • the reinforcement is formed from a tube from which sections 509 have been cut away to add lateral flexibility while maintaining column and hoop strength.
  • the actuatable seal 504 is located adjacent to the proximal end of the distal tubular section, where it also forms the exit/entry port to the proximal end of the distal tubular section 502 , but it could be positioned more distally in other variants of the invention.
  • the seal can be actuated to effect a seal between the proximal portion of the tubular section of the RX clot removal catheter and the inner lumen of the guide catheter.
  • a vacuum force can then be applied to the proximal end of the guide catheter using a syringe or pump.
  • This vacuum force will create a low pressure region inside the guide catheter which will extend (via the seal) into the distal tubular portion of the RX clot removal catheter. This low pressure will create a pressure gradient at the tip of RX clot removal catheter which will encourage the flow of clot into the catheter.
  • pressure gradient between the blood in the cerebral vasculature and the fluid within the guide catheter lumen causes a flow of the blood from the high pressure region to the low pressure region.
  • the seal as shown can also serve to create a guiding feature to assist the advancement of another device into the tubular distal section of the clot removal catheter. This might be advantageous if for example the catheter was used as a primary clot debulking tool—so that it was advanced to a target clot and aspiration was applied to it through the guide catheter to remove the occlusive clot but was not successful in removing all of the clot.
  • a microcatheter (and guidewire if desired) could be advanced through the RX clot removal catheter and across the remaining clot so that a thrombectomy device could then be advanced through the microcatheter.
  • the thrombectomy device and remaining clot could then be withdrawn into the RX clot removal catheter (under aspiration if desired) to complete the recanalization of the patient's vessel.
  • FIGS. 61 a -61 c illustrate a method of use of the RX clot removal catheter 500 .
  • This catheter can be used in a similar manner and for a similar purpose to catheter 101 illustrated previously in FIGS. 10 and 11 , except that the seal/flow restrictor of catheter 500 can be selectively activated or deactivated by the user.
  • the catheter can be used as the primary clot retrieval device as shown in FIGS. 61 a - c , or as an adjunctive device as shown in FIGS. 11 a - d .
  • FIG. 61 a shows the catheter 500 advanced through a guide catheter 550 towards a target clot 555 located in blood vessel 554 .
  • the catheter 550 has an external flow restrictor in the form of a balloon at its distal end.
  • the method of use of such a system could entail: Accessing the patient's vasculature using standard methods, advancing a guiding catheter or sheath 550 to a region proximal of the target occlusive clot 555 , advancing the RX clot removal catheter 500 through the guide/sheath to a location proximal or adjacent to or within the target clot as shown in FIG.
  • proximal flow restrictor/seal 504 of the catheter 500 activating the proximal flow restrictor/seal 504 of the catheter 500 to connect the lumens of the two catheters, inflating the external balloon (if present and if desired) at the end of the guide/sheath, aspirating using a syringe 556 or vacuum pump (not shown) through the a connector 551 attached to the proximal end of the guide/sheath 550 so that a pressure gradient is created which sucks blood and clot into the mouth 503 of the Rx clot removal catheter 500 and through the catheter 500 and the guide/sheath 550 and into the syringe as shown in FIG.
  • the flow restrictor/seal 504 may be deactivated so as to enable a vacuum force applied by the syringe to the guide/sheath to be transmitted to the distal end 553 of the guide/sheath and thus create flow reversal and draw blood and any clot fragments 557 back into the tip of the guide/sheath as the captured clot is retracted.
  • FIG. 62 depicts another system of this invention which functions in a similar manner to the previously described Rx catheter systems, but in this case the flow restrictor or seal between the inside of the guide/sheath 600 and the outside of the Rx catheter 603 is created by a sealing element 602 attached to the inside of the guide/sheath 600 .
  • This sealing element 602 may comprise an inflatable balloon, similar to the external flow restricting balloon 601 shown on the outside of the guide/sheath.
  • FIG. 63 depicts another system of this invention in which an Rx clot retrieval catheter 650 has two flow restrictor/seal elements 651 and 652 .
  • the more proximal restrictor 651 is used to restrict flow between the Rx catheter 650 and the guide catheter 655 within which it is positioned, while the more distal restrictor 652 is used to create a flow restriction within vessel 656 .
  • the combination of these two flow restrictors means that a vacuum or negative pressure can be applied to the proximal end of guide catheter 655 and transmitted to the distal end of Rx catheter 650 in such a way that any blood aspirated into the mouth of Rx catheter 650 is not supplied from the body of blood proximal to seal 652 in vessel 656 .
  • This system enables a physician to use a standard guide or sheath to rapidly create an access path to the region of the target occlusion, and then use the Rx catheter 650 to quickly access and aspirate the target clot from the vessel.
  • This system provides a major advantage in the speed and ease with which a physician will be able to access and retrieve the clot.
  • the provision of the distal vessel seal 652 on the Rx catheter rather than on the guide or sheath means that this seal can be placed more distally in the vasculature, past the petris portion of the carotid vasculature when used in the ICA for example, which means less likelihood of vessel collapse when a suction force is applied, and less likelihood of vessel spasm.
  • the flow restrictors/seals are actuatable and are formed from compliant balloons, which are inflated via a hollow shaft 657 by means of a syringe or inflator 653 applied to handle 654 of the Rx catheter 650 .
  • the proximal flow restrictor may be passive (i.e. it cannot be selectively activated or inactivated) as shown in several other designs in this disclosure.
  • the distal seal may be actuated by means of an actuating member rather than an inflation lumen.
  • catheter 500 of FIG. 60 have a distal generally tubular portion 502 having an inner lumen which starts with an opening or entry/exit port 517 and ends in a distal tip or mouth 503 into which clot is received. They have a proximal elongate shaft 501 which is connected at its distal end to the entry/exit port 517 and at its proximal end in some embodiments to a handle 513 .
  • the preferred geometry of these catheters depends on the target clot location.
  • the distal tubular portion 502 is preferably greater than 10 cm (so that it can extend from within the distal end of a guide/sheath which may be located in an internal carotid artery or a vertebral artery, right up to the proximal face of a target clot), and less than 40 cm so that the minimum possible length of tubular portion 502 is located within the lumen of the guide/sheath, thus maximizing the internal volume of the combined guide/Rx catheter system for optimum aspiration efficacy).
  • the optimal internal and external diameters of the Rx catheter depends very much on the site of the target clot and the size of the guide catheter or sheath through which the catheter is to be advanced. In the case of retrieval of occlusive clots from cerebral vessels the likely vessel diameters range from approximately 1.5 mm up to 6 mm, with 3 mm being a very typical diameter.
  • Guide catheters/sheaths used in these scenarios have typically an internal diameter of between 0.060′′ and 0.095′′, so that a suitable system might consist of a guide catheter with an internal diameter of 0.078′′ and an Rx clot retrieval catheter whose distal tubular section has an outside diameter of 0.070′′ and an inside diameter of 0.062′′.
  • Such a system provides a very significant benefit in terms of flow resistance over an equivalently sized conventional combination of a guide and intermediate/aspiration (not rapid exchange) catheter.
  • the effective proximal lumen of the system of this invention is that of the guide catheter (0.078′′), while the effective proximal lumen of the conventional system would be that of the intermediate/aspiration catheter (0.062′′).
  • a conventional (not rapid exchange) intermediate/aspiration catheter may be stepped in diameter to maximise its proximal internal diameter, this proximal internal diameter must always be significantly smaller than the guide/sheath in which it is positioned. This is not the case in the system of this invention.
  • FIGS. 64 a - d depict a distal end configuration which could be employed with any of the clot retrieval catheters previously shown.
  • the catheter distal end 700 has an integrated control member 701 , which forms a loop 704 at the tip where it is connected to tip members 703 so that it acts like a draw string when pulled.
  • the tip may comprise relatively stiff members 703 interspersed with relatively compliant members 702 , so that the tip has both axial stiffness (to permit effective operation of the drawstring mechanism) and radial compliance (to allow expansion and contraction of the tip).
  • the control member when actuated by pulling as shown in FIG. 64 b , the control member causes the tip of the catheter to reduce in diameter. This can improve the ability of the catheter to track through tortuousity and across obstacles such as the origin of the ophthalmic artery.
  • control member when the control member is pushed forward it can cause or allow the catheter tip to expand forming a funnel shape as shown in FIG. 64 c . This can improve the ability of the catheter to aspirate clots and also act as a flow restrictor in the vessel.
  • control member may be pulled back during insertion of the catheter to improve accessibility. It can then be forwarded to increase the diameter of the tip and aspirate the occlusion.
  • the tip diameter can be reduced again by pulling the control member, causing the clot to be trapped as shown in FIG. 64 d , reducing the risk of the clot travelling to a new territory during retraction of the catheter and improving dislodgement.
  • the flaps 703 of the catheter tip are not rigidly connected to the integrated control member 701 but form a loop which can slide over the control member.
  • the control member distal end 706 may also be fixed to the inner surface of the catheter.
  • FIG. 65 there is illustrated an aspiration catheter 801 according to this invention in use in a thrombectomy procedure.
  • the catheter 801 is similar to catheter 101 of FIGS. 10 and 11 and provides a proximal seal 802 against a guide catheter inner lumen 803 so that aspiration applied by syringe 811 (or a pump or by other means) through guide catheter 808 (via a rotating hemostasis valve (RHV) 814 ) can be transferred through to the distal end 812 of the aspiration catheter.
  • Thrombectomy device 800 is shown deployed within clot 810 , having been delivered through microcatheter 809 by means of proximal shaft 807 .
  • the method of use of the system illustrated is very similar to that described in FIGS.
  • proximal end 815 of the microcatheter 809 and proximal end 806 of Rx aspiration catheter 801 are positioned within separate branches of a rotating hemostasis valve (RHV) 813 .
  • RHV rotating hemostasis valve
  • This configuration provides significant ease of use advantages over the configuration described in FIG. 11 .
  • the RHV 813 can be more easily sealed around the proximal shaft 806 of the aspiration catheter to prevent any air ingress (or fluid leakage) during aspiration.
  • the user has better control over the aspiration catheter 801 , microcatheter 809 and thrombectomy device 800 relative to the guide catheter 808 , and can use RHVs 813 and 814 to lock and hold the aspiration catheter or microcatheter independently of each other.
  • One embodiment of the method of use of such a system could consist of the following steps: Accessing an arterial blood vessel of a patient using conventional means such as an introducer and guide catheter 808 and/or sheath, advancing Rx aspiration catheter 801 through a first branch of RHV 813 attached to proximal end of guide catheter 808 , advancing a microcatheter 809 through a second branch of RHV 813 and through the aspiration catheter 801 and guide catheter 808 up to and across a target occlusive clot 810 with or without the aid of a guidewire, removing the guidewire (if used) and advancing a mechanical thrombectomy device 800 such as a stent-retriever through the microcatheter 809 to the target clot 810 , retracting the microcatheter 809 at least a few cm to deploy a mechanical thrombectomy device 800 within the clot 810 , advancing the aspiration catheter 801 up to a position just proximal of the
  • a possible variant of the final step of the above method could involve removing the aspiration catheter along with the clot 810 , mechanical thrombectomy device 800 and microcatheter 809 .
  • This variant is useful if a large and/or firm clot is encountered which the physician cannot (or does not wish to) fully withdraw into the mouth of the aspiration catheter. In such a situation the RHV 813 must be removed once the exit port 805 of the aspiration catheter 801 reaches the RHV 813 .
  • Rx aspiration catheter system Another method of use of such an Rx aspiration catheter system is to retrieve clot using aspiration without the use of a thrombectomy device.
  • the rapid exchange shaft of this invention provides great advantages in terms of speed, deliverability, ease of use and aspiration lumen.
  • a microcatheter or other similar catheter and guidewire nay be used to provide support to assist in tracking the aspiration catheter to the target site in a similar manner to that illustrated in either FIG. 65 or FIGS. 11 a - d.
  • FIGS. 66 a -66 e illustrate an intermediate or aspiration catheter with an expansile tip that can be delivered in a constricted form.
  • the side and end view of this device showing the tip in the collapsed configuration are shown in FIGS. 66 a and b .
  • the tip material 901 can be folded inside the lumen to facilitate expansion.
  • the expanded tip configuration of the device is shown in FIGS. 66 c and 66 d . This increased tip diameter facilitates the aspiration and removal of large clot volumes by increasing the area of the catheter tip that applies aspiration to the clot.
  • 66 e illustrates the construction/support frame of the device, which can be cut from a metal or polymer tube and covered with a thin polymer sleeve 909 (as shown in FIG. 66 b ) containing highly elastic properties.
  • This construction can give good pushability and high compressive resistance.
  • the cut pattern can contain axial connections 908 and ring members 906 , which will provide a large level of axial support, lateral flexibility and hoop strength to withstand aspiration.
  • the tip of the device can contain a section 907 proximal of the highly flexible area 905 that can expand to except clot. This potential to increase body diameter facilitates the retrieval of large volume clots in a ‘snake belly effect’ while the construction of the catheter provides good column stiffness to avoid axial collapse and still maintain good flexibility.
  • frame 904 of the expansile tip can be gold or platinum coated to improve radiopacity and allow the user to visually confirm expansion of the tip.
  • a highly flexible area 905 is located proximal of the expansile tip to allow the tip to optimally align with the clot face.
  • this device can have an outer sleeve 909 with a high elastic strain limit and a low modulus to permit its expansion by a low radial force.
  • a preferred membrane is a polyurethane membrane, which might be extruded or blow moulded or ideally dip coated directly onto the frame. The membrane may be coated internally and externally with a low friction coating such as a hydrophobic silicone or a hydrophilic material.
  • the membrane is a hydrophilic material itself, having a hydrogel with sufficient thickness and modulus to retain its structure under the force of aspiration.
  • suitable materials for this cover include PTFE, ETFE and PFA.
  • the sleeve 909 can be inserted through the inner lumen of the support structure, wrapped around the distal tip and drawn back over the exterior of the catheter to create a one piece internal and external sleeve covering. This would have many benefits within manufacturing stages and also benefit device durability as there would be no material joints at the distal tip to delaminate, it could also provide an atraumatic tip profile.
  • FIGS. 67 a -67 c illustrate a rapid exchange clot retrieval catheter 953 with an internal self-expanding feature to help expand the distal tip for improved aspiration and also provide strong clot grip.
  • the device consists of a self-expanding element 950 connected proximally to a control wire 956 which is located inside the catheter Rx shaft 955 .
  • the catheter tip 952 is normally in the collapsed configuration as shown in FIG. 67 a when the internal self-expanding element 950 is in the proximal position shown.
  • the distal end of the self-expanding assembly 950 is kept proximal of the tapered catheter tip 952 during device advancement in the vasculature until the catheter 953 is at the target location adjacent to the clot 951 . Once the catheter 953 is in position the element 950 is advanced distally into the expansile tip 952 via the control wire 956 . This action expands the catheter tip 952 to create a large open mouth receptacle that is advantageous to clot 951 aspiration due to the increased contact area of the tip.
  • the self-expanding element 950 can be constructed from a super elastic material such as Nitinol and can be constructed from Nitinol wires or from an expanded laser cut tube. In this configuration the internal self-expanding element 950 does not protrude past the distal tip of the catheter 953 at any point in the procedure.
  • FIGS. 68 a -68 b illustrate a clot retrieval aspiration or intermediate catheter with mechanical and actuatable clot gripping features.
  • FIG. 68 a illustrates a barbed tipped shaft 1001 attached to a proximal control shaft 1004 , the device is delivered to the occlusion 1003 through the catheter 1000 .
  • Aspiration is applied to anchor/pull the clot 1003 into the catheter tip, once inside/anchored to the catheter tip a mechanical barbed device feature 1001 is advanced into the aspirated clot 1003 via the connected proximal control shaft 1004 .
  • Once mechanical grip is attained the clot 1003 is pulled further into the catheter 1000 or securely anchored within the catheter tip for retrieval with catheter.
  • This device could be constructed so that the barbed device 1001 cannot protrude past the tip of the catheter and hence cannot contact the vessel wall.
  • FIG. 68 b illustrates an actuated pinch/gripper mechanism 1002 attached to a proximal control shaft 1004 , the device is delivered to the occlusion 1003 through the aspiration catheter 1000 .
  • Aspiration is applied to anchor/pull the clot 1003 into the catheter tip and once partially inside/anchored to the catheter tip an actuatable pinch/gripper device 1002 is advanced to the aspirated clot 1003 and actuated by the user to grip/pinch the clot via the connected proximal control shaft 1004 .
  • Once mechanical grip is attained the clot 1003 is pulled further into the catheter 1000 or securely anchored within the catheter tip for retrieval with the catheter.
  • FIGS. 69 a -69 c illustrate a rapid exchange catheter device 1050 and associated snare system integrated within.
  • the snare consists of a distal loop 1054 located within the RX catheter 1055 tip and attached to actuator wires 1052 .
  • the distal loop 1054 is secured at two opposing points within the tip, on one side an internal feature 1056 that causes the snare to close down in diameter when pulled proximally and on the other side the snare loop is secured by a feature 1053 that holds the snare 1054 in position whilst the catheter 1055 is being pressed against the clot face.
  • the feature 1053 allows the snare 1054 to break free once it is actuated using control wires 1052 .
  • the catheter 1050 shown is a rapid exchange (RX) catheter with an exit port 1058 that defines a transfer port for aspiration and provides a deliverability advantage of minimal frictional engagement with the guide catheter proximal of the exit port.
  • RX rapid
  • the Rx aspiration catheter can be forwarded using the proximal hypotube 1059 to contact the clot face.
  • aspiration can be applied and the clot 1060 or a portion of the clot is drawn inside the RX catheter tip through the snare 1054 as shown in FIG. 69 c .
  • the snare is then actuated via the control wire 1052 that is housed within the catheter control hypotube 1059 . Once adequate resistance or lock up is felt the RX catheter 1050 and integrated snare device 1054 can be extracted with the clot 1060 securely held as shown in FIG. 69 d .
  • the integrated snare 1054 can be removed from the RX catheter 1055 by simply retracting the snare device proximally using the control wires 1052 housed with the RX catheter hypotube 1059 . This would allow the RX catheter 1055 to be used to deliver a microcatheter and/or stentriever device to a distal location.
  • FIGS. 70 a -70 b illustrate an actuated RX expansile tip catheter device that can be actuated to act as an expansile clot receptor during aspiration coupled with an integrated snare device.
  • the expansile tip/integrated snare is actuated via a slider mechanism 1106 housed within a proximal control handle 1105 .
  • the catheter tip consists of two materials, a support material 1104 to give lateral strength, resist compression and sustain integrity during aspiration coupled with an expansile material 1100 to facilitate expansion whilst maintaining a closed wall structure at the tip that is capable of maintaining aspiration.
  • the snare wire 1102 is integrated into a circumferential lumen 1101 within the expansile catheter tip where it is free to slide within the lumen 1101 when actuated via slider mechanism 1106 .
  • the wire 1102 is fixed to the end points 1103 of the circumferential lumen 1101 within the catheter tip.
  • the circumferential lumen 1101 located within the catheter tip provides an added grip feature for clot.
  • the actuator wire 1108 runs distally from the control handle assembly 1105 to the catheter tip via a separate lumen 1109 integrated within the main RX lumen 1110 , this allows the main lumen 1110 to be used to deliver further catheters or thrombectomy devices to the occlusion site.
  • the expansile tip can be closed down to a taper using the control handle assembly 1105 , this greatly improves catheter deliverability in tortuous anatomy along with lessening any traumatic effects on the vessel.
  • the catheter tip Once in position at the clot face the catheter tip can be actuated to expand using the slider 1106 on the control handle assembly 1105 .
  • Aspiration can be applied to draw clot within the expanded catheter tip, and any clot that is too large to aspirate can be secured within the catheter tip by closing the tip down via the control handle assembly 1105 and extracting the RX Catheter system and clot together.
  • FIGS. 71 a -71 b illustrate an expansile tip intermediate or aspiration catheter with inner grip features located on the internal surface of the catheter tip.
  • the internal grip features 1154 can be uni-directional features located upon the inner surface of the aspiration catheter 1151 that allow a low friction, low opposition entry of clot 1157 within the expansile catheter tip 1150 under aspiration. These uni-directional grip features 1154 serve to embed deeper, grip further and retain the clot when force is applied to them in an opposing direction during retrieval of catheter 1151 .
  • the expansile tip 1150 allows for accommodation of a larger clot volume during aspiration.
  • an atraumatic tip 1159 mounted on a control wire 1155 can be placed in position within the grip features 1154 of the catheter tip 1151 .
  • This tip 1159 consists of an inner lumen 1152 with a tapered atraumatic nose 1153 .
  • This tip 1159 is positioned within the distal tip of the catheter 1151 during advancement. It gives an atraumatic nose 1153 to the catheter 1151 which serves to aid catheter delivery and lessen vessel trauma.
  • the tip 1159 also provides an atraumatic inner lumen 1152 in which further devices can be delivered without any interaction with the inner grip features 1154 located within the catheter tip 1150 .
  • the tip 1159 can be withdrawn proximally using the control wire 1155 , this will serve to expose the uni-directional grip features 1154 within the catheter tip for use during clot 1157 retrieval.
  • FIGS. 72 a -72 b illustrate a multi-point aspiration catheter device 1210 in which sections of material constrained at one end are fixed into the catheter wall and act as a hinged tab.
  • FIG. 72 a illustrates a hinged tab 1200 in the closed position, which remains closed under aspiration until the catheter tip 1206 becomes occluded with clot 1205 .
  • FIG. 72 b illustrates that when aspiration is applied through the lumen of the catheter 1201 via either a vacuum pump or syringe the catheter tip can become occluded with clot 1205 .
  • the tab 1200 will bend at the hinge point 1204 , thus opening up the aspiration lumen within the catheter 1201 to continue aspiration of emboli 1202 .
  • the tab 1200 material can be specified such that the vacuum level within the catheter lumen can be balanced at a pre-determined range.
  • the tab 1200 can be formed from a variety of flexible materials with different properties such that they will bend at varying levels of aspirational force or alternatively they can be cut directly from the catheter material. Multiple tabs may be positioned at varying points around the catheter circumference and along the length to facilitate alternate aspiration points.
  • the clot engagement feature 1252 is an integral part of the intermediate catheter construction 1255 .
  • the intermediate catheter 1255 can be introduced into the vasculature and forwarded to a position proximal of the clot.
  • the microcatheter 1251 can then be forwarded through the intermediate catheter 1255 as per standard interventional techniques and a stentriever device 1250 deployed at the target location within the clot (not shown).
  • the clot engagement feature 1252 can be forwarded by advancing the push-wire 1256 until the engagement feature 1252 contacts the clot. This is facilitated by the handle construction 1265 attached to the proximal end of the catheter 1255 .
  • a slider button 1258 on the handle 1265 may be connected to the push-wire 1256 to enable the clot engagement feature to be advanced.
  • Aspiration can be applied to the vessel via the catheter 1255 and the luer connection on the handle 1259 .
  • a seal may be maintained on the proximal end of the microcatheter 1262 during aspiration by the hemostasis valve 1261 .
  • the clot engager 1252 , microcatheter 1251 and stentriever 1250 can then be held in a static position and the intermediate catheter 1255 advanced to cause the clot engagement feature 1252 to collapse down over the clot further enhancing grip on the clot, and partially resheathing the stentriever device 1250 .
  • the slider button 1260 which is connected to catheter 1255 in the handle 1265 .
  • the handle and slider buttons make it easier for the user to control the advancement and retraction of the devices used in the procedure.
  • the catheter 1255 , stentriever 1250 , microcatheter 1251 and clot can be removed from the vasculature as a single unit through the guide catheter or introducer sheath.
  • This device configuration may also be used without an additional stentriever and microcatheter.
  • the clot engagement feature 1251 is forwarded into the proximal face of the clot. Aspiration is applied through the catheter and then the catheter 1255 is forwarded to cause the clot engagement feature 1251 to wrap down over the clot, gripping the clot securely.
  • the clot engagement feature 1255 may be fully retracted into the catheter using the slider button 1258 to fully retrieve the clot, before the device is retracted.
  • the clot engager 1255 and the clot may be held static and the catheter 1255 advanced over the clot engager 1255 and clot.
  • FIGS. 74 a and 74 b illustrate the distal tip 1305 of an intermediate or aspiration catheter that has an inner sleeve 1300 and an outer sleeve 1301 .
  • the sleeves are connected at the distal end by a flexible polymer sleeve 1302 .
  • the flexible sleeve 1302 is shown in its initial position in FIG. 74 a .
  • the catheter is advanced in the vasculature until the distal end of the catheter contacts the clot 1304 .
  • Aspiration is applied to the catheter to pull the clot 1304 into the catheter and remove it from the vasculature.
  • the outer sleeve of the catheter 1301 may be advanced relative to the inner sleeve 1300 so that the flexible sleeve 1302 rolls over the clot providing enhanced grip and encapsulating the clot.
  • the catheter and clot may then be removed as a single unit.
  • the inner sleeve 1300 may be retracted proximally relative to the outer sleeve 1301 to help pull the clot 1304 into the catheter 1305 under aspiration. This may facilitate clot removal through the aspirate, or provide enhanced grip so that the catheter and clot may be removed as a single unit.
  • the length of the flexible sleeve may vary from 2 mm to 30 mm but in the preferred embodiment varies from 5 to 15 mm.
  • the sleeve may be formed from a flexible polymer such as polyurethane or may be constructed from a wire or polymer fibre braid. Nitinol wire braid is particularly suited to this construction due to its Superelastic and shape memory properties.
  • FIGS. 75 a to 75 d show a method of use to remove a clot 1351 from the vasculature 1355 .
  • FIG. 75 a shows a microcatheter 1352 advanced across the clot 1351 using standard neuro-interventional techniques.
  • the stentriever device 1350 is partially deployed to allow the fragment protection feature to expand and protect the distal vasculature from any emboli that may be released from the clot.
  • the catheter 1354 is introduced into the vasculature and forwarded until the distal tip 1356 is in contact with the proximal face of the clot. Aspiration is applied through the catheter during advancement or when in contact with the clot to attempt to retrieve the clot fully.
  • the catheter tip 1356 is shown in these images in a skive configuration but it may be any configuration described elsewhere in this patent.
  • the clot 1351 has a large volume or has a high fibrin content, it might not be fully aspirated but may be partially aspirated in the catheter 1354 as shown in FIG. 75 b .
  • the microcatheter 1352 can then be retracted to deploy the remainder of the stentriever device 1350 .
  • the deployment of the device 1350 pins the partially retrieved clot 1353 against the inner surface of the catheter 1354 providing enhanced grip to the clot.
  • the stentriever device 1350 may be further retrieved to pull the clot 1351 further into the catheter as shown in FIG. 75 d . In this manner the clot 1351 may be fully retracted into the catheter 1354 and be removed or the clot 1351 , catheter 1354 and stentriever device 1350 may be removed from the vasculature as a single unit.
  • FIGS. 76 a and 76 b show a partial cut-away view of a catheter tip construction 1410 suitable for use with a ‘rapid exchange’ (Rx) intermediate or aspiration catheter 1403 .
  • the Rx intermediate catheter is described elsewhere in this patent.
  • This tip construction 1410 can be integrated into any access catheter such as a balloon guide catheter or introducer sheath 1402 .
  • the catheter tip 1410 is constructed so that it forms a seal 1400 between the sheath 1402 and the intermediate catheter 1403 .
  • the seal 1400 between the sheath and the Rx intermediate catheter prevents blood flow into the tip of the sheath 1401 ; ensuring maximum aspiration effectiveness is transmitted to the tip of the Rx intermediate catheter 1409 .
  • the tip of the catheter 1401 may have a flared shape as shown to facilitate the retrieval of clot 1411 that may be exposed at the end of the Rx intermediate catheter 1409 .
  • FIG. 76 b shows an alternative embodiment of this invention where the catheter tip 1404 also forms a seal with the outer surface of the Rx intermediate catheter 1405 to ensure the maximum flow rate and pressure drop are transmitted through the Rx port 1408 of the Rx intermediate catheter 1405 during aspiration.
  • Catheter tip 1404 may be constructed from an elastic polymer material such as polyurethane and has a necked down profile in its relaxed configuration. When the intermediate catheter 1405 is forwarded through the tip 1404 , it stretches to accommodate the intermediate catheter and forms a seal.
  • the inner surface of the tip 1404 can be lined with a low friction material such as HDPE or PTFE or may have a hydrophilic or low friction coating applied to minimise resistance to advancing the intermediate catheter 1405 .
  • This tip configuration 1404 may also act as an atraumatic tip for the introducer sheath 1402 during insertion and may improve trackability over a 0.035′′ guidewire as the reduced tip diameter acts as a lead-in to the catheter.
  • FIG. 77 illustrates another configuration of an intermediate catheter 1450 where the tip 1451 is self-expandable so that when it is advanced distal to the guide catheter or sheath 1454 , it can expand to a diameter greater than the inner diameter of the access catheter 1454 .
  • the expanded diameter of tip 1451 can vary from 1.times. to 3.times. the inner diameter of the guide catheter or sheath 1454 and in the preferred embodiment can range from 1 ⁇ to 2 ⁇ . The construction of this tip is described elsewhere in this patent.
  • Proximal to the expanded tip 1451 is the catheter segment 1452 which has a reduced diameter compared to the body section of the catheter 1453 .
  • the reduced diameter section 1452 provides enhanced flexibility and trackability of the catheter allowing it to navigate through tortuous anatomy and reach the target location of the clot in the vasculature.
  • the reduced diameter section can vary in length from 20 mm to 200 mm and in the preferred embodiment is approximately 100 mm long.
  • the diameter of this section can vary from 30% to 80% of the body section 1453 diameter and in the preferred embodiment is approximately 50% to 60% of the body section diameter.
  • FIGS. 78 a and 78 b show another configuration of the invention and illustrate the distal section 1500 of a catheter.
  • the tip of the catheter is configured so that there is a neck down region 1501 just proximal of the distal tip 1502 .
  • the distal tip 1502 is the same diameter as the body section 1503 .
  • the neck down region 1501 provides a flare angle (a) to the distal tip 1502 .
  • This flare angle facilitates improved aspiration of clots as it improves the approach angle of the catheter to the clot as it is advanced in the vasculature. This is particularly relevant in bends and tortuous anatomy as shown in FIG. 78 b .
  • the catheter 1503 is advanced through the vessel 1505 until it is in contact with the clot 1506 .
  • the flare angle of tip 1502 ensures good contact with the clot 1506 and the necked down portion 1501 improves the flexibility of the tip and allows the tip 1502 to flex and align with the vessel facilitating improved aspiration of the clot.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Surgical Instruments (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)

Abstract

An aspiration catheter including an elongate body and an expansile distal tip continuous with the elongate body. An expanding assembly is alignable internal to the expansile distal tip and connected proximally to a control wire. The expanding assembly includes a proximal position within the expansile distal tip proximal of a distal most end of the expansile distal tip. In a distal position where the expanding assembly is distally moved, by the control wire, until being aligned with and contacting the distal most end of the expansile distal tip causing the expansile distal tip to form a funnel mouth to receive clot.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • The present application is a divisional of U.S. patent application Ser. No. 15/362,377 filed Nov. 28, 2016, which is a continuation in part of U.S. patent application Ser. No. 15/158,384 filed May 18, 2016, now U.S. Pat. No. 10,682,152 issued Jun. 16, 2020, which is a continuation of U.S. patent application Ser. No. 14/737,249 filed Jun. 11, 2015, now U.S. Pat. No. 10,441,301 issued Oct. 15, 2019, which claims benefit of U.S. Provisional Patent Application No. 62/080,724 filed Nov. 17, 2014 and also claims benefit of U.S. Provisional Patent Application No. 62/011,934 filed Jun. 13, 2014.
  • Further, U.S. patent application Ser. No. 15/362,377 filed Nov. 28, 2016, claims benefit of 62/266,344 filed Dec. 11, 2015. All of the above applications are incorporated by reference in their entirety.
  • FIELD OF THE INVENTION
  • This invention relates to devices intended for removing acute blockages from blood vessels. Acute obstructions may include clot, misplaced devices, migrated devices, large emboli and the like. Thromboembolism occurs when part or all of a thrombus breaks away from the blood vessel wall. This clot (now called an embolus) is then carried in the direction of blood flow. An ischemic stroke may result if the clot lodges in the cerebral vasculature. A pulmonary embolism may result if the clot originates in the venous system or in the right side of the heart and lodges in a pulmonary artery or branch thereof. Clots may also develop and block vessels locally without being released in the form of an embolus—this mechanism is common in the formation of coronary blockages. The invention is particularly suited to removing clot from cerebral arteries in patients suffering acute ischemic stroke (AIS), from coronary native or graft vessels in patients suffering from myocardial infarction (MI), and from pulmonary arteries in patients suffering from pulmonary embolism (PE) and from other peripheral arterial and venous vessels in which clot is causing an occlusion.
  • SUMMARY OF INVENTION
  • According to the invention there is provided a catheter having an expansile distal tip, the catheter tip having a constricted delivery configuration and an expanded deployed configuration, and having a support frame and an elastic sleeve extending over the frame, the sleeve being expandable in the deployed configuration to define an enlarged distal tip.
  • In one embodiment the sleeve is partially folded in the delivery configuration. In one case at least a portion of the support frame is configured to expand radially outwardly from the deployed configuration. In one embodiment the support frame comprises a flexible region just proximal of the distal tip. The support frame may be cut from a tube and the cut pattern defines ring members and axially extending connections between the ring members. At least a distal region of the support frame may comprise a radiopaque material. In one embodiment the sleeve comprises a polymeric membrane. The membrane may have an internal and/or external low friction coating.
  • The invention also provides a clot retrieval system having a first catheter of the invention; and an access catheter. The self expanding distal tip of the first catheter being collapsible to a diameter less than or equal to that of the access catheter for delivery through the lumen of the access catheter, and being expandable to a diameter which is greater than that of the access catheter lumen in an unconstrained state.
  • The invention further provides a system having a clot retrieval catheter having a self expanding distal tip which is expansile from a radially retracted delivery configuration to a radially expanded configuration for reception of a clot; and an access catheter. The self expanding distal tip being collapsible to a diameter less than or equal to that of the access catheter for delivery through the lumen of the access catheter, and being expandable to a diameter greater than that of the access catheter lumen in an unconstrained state.
  • The invention also provides a system having a clot retrieval catheter having a distal tip which is expansile from a radially retracted delivery configuration to a radially expanded configuration for reception of a clot; and a self expanding element having a retracted delivery configuration and an expanded configuration, the self expanding element being axially movable within the catheter from an axially retracted configuration proximal of the distal tip to an axially extended configuration to expand the distal tip of the catheter.
  • The self expanding element may be mounted to a proximally extending control element. The control element may comprise a control wire extending from the self expanding element. The self expanding element may comprise a super elastic material such as Nitinol.
  • In another aspect the invention provides a system having a catheter selected from an aspiration catheter and an intermediate catheter; and a clot gripper which is adapted for gripping clot. The clot gripper may be a separate element which is movable relative to the catheter. The clot gripper may comprise a shaft having clot gripping means at the distal end of the shaft. In one case the clot gripper comprises a barbed tipped shaft for gripping clot. In one case the clot gripping means is movable from a delivery configuration to an expanded clot gripping configuration.
  • The clot gripping means may comprise two or more jaws for gripping clot. In some cases the clot gripper is integrated with the catheter. In one case the clot gripper comprises a snare.
  • In some embodiments the clot gripper comprises a distal loop which is movable from an inactive position at the distal end of the catheter to an active configuration and an actuator for activating the loop. The loop may be retained in the inactive position within receivers at the distal end of the catheter and the activator is adapted to remove the loop from the receivers.
  • In the system of the invention the catheter may comprise an expansile distal tip. In a further aspect the invention provided a catheter having an expandable distal tip and having an integral actuator for expanding and contracting the distal tip.
  • The distal tip may comprise a support material to provide lateral strength, and an expansile material to maintain a closed wall at the tip on expansion and contraction of the tip.
  • In one case the actuator comprises a wire which extends around the distal tip. The wire may extend around a guide lumen at the distal tip of the catheter. The wire may be fixed at a fixation location within the guide lumen. In some cases the wire extends through a lumen in the catheter which extends along the length of the catheter. The invention also provides a catheter having a distal tip and having internal grip features on the internal surface of the distal tip. The grip features may be unidirectional grip features. The distal tip may be an expansile distal tip.
  • An atraumatic element may be provided for location at the distal tip to cover the grip features during advancement of the catheter. In one case the atraumatic element is mounted on an elongate control element. The atraumatic element may comprise a lumen.
  • In a further aspect the invention provides an aspiration catheter having an open distal end, a secondary hole in the wall of the catheter adjacent to the distal end and a closure element which is movable from a closed position normally closing the secondary hole to an open position in which the secondary hole is exposed.
  • In one embodiment the closure element comprises a hinged tab. The closure element may be movable in response to blockage of the distal end of a catheter.
  • A catheter having an inner sleeve, an outer sleeve and a flexible element interconnecting the sleeves at the distal end of the catheter, the inner and/or the outer sleeves being movable relative to one other. The length of the flexible element in some cases is from 2 mm to 30 mm, from 5 mm to 15 mm. The flexible element may comprise a polymeric material such as polyurethane. The flexible element may comprise a braid of superelastic material such as Nitinol.
  • The invention further provides a clot retrieval system having an outer access catheter and an inner rapid exchange clot retrieval catheter which is adapted to be advanced through the outer catheter wherein the system comprises a narrowed region which forms a seal between at least a portion of the inner wall of the outer access catheter and at least a portion of an outer region of the inner clot retrieval catheter.
  • In some cases the outer catheter comprises a narrowed region which forms a seal between the inner wall of the outer access catheter and the outer wall of the inner clot retrieval catheter.
  • Also provided is a method of retrieving an obstructive thrombus from a patient's blood vessel using the clot retrieval system of the invention, the method having the steps of advancing the access catheter into the vasculature of the patient; advancing the rapid exchange clot retrieval catheter through the access catheter; continuing to advance the rapid exchange clot retrieval catheter until the distal mouth of the rapid exchange clot retrieval catheter is adjacent the proximal face of the obstructive thrombus; and aspirating through the access catheter to reduce the pressure within the distal mouth of the rapid exchange clot retrieval catheter to urge clot into the catheter mouth.
  • Also provided is a catheter having a self expandable distal tip and having a narrowed section of reduced diameter adapted to provide enhanced flexibility and trackability. The reduced diameter section may have a length of from 20 mm to 200 mm, in one case approximately 100 mm. In one case the diameter of the reduced diameter section is from 50% to 60% of the diameter of the main body of the catheter. Also provided is a catheter having a distal tip and a neck-down region just proximal of the distal tip. In one case the transition from the neck down region to the distal tip defines a flare.
  • The invention also provides a method of retrieving an obstructive thrombus from a patient's blood vessel, the method having the steps of advancing a microcatheter across the thrombus; advancing a clot retrieval device through the microcatheter; partially retracting the microcatheter to deploy at least a portion of the clot retrieval device distal of the thrombus; advancing a clot retrieval catheter to a position adjacent the proximal face of the thrombus; aspirating through the clot retrieval catheter to urge at least a portion of the thrombus into the distal mouth of said catheter; and removing the clot retrieval catheter and at least a portion of the thrombus from the patient.
  • In one case at least of portion of the clot retrieval device remains constrained within the microcatheter during at least part of the aspiration step. In one case portion of the clot retrieval device distal of the thrombus comprises a fragment capture basket.
  • In some embodiments the method includes the additional step of further retracting the microcatheter to deploy an additional portion of the clot retrieval device within the clot prior to removal of the clot retrieval catheter.
  • In some cases the method includes the additional step of retracting the clot retrieval device at least partially into the mouth of the clot retrieval catheter.
  • In some embodiments the clot retrieval device is removed from the patient simultaneously with the clot retrieval catheter.
  • Also provided is a clot retrieval system having an outer access catheter, an inner rapid exchange clot retrieval catheter, and a clot capture device. The rapid exchange clot retrieval catheter having a proximal elongate shaft and a distal tubular member. The clot capture device having a proximal elongate shaft and a distal expandable portion. The system having a restriction to effect a seal between at least a portion of the inner wall of the outer access catheter and at least a portion of the distal tubular member of the inner clot retrieval catheter.
  • The invention also provides a method of retrieving an obstructive thrombus from a patient's blood vessel using the clot retrieval system of the invention, the method having the steps of advancing the access catheter into the vasculature of the patient; advancing a clot capture device up to and across the thrombus; deploying at least a portion of the clot capture device distal of the thrombus; advancing the rapid exchange clot retrieval catheter through the access catheter to a position adjacent the proximal face of the thrombus; applying an aspiration force to the proximal end of the access catheter to effect aspiration through the rapid exchange clot retrieval catheter to urge clot into the catheter mouth; and withdrawing the rapid exchange clot retrieval catheter through the access catheter and out of the patient.
  • The method may further comprise the step of retracting the clot capture device and any captured thrombus through the access catheter and out of the patient. The method may comprise the step of retracting the clot capture device and the rapid exchange clot retrieval catheter and captured thrombus simultaneously through the access catheter and out of the patient.
  • In some cases the method includes the step of partially retracting the clot capture device into the distal mouth of the rapid exchange clot retrieval catheter and then removing the clot capture device and rapid exchange clot retrieval catheter and any captured thrombus simultaneously through the access catheter and out of the patient.
  • Also provided is a method of retrieving an obstructive thrombus from a patient's blood vessel using the clot retrieval system of the invention, the method having the steps of advancing the access catheter into the vasculature of the patient; advancing a clot capture device up to and across the thrombus; deploying at least a portion of the clot capture device distal of the thrombus; advancing the rapid exchange clot retrieval catheter through the access catheter to a position adjacent the proximal face of the thrombus; applying an aspiration force to the proximal end of the access catheter to effect aspiration through the rapid exchange clot retrieval catheter; retracting the clot capture device and at least a portion of the thrombus into the mouth of the rapid exchange clot retrieval catheter; and withdrawing the clot capture device and at least a portion of the thrombus through the rapid exchange clot retrieval catheter and access catheter and out of the patient.
  • Further provided is a method of retrieving an obstructive thrombus from a patient's blood vessel using the clot retrieval system of the invention, the method having the steps of a) advancing the access catheter into the vasculature of the patient; b) advancing a clot capture device up to and across the thrombus; c) deploying at least a portion of the clot capture device distal of the thrombus; d) advancing the rapid exchange clot retrieval catheter through the access catheter to a position adjacent the proximal face of the thrombus; e) applying an aspiration force to the proximal end of the access catheter to effect aspiration through the rapid exchange clot retrieval catheter and urge at least a portion of the thrombus into the mouth of the catheter; f) withdrawing the rapid exchange clot retrieval catheter through the access catheter and out of the patient; g) re-advancing the rapid exchange clot retrieval catheter over the shaft of the clot capture device and up to the remainder of the thrombus; h) repeating steps e-g one or more times; and i) removing the system from the patient.
  • In all cases the method may comprise the step of injecting contrast media through the access catheter and thus on through the distal tubular member of the rapid exchange clot retrieval catheter to assess the degree of obstruction remaining in the vessel prior to further treatment steps.
  • In some cases the method includes the step of injecting contrast media through the access catheter after step f to assess the degree of obstruction remaining in the vessel, and then removing the clot capture device if adequate revascularisation of the target vessel is observed.
  • Also described is a catheter for assisting in the retrieval of a clot from a vessel having a distal end and a proximal end, a distal segment and a proximal segment and a lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment and a flow restrictor located on the outer surface of the catheter distal of the transfer port.
  • In one case the catheter is an aspiration catheter for aspirating a clot.
  • In one embodiment the flow restrictor is actuatable between engaged and disengaged configuration. The catheter may comprise an actuator for selectively engaging and/or disengaging the flow restrictor.
  • In one case the flow restrictor includes a framework and a membrane coupled to the framework, the framework being movable by the actuator between an expanded configuration and a retracted configuration.
  • The aspiration catheter may comprise a proximal flow restrictor proximate the proximal end of the distal segment and a distal flow restrictor spaced distally from the proximal flow restrictor.
  • In one case the distal end of the catheter includes a mouth for reception of clot. The mouth may be defined by an expansile tip.
  • In one embodiment the distal segment includes a hinge adjacent to the distal mouth. The hinge may be defined by a region of the distal segment which is configured to have lateral flexibility.
  • In one case the mouth has an expanded configuration and a retracted configuration. The catheter may comprise a control member for controlling the movement of the mouth between the expanded and retracted configurations.
  • In one embodiment the mouth includes a number of segments and the control member is configured to move at least some of the segments. The control member may comprise a draw string or the like.
  • In another aspect the invention provides a catheter for aspirating a clot in a vessel having a distal end and a proximal end, a distal segment and a proximal segment and a lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment wherein the distal end of the catheter includes a mouth for reception of clot. The mouth may be defined by an expansile tip. In one case the catheter has a flow restrictor located on the outer surface of the catheter distal of the transfer port.
  • Also provided is a system for treating an occlusion in a vessel the system having a first catheter and a second catheter; the first catheter having a proximal end, a distal end and a lumen extending between the proximal end and the distal end, the lumen of the first catheter further having a proximal segment and a distal segment; the second catheter having a distal end and a proximal end, a distal segment and a proximal segment, and a lumen, said lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment; the first catheter being configured to facilitate aspiration through the lumen; the transfer port being configured to transmit aspiration in the proximal lumen of the first catheter into the lumen of the distal segment of the second catheter and the distal end of the second catheter being configured to receive clot into at least a portion of the lumen of the second catheter.
  • In one embodiment the system further includes a flow restrictor between the first catheter and the distal segment of the second catheter, distal of the transfer port. The flow restrictor may be located on the inner surface of the first catheter. Alternatively or additionally the flow restrictor is located on the outer surface of the second catheter.
  • In one embodiment there is a proximal flow restrictor proximate the proximal end of the distal segment of the second catheter and a distal flow restrictor spaced distally from the proximal flow restrictor.
  • In one case the distal end of the second catheter includes a mouth for reception of clot. The mouth may be defined by an expansile tip.
  • In one embodiment the transfer port includes a rapid exchange port.
  • In one case the first catheter is a guide catheter. The second catheter may be an intermediate catheter.
  • The system may also include a microcatheter which is adapted to be advanced through the first catheter and the second catheter. The system may further comprise a clot engaging device for delivery from the microcatheter.
  • Also provided is a method of removing a clot from a vessel, the method having the steps of providing a guide catheter and an intermediate catheter, the intermediate catheter having a distal mouth and being configured such that it is advanceable within the lumen of the guide catheter; inserting the guide catheter into a first vessel proximal of an occlusion; advancing the intermediate catheter through the lumen of the guide catheter until the tip of the intermediate catheter extends distal of the guide catheter into a second vessel adjacent to the occlusion; applying aspiration to the proximal end of the guide catheter; and the intermediate catheter being configured to direct said aspiration through the distal lumen of the intermediate catheter to aspirate the clot into the mouth of said intermediate catheter.
  • The aspiration catheter may comprise a distal end, a proximal end, a distal segment, a proximal segment and a lumen extending proximal of the distal end and terminating at a transfer port at the proximal end of the distal segment.
  • In one embodiment the method includes restricting flow between the outside surface of the intermediate catheter and the inside surface of the guide catheter.
  • In one embodiment the method includes the step, before or after aspiration, of delivering a microcatheter to the occlusion and deploying a clot capture device from the microcatheter. The method may comprise advancing the microcatheter to the clot, deploying a clot capture device from the microcatheter, retracting the microcatheter to a location proximal of a transport port at the proximal end of a distal segment of the aspiration catheter.
  • In a further aspect the invention provides method of removing an occlusion from a vessel having the steps of providing a first aspiration catheter and a second aspiration catheter, the second aspiration catheter extending distal of the first aspiration catheter and further having a transfer lumen proximal of the distal end of the first aspiration catheter; inserting the first catheter into a first vessel proximal of the occlusion; advancing the second catheter through the lumen of the first catheter until the tip of the second catheter extends distal of the first catheter into a second vessel and is substantially opposing the occlusion; and aspirating through the proximal lumen of the first catheter so as to urge the clot into the distal lumen of the second catheter.
  • The method may comprise restricting flow between the outside surface of the second catheter and the inside surface of the first catheter.
  • The method may comprise the step, before or after aspiration, of delivering a microcatheter to the occlusion and deploying a clot capture device from the microcatheter. In one case the method as includes the step, prior to aspiration, of retracting the microcatheter to a location proximal of the transfer port.
  • In one embodiment the first aspiration catheter is a guide catheter. In one case the second aspiration catheter is an intermediate catheter.
  • In one aspect the invention provides a clot receptor device. In one case the device is a catheter which may include rapid exchange features. In one embodiment the device provides a self-expanding aspiration catheter with flow-arrest.
  • The aspiration assist device has a distal end which expands to seal against the vessel proximal of the clot and provides a large open mouth to receive clot easily without risk of dislodging the clot from the thrombectomy device (if used).
  • The inner rapid exchange expandable device is delivered through an outer catheter, which may be a conventional intermediate or aspiration catheter or a distal access catheter (DAC). In one case it is a tailored catheter with an extremely trackable distal section for ease of access. This outer catheter trackability is possible because the distal section does not require much axial stiffness, as neither clot not thrombectomy device are retracted directly into it.
  • The rapid exchange (RX) expanding device may be supplied within the outer catheter (about 15 cm proximal of the distal end) and both are delivered together over a microcatheter (or wire) until the outer catheter tip approaches the clot. The inner RX expanding device is advanced to the distal end of the outer, and the outer is then retracted to deploy the self expanding RX device.
  • The Rx device seals against the vessel wall and against the inner lumen of the outer catheter to allow highly effective aspiration, and its distal end expands to provide a large opening and reception space to receive the target clot and thrombectomy device (if used).
  • In another similar embodiment the self expanding aspiration catheter has a full length tubular proximal shaft, rather than a rapid exchange shaft, so that it does not require a proximal seal and aspiration can be applied by applying a vacuum force to its proximal hub.
  • The invention also provides a rapid exchange aspiration catheter.
  • The catheter provides a proximal seal against guide catheter inner lumen so that aspiration may be applied through the guide taking advantage of the large proximal lumen.
  • The catheter having deliverability advantages of minimal frictional engagement with guide or microcatheter proximal of exit port.
  • Retracting the microcatheter just proximal of exit port (rather than completely removing it) creates a large aspiration advantage.
  • Also provided is a removable microcatheter hub that enables physician to advance a DAC over the microcatheter after the microcatheter (and thrombectomy device) are already in position (as bail, out for example).
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1 and 2 a-2 f illustrate a clot receptor device and system according to the invention;
  • FIGS. 3 to 5, 6 a, 6 b, 7 a, 7 b, 8 a, 8 b, and 9 illustrate various alternative clot receptors;
  • FIGS. 10 and 11 a-11 d illustrate a rapid exchange aspiration catheter according to the invention;
  • FIGS. 12a, 12b, and 13a-13l illustrate various proximal and distal seals;
  • FIGS. 14 to 21, 22 a, 22 b, 23 a-23 d, 24-33, 34 a, 34 b, 35, 36 a, 36 b, 37 a, and 37 b illustrate various alternative distal ends and expansile tips of a clot collector device of the invention;
  • FIG. 38 illustrates an alternative rapid exchange configuration;
  • FIGS. 39 to 46 illustrate a removable microcatheter hub according to the invention;
  • FIGS. 47 to 51 illustrate the creation of the distal segment with a continuous and smooth stiffness profile;
  • FIGS. 52 to 55 illustrate a dual lumen aspiration catheter according to the invention;
  • FIGS. 56 to 59 illustrate a clot receptor device and system according to the invention;
  • FIG. 60 illustrates a clot receptor device according to the invention;
  • FIGS. 61a-61c illustrate a clot receptor device and system according to the invention;
  • FIG. 62 illustrates a portion of a clot receptor device and system according to the invention;
  • FIG. 63 illustrates a clot receptor device according to the invention;
  • FIGS. 64a-64d illustrates an expansile tip of a clot collector device of the invention;
  • FIG. 65 illustrates a rapid exchange aspiration catheter according to the invention;
  • FIGS. 66a-66e illustrate a clot retrieval catheter with expansile radiopaque tip according to the invention;
  • FIGS. 67a-67c illustrate a rapid exchange clot retrieval catheter according to the invention;
  • FIGS. 68a and 68b illustrate aspiration catheter clot receptor devices and associated systems according to the invention;
  • FIGS. 69a-69d illustrate a rapid exchange catheter device and system according to the invention;
  • FIGS. 70a-70c illustrate an actuated expansile tip catheter device and system according to the invention;
  • FIGS. 71a and 71b illustrate an expansile tip aspiration catheter with inner tip features according to the invention;
  • FIGS. 72a and 72b illustrate a multi-point aspiration catheter according to the invention;
  • FIGS. 73a and 73b illustrate a clot receptor device and system according to the invention;
  • FIGS. 74a and 74b illustrate a dual extrusion expansile tip catheter according to the invention;
  • FIGS. 75a-75d illustrate a method of use combining a mechanical thrombectomy device and aspiration catheter according to the invention;
  • FIGS. 76a and 76b illustrate an aspiration catheter with flared sealable distal tip according to the invention;
  • FIG. 77 is an illustration of an intermediate catheter according to the invention; and
  • FIGS. 78a and 78b illustrate the distal tip of another catheter according to the invention.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a clot receptor device 2 of this invention being used in the retrieval of a clot 1 from the blood vessel of a patient. The clot receptor device 2 includes an elongate proximal shaft 13 and a tubular expansile distal section 4. The proximal end 5 of the expansile distal section 4 is configured to seal against the inner lumen of a distal section 6 of a catheter 7 through which it is advanced, while the distal end 8 of the expansile distal section is configured to seal against the wall of the blood vessel. The proximal seal against the lumen of the intermediate catheter 7 enables an aspiration force (such as a vacuum or a negative pressure differential, as may be induced by retracting a syringe plunger or through a vacuum pump) to be transmitted through the intermediate catheter 7 to the clot receptor device 2 and thus to the clot. The low profile proximal shaft 13 of the clot receptor device 2 minimizes the space occupied within the intermediate catheter 7, maximizing the effectiveness of the transmission of this vacuum/aspiration force to and trough the clot receptor 2. The seal at the proximal end of the clot receptor 2 may be provided by the expansile body of the clot receptor 2 opposing the lumen of the intermediate catheter 7. Other embodiments of this seal include a soft cuff of a foam or fibre construction, or polymer leaves or leaflets, or a balloon cuff, or a stent-like construction with a membrane cover, or combinations of these or other designs
  • The distal end 8 of the expansile distal section 4 is configured to open to a larger diameter than the proximal end, typically at least 50% larger, and in some embodiments up to 500% larger or more, depending on the relative size of the target blood vessel and the lumen of the catheter 7 through which the device is advanced. The large open mouth of the distal end 8 of the clot receptor 2 provides an easy path for retraction of clot into its interior space, and once within this space the clot can be safely retrieved from the patient. In one embodiment the inner lumen of the clot receptor device 2 has a profiled surface (like a sharkskin, or backward facing teeth) which allows clot to slide easily into the device, but resist the clot from escaping back out of the device.
  • FIGS. 2a to 2f illustrate a typical method of use of such a device and system. The method may include at least some of the following steps: Accessing an arterial blood vessel of a patient using conventional means such as an introducer 10 and guide catheter or sheath 11, advancing a microcatheter 12 up to and across a target occlusive clot with the aid of a guidewire 17, removing the guidewire 17 and advancing a mechanical thrombectomy device 15 such as a stent-retriever through the microcatheter 12 to the target clot 1, retracting the microcatheter 12 at least a few cm to deploy a mechanical thrombectomy device 15 within the clot 1, advancing an intermediate catheter 7 containing the clot receptor device 2 up to a position just proximal of the clot 1 (or within the clot, or considerably proximal of the clot if vessel disease or tortuosity makes access difficult), advancing the clot receptor device 2 up the distal end of the intermediate catheter 7 (or up to and out of the catheter and into or over the clot), retracting the intermediate catheter 7 a short distance to deploy the clot receptor device 2, aspirating through the intermediate catheter 7 using a syringe or pump to suck blood and the target clot into the clot receptor device 2, withdrawing the mechanical thrombectomy device 15 into the clot receptor 2 while continuing to aspirate, withdrawing the clot receptor device 2 and its contents at least partially into the lumen of the intermediate catheter 7, withdrawing the intermediate catheter 7, clot receptor device 2, clot and mechanical thrombectomy device 15 through the guide or sheath 11 and out of the patient.
  • Many variants of this method are possible.
  • For example it may be desirable to withdraw the clot 1 and mechanical thrombectomy device 15 through the clot receptor 2, intermediate catheter 7 and guide 11 and out of the patient while leaving the intermediate catheter 7 and clot receptor 2 in place. This allows the physician to retain a protective seal in the vessel to prevent the escape of any clot particles that may be dislodged, and also preserves a means of quick and easy access back to the target site with a microcatheter and thrombectomy device in case additional passes are needed to completely clear the vessel.
  • Another method variant involves removing the clot receptor device 2 and thrombectomy device together through the intermediate catheter 7, leaving the intermediate catheter 7 in place for easy re-access to the target site.
  • Yet another method variant involves using the clot receptor device 2 as the primary clot retrieval tool, without the aid of a mechanical thrombectomy device such as a stent-retriever. The clot receptor 2 is configured to expand and seal against the vessel wall adjacent the proximal end of the clot, thus aspirating through the intermediate catheter 7 and clot receptor 2 provides a highly effective suction force to draw the clot into the clot receptor 2. If the clot passes through the clot receptor 2 and into the intermediate catheter 7 it may be aspirated through the intermediate catheter 7 and right out of the patient. If the clot is too large or too firm to pass through the clot receptor 2 then the clot receptor 2 may be withdrawn into the intermediate catheter 7. Because the clot receptor 2 has a smooth and funnel shaped exterior it can be easily retracted into the intermediate catheter 7 even when containing a bulky and/or firm clot.
  • The distal end 8 of the clot receptor device 2 is intended to open up upon exiting the catheter through which it is delivered to provide a large open mouth approximately equal in size to the inner diameter of the vessel in which it is located and provide a seal against this vessel or significant flow restriction such that when a suction force is applied through the clot receptor 2 this force causes blood and clot distal of the receptor 2 to flow into the receptor 2 rather than blood proximal of the receptor 2. This flow occurs because the pressure inside the clot receptor 2 is lower than that outside (distal and proximal) of the clot receptor 2. If the seal were not present two flow paths into the clot receptor 2 would exist and the less restricted proximal flow path would dominate, reducing the effectiveness of the clot retraction.
  • In order to adequately seal against the vessel wall the clot receptor 2 should have either a) a high radial force or hoop strength so that the pressure gradient created by the application of suction/aspiration does not collapse the clot receptor or create a flow path past it or b) a seal construction such that the presence of a pressure gradient across the clot receptor 2 serves to tighten the seal rather than reduce it. The geometry and construction of the clot receptor sealing end should be such that it can conform well to the vessel wall, which may be not be effectively circular (such as when close to bifurcations for example, or when inclined at an angle to the vessel wall).
  • Thus one embodiment of the distal portion of a clot receptor may comprise a self-expanding frame with a relatively non-porous cover, such that the cover prevents any significant passage of blood through the wall of the clot receptor, and the self-expanding frame has sufficient radial or hoop strength to resist the pressure gradient created by the application of suction/aspiration. The cover may be a polymeric membrane, or may be a woven or braided or knitted structure. In one embodiment the membrane is a polymer membrane, preferably with a high elastic strain limit and a low modulus to permit its expansion by a low radial force frame structure. A preferred membrane is a polyurethane membrane, which might be extruded or blow moulded or ideally dip coated directly onto the frame. The membrane may be coated with a low friction coating such as a hydrophobic silicone or a hydrophilic material. In one embodiment the membrane is a hydrophilic material itself, having a hydrogel with sufficient thickness and modulus to retain its structure under the force of aspiration. Other suitable materials for this cover include PTFE, ETFE and PFA. Materials such as PET, UHMWPE, PET and PEN would be particularly suitable for use in the making of a cover that is woven, braided, knitted or otherwise formed from fibres
  • Another embodiment of the distal portion of a clot receptor may comprise a combination of a self-expanding frame with a relatively non-porous membrane cover, and a plurality of flexible leaflets or vanes disposed around its outer circumference in a manner similar to that of a leaflet valve. In yet other embodiments the additional seal provided by these flexible leaflets is instead provided by an outer cuff, and this outer cuff may comprise a compressible material such as a foam or a hydrogel or a fibre bundle or a shaped polymer.
  • In yet another embodiment the expansion of the distal end of the clot receptor may be actuatable by the user, by retraction of a pull wire within the device shaft for example, or by inflation of a balloon cuff.
  • Some of the various embodiments of the distal end of the clot receptor are illustrated in FIGS. 3 to 9.
  • FIG. 3 depicts one embodiment of the distal end of the clot receptor having a stent-like self-expanding frame 25 with an outer membrane covering 27. A proximal shaft 21 is connected to the frame and membrane at a proximal entry port 20. The proximal end 24 of the expansile section is configured to gently appose the wall of a catheter through which it is delivered, while the distal end 23 is configured to expand and appose the vessel wall, creating a large opening 22 into the internal reception space. The frame structure 25 is in one embodiment a Nitinol structure laser cut from a tube or sheet, and in another embodiment is a wire structure, wound or braided from Nitinol or stainless steel or other such biocompatible metallic material as are commonly used in the construction of stents or snares. The membrane 27 may comprise a lip 26 which is folded over and wrapped inside the frame 25.
  • FIGS. 4 and 5 depict a typical embodiment of the distal end of the clot receptor. FIG. 4 shows a clot receptor 30 housed in an outer intermediate catheter 31, positioned in a vessel 32. The distal end 35 of the clot receptor is folded to wrap it into a suitable profile to fit into the lumen of the intermediate catheter 31. FIG. 5 shows the deployed clot receptor upon retraction of the intermediate catheter 31, such that distal end 35 has expanded and is contacting the vessel wall 32, and proximal end 34 is sealing against the inner lumen of the intermediate catheter 31. In another embodiment the distal end 35 expands to a smaller diameter than that of the vessel, but a larger diameter than that of the intermediate catheter.
  • The intermediate catheter inner lumen may be as small as 0.75 mm or as large as 2.0 mm, but is preferably between 1.0 mm and 1.7 mm. The clot receptor distal end may be configured to expand to a diameter equal to or slightly larger than the target vessel in order to provide a seal, or to a diameter slightly smaller than the target vessel in cases where a low profile, deliverable device is a higher priority than a perfect seal. In one embodiment configured for use in middle cerebral arteries of the brain, the clot receptor distal end is configured to expand to a diameter of between 2 mm and 4 mm. In another embodiment such as might be used in the internal carotid artery, the clot receptor distal end is configured to expand to a diameter of between 4 mm and 7 mm.
  • FIGS. 6a and 6b illustrate the collapsed (for delivery) and expanded forms of the distal end of a clot receptor 40 of this invention. In this case the mechanism of collapse for delivery through an intermediate catheter is a creasing and folding mechanism, similar to that used to wrap angioplasty balloons. The material of the distal expansile end 42 is configured into pleats or folds 41 to wrap it efficiently into delivery form.
  • FIGS. 7a and 7b illustrate the collapsed (for delivery) and expanded forms of the distal end of a clot receptor 50 of this invention. In this case the mechanism of collapse for delivery through an intermediate catheter is a rolling mechanism, with an unrolling mechanism taking place for expansion. The distal expansile end 52 exists in its minimum strain state when fully expanded as shown in FIG. 7b . It is configured with a seam 51 running from its distal most end to a point distal of its proximal end. The seam allows the self-expanding clot receptor to be rolled up like a cigarette paper to assume a lower profile shape for delivery.
  • FIGS. 8a and 8b illustrate the collapsed (for delivery) and expanded forms of a frame 60 of the distal end of a clot receptor of this invention. This frame may be formed from Nitinol or another material with a sufficient elastic strain limit such that this limit is not exceeded when the device is collapsed for delivery through an intermediate catheter. In one embodiment the frame is laser cut from a Nitinol tube or sheet, and includes struts 61 connected at crowns 62. The distal end of the frame includes terminal crowns 63, which may be formed with atraumatic ends of a higher radius of curvature than that used for the more proximal crowns. The frame may be covered with a polymeric membrane as described earlier.
  • FIG. 9 illustrates the expanded form of a frame 70 of the distal end of a clot receptor of this invention, which is similar to frame 60 of FIG. 8 but is formed from wires 73 rather than cut from a tube or sheet. One advantage of such a structure is that non superelastic materials (such as SS, MP35N or other materials commonly used in the manufacture of balloon expandable stents) can be used in its construction. This is because a much lower strain is induced in the frame in moving from its expanded to collapsed state, because the wires are free to move and slide relative to one another, even at crossover points 72. The wires form crowns 71 of a large and gentle radius at the distal end of the frame, rendering the tip of the device atraumatic to a blood vessel.
  • Referring to FIGS. 10 and 11 there is illustrated an aspiration catheter 101 according to the invention. In FIG. 11a the aspiration catheter 101 is illustrated as part of a clot retrieval system for retrieval of a clot 110. The clot retrieval system further includes a clot engaging device 100, a microcatheter 109 through which the clot engaging device is delivered and a guide catheter 108 through which the aspiration catheter 100 and microcatheter 109 are delivered. The aspiration catheter 101 includes a distal segment 90 and a proximal segment 91. The distal segment 90 includes a distal end provided with a distal tip 112 and a proximal end provided by a transfer port 105. A lumen of the distal segment 90 extends proximal of the distal end 112 and terminates at the transfer port 105. The proximal segment 91 extends from the distal segment 90 and in this case is provided by a proximal shaft 106. A flow restrictor 102 is located on the outer surface of the aspiration catheter 101 distal of the transfer port 105. The aspiration catheter 101 provides a proximal seal 102 against a guide catheter inner lumen 103 so that aspiration may be applied through the guide catheter 108 and thus take advantage of a large proximal lumen.
  • FIG. 10 shows a simplified view of a distal region of the system, illustrating more clearly how the aspiration catheter flow restrictor 102 interacts with the inner lumen of the guide catheter 108. The guide catheter 108 may also have a flow restrictor component such as the inflatable balloon portion 104 shown in this illustration.
  • The aspiration catheter 101 is a rapid exchange (RX) catheter in which the exit port 105 defines a transfer port for aspiration and provides a deliverability advantage of minimal frictional engagement with the guide catheter 108 proximal of the exit port 105.
  • In some cases a microcatheter 109 may be provided through which a clot capture device 100 is delivered. Retracting the microcatheter 109 just proximal of the exit port 105 (rather than completely removing it) creates large aspiration advantage.
  • In one case the microcatheter 109 and the Rx aspiration catheter 101 are introduced together into the guide catheter 108.
  • The guide wire and microcatheter 109 are then advanced across the clot 110. The guidewire can be removed and a clot retrieval device such as a stent retriever device 100 is introduced.
  • Using the microcatheter 109 for support, the Rx aspiration catheter 101 can be forwarded to a position proximal to the clot 110 by pushing the proximal shaft 106 or handle into the guide catheter 108. The stentriever device 100 can be deployed by retracting the micro catheter 109.
  • The Rx aspiration catheter 101 can then be forwarded to contact the clot 110 or be positioned just proximal to or at the proximal face of the clot 110. The microcatheter 109 can then be retracted sufficiently to be proximal of the Rx port 105 of the Rx aspiration catheter 101. This facilitates an increased lumen for aspiration without the necessity of removing the microcatheter 109 fully from the intermediate/aspiration catheter.
  • Aspiration can be applied to the lumen of the guide catheter 108 with a manual syringe 111 or vacuum pump. This aspiration is directed to and effective at the distal tip 12 of the Rx aspiration catheter 101 due to the presence of the flow restrictor or seal 102 between the outer surface of the Rx aspiration catheter 101 and the inner guide catheter 108. This seals the lumen between the outside of the Rx aspiration catheter 101 and the inner lumen 103 of the guide catheter 108 and prevents backflow of blood into the tip of the guide catheter 108 which would reduce the effectiveness of the aspiration. The seal 102 may not need to stop flow in the lumen completely but needs to restrict flow sufficiently so as not to have a significant effect on aspiration performance. This seal 102 can be generated in a number of ways such as those described in FIGS. 12 to 131. In some cases the seal 102 is located on the inside surface of the guide catheter 108 and/or on the outside surface of the aspiration catheter 101.
  • The Rx aspiration catheter 101 is constructed of a proximal handle (not shown) to facilitate grip and a proximal shaft 106 constructed from a wire or tube formed preferably from Nitinol, stainless steel, PEEK or some other similar material. An additional seal may be provided on a proximal haemostasis valve to assist in sealing against the proximal shaft 106. The material of the shaft 106 has high compressive and tensile strength and may have a low friction coating or jacket to minimise insertion and retraction forces. The low friction coating or jacket could be formed from PTFE, HDPE or a similar material.
  • The Rx exit port 105 on the aspiration catheter 101 can facilitate forwarding a microcatheter 109 through the port 105 and through the distal section 90 of the Rx catheter 101 prior to insertion into the guide catheter 108. The Rx exit port 105 may be formed in a funnel shape to make it easier to forward a microcatheter 109 into the port even in position in the guide catheter 108. The port 105 may be formed from a moulded component or from the tubing of the distal section 90 of the catheter 101.
  • The distal section of the Rx aspiration catheter 101 has good push and trackability characteristics to allow it to be forwarded to the target location. Therefore it may be constructed of one or more materials to give a reducing stiffness profile along the length. A braided wire or coil wire construction or combination of both may be used to improve compressive strength and track ability. Linear wire supports running parallel to the tube axis may also be used.
  • A top layer of low friction material may be applied to the distal section of the catheter 101 or alternatively a hydrophilic coating or silicon oil coating may be applied to the surface. The inner lining of the distal section of the catheter 101 consists of PTFE or similar low friction material to minimise insertion and retraction forces.
  • The seal 102 on the outer surface of the Rx aspiration catheter 101 distal section 90 prevents or significantly reduces blood flow travelling from the guide catheter distal tip 113 to the Rx port 105 of the Rx aspiration catheter 101 as shown in FIG. 12a . Various embodiments of proximal seals 102 are illustrated in FIGS. 12 to 131.
  • In another embodiment of the device shown in FIG. 12b an additional seal 114 is provided on the distal end of the catheter 101 to seal between the Rx catheter and the target vessel. This seal 114 is spaced distally from the proximal flow restrictor 102 and occludes blood flow in the vessel and improves aspiration effectiveness without the need for a balloon guide catheter. The seal 114 can be constructed in a similar manner to those shown in FIGS. 12a to 131.
  • The seal 102 can be formed from an outer sleeve on the catheter which may be smooth or have a grooved or profiled surface 116 as shown in FIG. 13a . FIG. 13j shows a profiled surface with a spiral groove 125. The seal could also be formed from one or more moulded rings with a sealing lip or “0” ring profile 117 as shown in FIG. 13b . It could also be formed from an inflatable balloon 115 which is inflated by injecting saline through a lumen in the shaft and catheter as shown in FIGS. 12a, 12b and 13 g.
  • In another embodiment illustrated in FIG. 13d the seal 102 can be constructed of fibres in a brush/bristle configuration 119 or from a fibre mesh 123 formed of PET fibres or similar material as shown in FIG. 13h . Similarly the seal could be formed of a sponge material 121 which is compressed when inserted into the lumen of the guide catheter 108 as shown in FIG. 13 f.
  • In a further embodiment the seal 102 could be provided by a body 124 formed from a hydrophilic 124 or similar material which swells and increases in diameter when in contact with saline or blood. The seal 102 may also be formed by having a close tolerance clearance fit between the outer diameter of the distal end of the Rx aspiration catheter 101 and the inner diameter of the guide catheter 103. In another embodiment, the seal 102 is formed from a lip 118 or membrane 120 which restricts flow particularly in one direction as shown in FIGS. 13c and 13 e.
  • In another embodiment of the seal 102 shown in FIGS. 13k and 13l , the occlusion between the Rx aspiration catheter 101 and the guide catheter 108 is achieved through longitudinal compression of the aspiration catheter 101. This can be achieved by having an expansile section 127 which increases in diameter when the catheter is under compression. The compression can be a result of retrieving clot 110 and the stentriever device 100 into the tip 112 or may be manually actuated through a pull wire 126. This pull wire 126 may run through a separate lumen from the proximal end of the device as shown in the cross sectional view A-A in FIG. 13 l.
  • The clot 110 and stentriever type device 100 can be fully or partially retrieved into the Rx aspiration catheter 101 as controlled by the physician and depending on the resistance felt by the user or clot obstruction of the lumen as indicated by an increase in vacuum/loss of suction. The expansile tip 112 of the Rx aspiration catheter 101 facilitates aspiration and retrieval of the clot 110 and stentriever device 100 by expanding under load to reduce the retraction force and lessen the risk of scraping clot off the surface of the stentriever device 100. The expansile tip 112 can also partially or fully occlude the vessel providing flow arrest improving aspiration effectiveness.
  • The expansile tip 112 can be formed in a number of ways and various embodiments are shown in FIGS. 14 to 37.
  • In one embodiment the expansile tip 112 can be formed from a co-extrusion of materials with different properties such as a soft expansile polymer 131 co-extruded with a higher modulus polymer 130 to provide longitudinal support. A fully expansile ring 132 could then be connected to this tip as shown in FIG. 14. The tip 112 may also include one or multiple metallic wire supports 133 as shown in FIGS. 15 and 24. In another embodiment shown in FIG. 18 the tip has a skived profile to increase contact area with the clot during retrieval or aspiration. The tip may be formed with holes 134 or perforations 137 to allow it to split and change shape when a device 100 and clot 110 is retracted into the tip as shown in FIGS. 16 and 17. These features can be combined with tip constructions containing materials of different durometers such as shown in FIGS. 16, 17, 18, 21 and 25. In these embodiments the tip materials 143, 136, 146, 151, 164 have a lower durometer and are more expansile than the support materials 135, 144, 145, 150, 165.
  • These support materials may be embedded within the wall of the tubing or may be on the inner or outer surface. They may also be formed in a spline, coil, stripe, “U” shape or other configuration to provide longitudinal support to the expansile material to prevent it collapsing or buckling under compressive load, such as occurs during retrieval of a clot or stentriever device, or during insertion through a guide or access catheter. FIG. 19 shows another embodiment where multiple holes 139 produce a lattice or framework in the tip. Single or multiple protrusions or “teeth” 141 may also be applied to the inner surface 142 at the distal tip to improve grip on the clot as shown in FIG. 20.
  • The expansile tip may be pre shaped to form a flared profile (FIG. 22a ) or a tapered profile as shown in FIG. 22b . Alternatively the tip shape may be a combination of these profiles such as bulbous or ‘pear’ shaped as shown in FIGS. 23a to 23d . In the configuration shown in FIG. 23a the tip 160 has an increased diameter larger than the proximal catheter diameter 161 which then tapers to a reduced diameter 162 for ease of insertion. In the configuration shown in FIG. 23b the tip 166 has an increased diameter larger than the proximal catheter diameter 161 which then tapers to a reduced diameter 167, however the reduced diameter 167 is still larger than the proximal catheter diameter 161. This tip configuration provides benefits of improved aspiration effectiveness and reduced retrieval force but also low insertion force and trackability benefits due to the distal tip radius or taper 167. The tip radius 167 also prevents the tip snagging on a bifurcation on insertion, such as at the ostium of the ophthalmic artery in the internal carotid artery. FIG. 23c shows how the tip 160 elongates during insertion through a guide or access catheter 108, while FIG. 23d shows the tip 160 expanding to accommodate the retrieval of a clot 110 and stentriever device 100. The profiled tips can also be constructed using multiple materials of varying durometer and expansile characteristics.
  • The expansile tip 112 could also be profiled and contain one or more slot cuts 170 to facilitate expansion as shown in FIGS. 26, 29 and 30. Other embodiments of profiled tips to facilitate expansion and retrieval of the clot 110 and stentriever device 100 are shown in FIGS. 27 and 28.
  • In another embodiment of the Rx aspiration catheter tip 112 shown in FIG. 31, the distal end of the tip has a collar 171 which tracks closely over the guidewire. This helps direct the catheter over the guidewire to the target location reducing the risk of snagging. The tip configuration shown in FIG. 32 has a flattened section 173 which contains a large number of aspiration pores 174, and aspiration windows 172. This design potentially increases the contact area with the clot improving grip where the catheter is used without a stentriever device. FIG. 33 shows an end view of FIG. 32 with the arrows indicating the direction of blood flow.
  • Referring to FIGS. 34 to 35 there is illustrated a catheter with an expandable distal end 180, which is expanded by means of a lifebelt shaped annular balloon 181 at or adjacent its distal end. The balloon is inflated by injecting a fluid through an inflation lumen 182 running from the proximal to distal end of the device. The distal end of the catheter has a ring of petals 183 which act as a seal or occluder to limit the volume of blood flowing from proximal of the tip into the catheter, when aspirating through the catheter. The petals 183 may be formed from a polymeric material. FIG. 34a shows the tip in the collapsed configuration and FIG. 34b shows the tip when the annular balloon 181 is inflated. FIG. 35 shows an additional embodiment where the catheter has an Rx construction with the inflation lumen 182 running through the shaft to the proximal end of the device.
  • In another embodiment of the catheter tip 112, shown in FIGS. 36a and 36b , the tip 184 is constructed so that it can invert as the stentriever device 100 and clot 110 are retrieved into the catheter. This can reduce the retraction force and constrain the clot so fragments are not released during the retrieval process. FIG. 36b shows the tip after inversion.
  • Referring to FIGS. 37a and 37b there is illustrated a clot retrieval catheter with a self-expanding distal tip 190 that is constrained by a tapered cap 191 for ease of deliver and atraumatic access to a target site. The cap component 191 can be retracted to allow the catheter mouth 192 to expand, creating a large opening to accept clot or other material into its lumen. The cap component 191 has a distal end whose outer diameter is ideally lower than that of the catheter shaft immediately proximal of the cap, and an inner lumen sized to enable the device to be advanced over a thrombectomy device shaft and microcatheter. The cap component 191 may also comprise a guide tube 193 to aid the device in moving smoothly over a thrombectomy device shaft or microcatheter.
  • In another embodiment of the device shown in FIG. 38 the distal section of the catheter 194 is shortened so that distance X is typically between 5 and 50 mm long. This device can be forwarded over the shaft of the stentriever device 100 to the target location to facilitate partial or full retrieval of the stentriever 100 into the expansile tip 112. In this embodiment the distal section 194 is forwarded out of the guide catheter 108 and does not translate aspiration to the distal tip 112, but has improved trackability and access performance to reach the target vessels due to reduced friction and pushability of the wire shaft. The short length distal section 194 and tip 112 are connected to a shaft 106 constructed from a wire or tube formed preferably from Nitinol, stainless steel, PEEK or some other similar material. The shaft material has high compressive and tensile strength and has a low friction coating or jacket to minimise insertion and retraction forces. The expansile tip 112 can be constructed in a similar manner to those shown in FIGS. 14 to 37.
  • The Rx aspiration catheter 101, microcatheter 109, stentriever device 100 and clot 110 can be retracted as a unit back to the tip of the guide catheter 113 and then fully into the guide catheter 108. The guide or access catheter 108 may also have an expansile tip 113 to facilitate retraction of the devices and clot, with a reduced force and lower risk of dislodging the clot from the devices. This expansile tip 113 on the guide catheter may be constructed in a similar manner to those shown in FIGS. 14 to 37. Likewise the expansile tip 112 construction and seal 102 construction shown in FIGS. 12 to 37 may also be applied to a standard length intermediate or aspiration catheter.
  • The Rx aspiration catheter 101, microcatheter 109, stentriever device 100 and clot 110 can then be retrieved from the guide catheter 108 and removed fully from the patient.
  • Referring to FIGS. 39 to 46 there is illustrated a removable microcatheter hub according to the invention. The removable hub enables a physician to advance an intermediate or access catheter over the microcatheter after the microcatheter (and thrombectomy device) are already in position (as bail out for example). It is not possible with a standard microcatheter to forward an intermediate or access catheter over the proximal end as the fixed hub is in the way, therefore the standard microcatheter has to be removed to introduce an intermediate catheter.
  • Use of a microcatheter with a removable hub that facilitates the use of an extension wire facilitates improved control on the microcatheter position as the intermediate catheter is introduced.
  • In FIGS. 39 to 46 the following numerals are used:
      • 300 detachable hub
      • 301 microcatheter shaft
      • 302 strain relief element extending from microcatheter hub
      • 303 internal connector (see FIGS. 42/43 for detail)
      • 304 end of microcatheter shaft which has detached
      • 305 extendable shaft for intermediate catheter exchange
      • 306 internal thread on microcatheter hub
      • 307 microcatheter connector
      • 308 O-ring seal
      • 309 external thread on microcatheter connector
      • 310 bond
      • 311 closed end to prevent outbleed
      • 312 bond
      • 313 a extension wire
      • 313 b extension wire housing
      • 314 laser cut hypotube which acts as a core reinforcement for microcatheter
      • 315 stiff proximal shaft so that it can be gripped and pulled/twisted during microcatheter removal
      • 316 compressible O-ring which locks the microcatheter into recess incorporated into moulded catheter hub
      • 317 detachable hub
      • 318 extension tube
      • 319 spring clip—e.g. stainless steel or Nitinol
      • 320 injection moulded hub
      • D1 0.021 inch ID approx.
      • D2 0.029 inch OD approx.
      • D3 0.039 inch OD approx.
      • D4 0.045 inch OD approx.
  • FIG. 39 shows the microcatheter hub 300 assembled with the microcatheter shaft 301. FIG. 40 shows the microcatheter shaft after detachment and FIG. 41 shows the mating end of the extendable shaft 305. By connecting the extendable shaft 305 to the microcatheter shaft 301 the working length of the catheter is increased to facilitate forwarding an intermediate or access catheter over the microcatheter while maintaining positional control. The extendable shaft 305 can then be removed and the detachable hub reconnected to the microcatheter.
  • FIG. 42 illustrates the construction of the microcatheter connector 307 and detachable hub 300. The detachable hub 300 can be screwed onto the microcatheter connector 307 due to thread 309 on the connector and the mating thread 306 on the hub. ‘0’ ring 308 prevents any blood loss or air ingress between the connector 307 and the hub 300 when tightened.
  • FIG. 43 shows a section view of an embodiment of the extendable shaft 305 which utilises an extension wire 313 a and extension wire hub 313 b. The extension wire 313 a and hub 313 b are shown screwed onto the microcatheter shaft 301 and connector 307.
  • FIGS. 44 to 46 show another embodiment of a detachable hub where the microcatheter shaft 301 is connected to the detachable hub 317 by a compressible ‘0’ ring 316. The ‘0’ ring 316 sits in a groove on the moulded hub 320 which is connected to the microcatheter shaft 301. The ‘0’ ring is compressed by rotating part of the housing 321 on the detachable hub 317. The extension tube 318 can be pushed over the moulded hub 320 on the microcatheter shaft 301 after the hub 317 has been removed. The extension tube 318 is then held in position by the spring clip 319 engaging with the groove on the moulded hub 320.
  • FIGS. 47 to 50 illustrate a method of manufacture of a large diameter aspiration catheter. The aspiration catheter is highly trackable so that it can be navigated to tortuous/distal cerebrovascular location.
  • FIG. 47 is a graph of lateral stiffness with distance from the tip.
  • FIG. 48 illustrated a conventional diagram in which different tubular segments 200, 201, 202, 203, 204 are of different materials. The segments are used to create a stepped material stiffness profile (gradually increasing modulus/share hardness).
  • FIG. 49 illustrates a distal segment according to the invention in which a smooth stiffness profile is created by blending elements 205, 206 of different modulus. For example, tapered tubes 205, 206 (FIGS. 50, 51) may be placed on a mandrel overlapping each other and use heat to cause them to melt and flow into each other. The resultant tube may then be applied to a threaded or spiral wire or unreinforced base, or use as a stand-alone catheter.
  • Referring to FIGS. 52 to 55 there is illustrated a dual lumen aspiration catheter to aid with aspiration and prevent the lumen of the catheter getting blocked with clot.
  • Lumen A—smaller diameter lumen can be used to retrieve the device into and cause the clot to shear off. The distal end of Lumen A could be flush with or recessed from the distal tip of Lumen B.
  • Lumen B—the larger lumen would have aspiration constantly applied to it, to aspirate the clot that is sheared off the device when it is retrieved into the smaller lumen (Lumen A).
  • The smaller lumen A may have an inner diameter to facilitate the introduction of a microcatheter through the lumen. The microcatheter can then be inserted through this lumen and across the clot as per standard procedure. The stentriever device can then be deployed across the clot. Retrieving the stentriever and clot into the catheter causes the clot to be sheared off the stentriever within the aspiration catheter. This configuration prevents the clot snagging on the struts of the stentriever device and blocking the aspiration lumen. The larger diameter lumen may have a diameter of about 0.058 inch and may have aspiration applied to it to aspirate the clot as the device is being retrieved into the smaller diameter lumen.
  • One clot receptor catheter tip according to the invention the clot receptor tip is expanded by means of a balloon, which may be attached to the shaft of a thrombectomy device, or to a microcatheter, or may be integral to the clot receptor catheter itself.
  • One embodiment of such a device is shown in these FIGS. 56 to 59. The device includes a thrombectomy device 400 with an inflation lumen 402 extending from the proximal end of the shaft to a balloon 401 at the distal end of the shaft, and a clot receptor catheter 404 with a flexible expandable distal section 405. The thrombectomy device 400 is expanded in the clot 403. Either the thrombectomy device and clot are then retrieved towards the clot receptor catheter 404 or the clot receptor catheter is advanced towards the thrombectomy device. The balloon 401 at the distal end of the device is positioned so that the distal end is in line with the distal end of an intermediate catheter. The balloon is expanded to plastically deform 406 the distal end of the clot receptor catheter and then deflated. The resultant open mouth 407 of the clot receptor catheter allows the entire device and clot to be retrieved into the intermediate catheter. This prevents loss of clot on retrieval into a small lumen of a conventional intermediate catheter. The expansile distal portion 405 of the clot receptor catheter may be formed of a polymeric material with a low modulus and a high elongation strain to break of greater than 100%, and ideally greater than 300%. It may also comprise a support structure of a metallic material such as stainless steel which can be plastically deformed by the balloon and can then retain its deformed shape with sufficient integrity to accept the thrombectomy device and clot.
  • The balloon expandable tip of the invention can be applied to any catheter—standard or rapid exchange, and can be used with or without a thrombectomy device to aid in the aspiration and/or retrieval of clot from blood vessels.
  • FIG. 60 illustrates an RX clot removal catheter 500. This device 500 is very similar in design and in use to that shown in FIGS. 11a-d , except that the element 504 is an actuatable flow restrictor or seal, which can be selectively engaged or disengaged by the operator. The catheter 500 includes a proximal elongate shaft 501 and a distal generally tubular portion 502. The distal portion 502 includes reinforcement member 507 and a polymeric cover member 510, and extends from an entry/exit port 517 to a distal clot reception tip 503. The cover member 510 may comprise multiple layers and segments. A low friction inner layer may be employed as a lining for the lumen of the tubular section, a highly compliant membrane 506 may be employed to cover the actuatable flow restrictor/seal region, and a low modulus polymer may be employed to cover the main tubular body. The distal end or tip 503 may comprise any of the designs shown elsewhere in this document. In a preferred embodiment the tip 503 is connected to the distal end of the tubular portion 502 by a hinge element 511. This hinge element may simply be a short region of the tubular section configured to have a high degree of lateral flexibility relative to the rest of the tubular section. This flexibility may be achieved by having a short region of the tubular section without any reinforcement element 507, or alternatively the reinforcement at that region could be a highly flexible reinforcement such as a generally spiral metallic coil.
  • The actuatable flow restrictor or seal 504 includes a framework 508, with a membrane covering 506. The framework 508 is at least partially collapsible by retraction of actuation member 512, which runs through proximal elongate shaft 501 and is connected at its proximal end to slider element 514, which is in turn slidably constrained within handle 513, and coupled to spring element 515. Proximal elongate shaft 501 may comprise a tube of stainless steel, Nitinol or other metallic or high modulus polymeric material, and may contain a liner in order to provide a low friction internal surface against which the actuation member 512 may slide. The shaft 501 may be tapered or may be slotted in order to provide a smooth transition in stiffness over its length. In the embodiment shown a portion of the shaft material has been removed from the distal portion 516 of shaft 501 in order to provide an exit port for actuation member 512 and to provide a connection member to the proximal end of tubular portion 502. This distal portion 516 may also be flattened, which may assist in creating a similar curvature to that of the tubular portion 502 so that the two portions can be smoothly joined together by welding, soldering, bonding or other appropriate method of fixation. The main body of the shaft may also have an oval or somewhat flattened profile, as this may be beneficial in allowing the user to seal a hemostasis valve around the shaft and a microcatheter when the two are side by side in the guide/sheath as shown previously in FIG. 11 a.
  • The reinforcement member 507 may be formed from a metal (such as stainless steel or Nitinol or MP35N or other suitable alloy) or from a high modulus polymer material. In one embodiment (as shown) the reinforcement is formed from a tube from which sections 509 have been cut away to add lateral flexibility while maintaining column and hoop strength.
  • In the catheter illustrated in FIG. 60 the actuatable seal 504 is located adjacent to the proximal end of the distal tubular section, where it also forms the exit/entry port to the proximal end of the distal tubular section 502, but it could be positioned more distally in other variants of the invention. Once the catheter has been advanced to a position proximal of or adjacent the target clot the seal can be actuated to effect a seal between the proximal portion of the tubular section of the RX clot removal catheter and the inner lumen of the guide catheter. A vacuum force can then be applied to the proximal end of the guide catheter using a syringe or pump. This vacuum force will create a low pressure region inside the guide catheter which will extend (via the seal) into the distal tubular portion of the RX clot removal catheter. This low pressure will create a pressure gradient at the tip of RX clot removal catheter which will encourage the flow of clot into the catheter.
  • In some scenarios, such as when retrieving a firm clot with a high fibrin content, it may not be possible to aspirate the clot fully into and through the RX clot removal catheter, and the clot may become lodged at the tip of the catheter. In such a case it may be necessary to remove the RX clot removal catheter with the clot through the guide catheter and out of the patient. It may be desirable to create reverse flow in the cerebral vasculature during this retrieval process in order to prevent the escape and distal migration of any fragments of the clot being retrieved. This can be done by disengaging the RX clot removal catheter seal so that the low pressure zone is redirected into the distal lumen of the guide catheter. Thus pressure gradient between the blood in the cerebral vasculature and the fluid within the guide catheter lumen causes a flow of the blood from the high pressure region to the low pressure region. The seal as shown can also serve to create a guiding feature to assist the advancement of another device into the tubular distal section of the clot removal catheter. This might be advantageous if for example the catheter was used as a primary clot debulking tool—so that it was advanced to a target clot and aspiration was applied to it through the guide catheter to remove the occlusive clot but was not successful in removing all of the clot. In this case a microcatheter (and guidewire if desired) could be advanced through the RX clot removal catheter and across the remaining clot so that a thrombectomy device could then be advanced through the microcatheter. The thrombectomy device and remaining clot could then be withdrawn into the RX clot removal catheter (under aspiration if desired) to complete the recanalization of the patient's vessel.
  • FIGS. 61a-61c illustrate a method of use of the RX clot removal catheter 500. This catheter can be used in a similar manner and for a similar purpose to catheter 101 illustrated previously in FIGS. 10 and 11, except that the seal/flow restrictor of catheter 500 can be selectively activated or deactivated by the user. The catheter can be used as the primary clot retrieval device as shown in FIGS. 61a-c , or as an adjunctive device as shown in FIGS. 11a-d . FIG. 61a shows the catheter 500 advanced through a guide catheter 550 towards a target clot 555 located in blood vessel 554. In this case the catheter 550 has an external flow restrictor in the form of a balloon at its distal end.
  • The method of use of such a system could entail: Accessing the patient's vasculature using standard methods, advancing a guiding catheter or sheath 550 to a region proximal of the target occlusive clot 555, advancing the RX clot removal catheter 500 through the guide/sheath to a location proximal or adjacent to or within the target clot as shown in FIG. 61a (which may be achieved with the aid of a microcatheter and/or guidewire and/or thrombectomy device), activating the proximal flow restrictor/seal 504 of the catheter 500 to connect the lumens of the two catheters, inflating the external balloon (if present and if desired) at the end of the guide/sheath, aspirating using a syringe 556 or vacuum pump (not shown) through the a connector 551 attached to the proximal end of the guide/sheath 550 so that a pressure gradient is created which sucks blood and clot into the mouth 503 of the Rx clot removal catheter 500 and through the catheter 500 and the guide/sheath 550 and into the syringe as shown in FIG. 61b . If any clot remains caught in the end of the catheter tip 503 (as may happen if the clot has a significant organized fibrin component such as may occur in clots originating from a heart valve or an atrial appendage for example) it may be necessary to withdraw the catheter 500 and the trapped clot 555 together through guide/sheath 550 and out of the patient as shown in FIG. 61c . In such a scenario the flow restrictor/seal 504 may be deactivated so as to enable a vacuum force applied by the syringe to the guide/sheath to be transmitted to the distal end 553 of the guide/sheath and thus create flow reversal and draw blood and any clot fragments 557 back into the tip of the guide/sheath as the captured clot is retracted.
  • FIG. 62 depicts another system of this invention which functions in a similar manner to the previously described Rx catheter systems, but in this case the flow restrictor or seal between the inside of the guide/sheath 600 and the outside of the Rx catheter 603 is created by a sealing element 602 attached to the inside of the guide/sheath 600. This sealing element 602 may comprise an inflatable balloon, similar to the external flow restricting balloon 601 shown on the outside of the guide/sheath.
  • FIG. 63 depicts another system of this invention in which an Rx clot retrieval catheter 650 has two flow restrictor/ seal elements 651 and 652. The more proximal restrictor 651 is used to restrict flow between the Rx catheter 650 and the guide catheter 655 within which it is positioned, while the more distal restrictor 652 is used to create a flow restriction within vessel 656. The combination of these two flow restrictors means that a vacuum or negative pressure can be applied to the proximal end of guide catheter 655 and transmitted to the distal end of Rx catheter 650 in such a way that any blood aspirated into the mouth of Rx catheter 650 is not supplied from the body of blood proximal to seal 652 in vessel 656.
  • This system enables a physician to use a standard guide or sheath to rapidly create an access path to the region of the target occlusion, and then use the Rx catheter 650 to quickly access and aspirate the target clot from the vessel. This system provides a major advantage in the speed and ease with which a physician will be able to access and retrieve the clot. The provision of the distal vessel seal 652 on the Rx catheter rather than on the guide or sheath means that this seal can be placed more distally in the vasculature, past the petris portion of the carotid vasculature when used in the ICA for example, which means less likelihood of vessel collapse when a suction force is applied, and less likelihood of vessel spasm.
  • In a preferred embodiment the flow restrictors/seals are actuatable and are formed from compliant balloons, which are inflated via a hollow shaft 657 by means of a syringe or inflator 653 applied to handle 654 of the Rx catheter 650. In other embodiments the proximal flow restrictor may be passive (i.e. it cannot be selectively activated or inactivated) as shown in several other designs in this disclosure. In yet other embodiments the distal seal may be actuated by means of an actuating member rather than an inflation lumen.
  • Most of the Rx (rapid exchange) catheters disclosed herein share some common features and geometry. Taking catheter 500 of FIG. 60 as an example: They have a distal generally tubular portion 502 having an inner lumen which starts with an opening or entry/exit port 517 and ends in a distal tip or mouth 503 into which clot is received. They have a proximal elongate shaft 501 which is connected at its distal end to the entry/exit port 517 and at its proximal end in some embodiments to a handle 513. The preferred geometry of these catheters depends on the target clot location. For clots located in the anterior or posterior cerebral anatomy the distal tubular portion 502 is preferably greater than 10 cm (so that it can extend from within the distal end of a guide/sheath which may be located in an internal carotid artery or a vertebral artery, right up to the proximal face of a target clot), and less than 40 cm so that the minimum possible length of tubular portion 502 is located within the lumen of the guide/sheath, thus maximizing the internal volume of the combined guide/Rx catheter system for optimum aspiration efficacy).
  • The optimal internal and external diameters of the Rx catheter depends very much on the site of the target clot and the size of the guide catheter or sheath through which the catheter is to be advanced. In the case of retrieval of occlusive clots from cerebral vessels the likely vessel diameters range from approximately 1.5 mm up to 6 mm, with 3 mm being a very typical diameter. Guide catheters/sheaths used in these scenarios have typically an internal diameter of between 0.060″ and 0.095″, so that a suitable system might consist of a guide catheter with an internal diameter of 0.078″ and an Rx clot retrieval catheter whose distal tubular section has an outside diameter of 0.070″ and an inside diameter of 0.062″. Such a system provides a very significant benefit in terms of flow resistance over an equivalently sized conventional combination of a guide and intermediate/aspiration (not rapid exchange) catheter. In particular the effective proximal lumen of the system of this invention is that of the guide catheter (0.078″), while the effective proximal lumen of the conventional system would be that of the intermediate/aspiration catheter (0.062″). This results in a significantly lower flow restriction in the Rx system of the invention, which means that for a given vacuum/suction force applied to the proximal end of the system, a much greater flow will be created through the system of this invention. While a conventional (not rapid exchange) intermediate/aspiration catheter may be stepped in diameter to maximise its proximal internal diameter, this proximal internal diameter must always be significantly smaller than the guide/sheath in which it is positioned. This is not the case in the system of this invention.
  • Yet another embodiment of this invention is shown in FIGS. 64a-d , which depict a distal end configuration which could be employed with any of the clot retrieval catheters previously shown. The catheter distal end 700 has an integrated control member 701, which forms a loop 704 at the tip where it is connected to tip members 703 so that it acts like a draw string when pulled. The tip may comprise relatively stiff members 703 interspersed with relatively compliant members 702, so that the tip has both axial stiffness (to permit effective operation of the drawstring mechanism) and radial compliance (to allow expansion and contraction of the tip).
  • Therefore when actuated by pulling as shown in FIG. 64b , the control member causes the tip of the catheter to reduce in diameter. This can improve the ability of the catheter to track through tortuousity and across obstacles such as the origin of the ophthalmic artery.
  • Similarly when the control member is pushed forward it can cause or allow the catheter tip to expand forming a funnel shape as shown in FIG. 64c . This can improve the ability of the catheter to aspirate clots and also act as a flow restrictor in the vessel.
  • In use the control member may be pulled back during insertion of the catheter to improve accessibility. It can then be forwarded to increase the diameter of the tip and aspirate the occlusion.
  • If the occlusion or blood clot can only be partially aspirated, then the tip diameter can be reduced again by pulling the control member, causing the clot to be trapped as shown in FIG. 64d , reducing the risk of the clot travelling to a new territory during retraction of the catheter and improving dislodgement.
  • The flaps 703 of the catheter tip are not rigidly connected to the integrated control member 701 but form a loop which can slide over the control member. The control member distal end 706 may also be fixed to the inner surface of the catheter.
  • Referring to FIG. 65 there is illustrated an aspiration catheter 801 according to this invention in use in a thrombectomy procedure. The catheter 801 is similar to catheter 101 of FIGS. 10 and 11 and provides a proximal seal 802 against a guide catheter inner lumen 803 so that aspiration applied by syringe 811 (or a pump or by other means) through guide catheter 808 (via a rotating hemostasis valve (RHV) 814) can be transferred through to the distal end 812 of the aspiration catheter. Thrombectomy device 800 is shown deployed within clot 810, having been delivered through microcatheter 809 by means of proximal shaft 807. The method of use of the system illustrated is very similar to that described in FIGS. 11a-d , except that in this embodiment the proximal end 815 of the microcatheter 809 and proximal end 806 of Rx aspiration catheter 801 are positioned within separate branches of a rotating hemostasis valve (RHV) 813. This configuration provides significant ease of use advantages over the configuration described in FIG. 11. In particular the RHV 813 can be more easily sealed around the proximal shaft 806 of the aspiration catheter to prevent any air ingress (or fluid leakage) during aspiration. In addition the user has better control over the aspiration catheter 801, microcatheter 809 and thrombectomy device 800 relative to the guide catheter 808, and can use RHVs 813 and 814 to lock and hold the aspiration catheter or microcatheter independently of each other.
  • One embodiment of the method of use of such a system could consist of the following steps: Accessing an arterial blood vessel of a patient using conventional means such as an introducer and guide catheter 808 and/or sheath, advancing Rx aspiration catheter 801 through a first branch of RHV 813 attached to proximal end of guide catheter 808, advancing a microcatheter 809 through a second branch of RHV 813 and through the aspiration catheter 801 and guide catheter 808 up to and across a target occlusive clot 810 with or without the aid of a guidewire, removing the guidewire (if used) and advancing a mechanical thrombectomy device 800 such as a stent-retriever through the microcatheter 809 to the target clot 810, retracting the microcatheter 809 at least a few cm to deploy a mechanical thrombectomy device 800 within the clot 810, advancing the aspiration catheter 801 up to a position just proximal of the clot 810 (or within the clot, or considerably proximal of the clot if vessel disease or tortuosity makes access difficult), optionally creating flow arrest by inflating the balloon of the guide catheter 808 (if used, or by other means), aspirating through the aspiration catheter 801 using a syringe 811 or pump connected to the guide catheter 808 while withdrawing the mechanical thrombectomy device 800 towards and into the distal mouth 812 of the aspiration catheter 801, withdrawing the clot 810, mechanical thrombectomy device 800 and microcatheter 809 through the aspiration catheter 801 and guide catheter 808 and out of the patient while continuing to aspirate.
  • A possible variant of the final step of the above method could involve removing the aspiration catheter along with the clot 810, mechanical thrombectomy device 800 and microcatheter 809. This variant is useful if a large and/or firm clot is encountered which the physician cannot (or does not wish to) fully withdraw into the mouth of the aspiration catheter. In such a situation the RHV 813 must be removed once the exit port 805 of the aspiration catheter 801 reaches the RHV 813.
  • Another method of use of such an Rx aspiration catheter system is to retrieve clot using aspiration without the use of a thrombectomy device. The rapid exchange shaft of this invention provides great advantages in terms of speed, deliverability, ease of use and aspiration lumen. A microcatheter or other similar catheter and guidewire nay be used to provide support to assist in tracking the aspiration catheter to the target site in a similar manner to that illustrated in either FIG. 65 or FIGS. 11a -d.
  • FIGS. 66a-66e illustrate an intermediate or aspiration catheter with an expansile tip that can be delivered in a constricted form. The side and end view of this device showing the tip in the collapsed configuration are shown in FIGS. 66a and b . The tip material 901 can be folded inside the lumen to facilitate expansion. The expanded tip configuration of the device is shown in FIGS. 66c and 66d . This increased tip diameter facilitates the aspiration and removal of large clot volumes by increasing the area of the catheter tip that applies aspiration to the clot. FIG. 66e illustrates the construction/support frame of the device, which can be cut from a metal or polymer tube and covered with a thin polymer sleeve 909 (as shown in FIG. 66b ) containing highly elastic properties. This construction can give good pushability and high compressive resistance. The cut pattern can contain axial connections 908 and ring members 906, which will provide a large level of axial support, lateral flexibility and hoop strength to withstand aspiration. The tip of the device can contain a section 907 proximal of the highly flexible area 905 that can expand to except clot. This potential to increase body diameter facilitates the retrieval of large volume clots in a ‘snake belly effect’ while the construction of the catheter provides good column stiffness to avoid axial collapse and still maintain good flexibility.
  • In one embodiment frame 904 of the expansile tip can be gold or platinum coated to improve radiopacity and allow the user to visually confirm expansion of the tip. A highly flexible area 905 is located proximal of the expansile tip to allow the tip to optimally align with the clot face. In one embodiment this device can have an outer sleeve 909 with a high elastic strain limit and a low modulus to permit its expansion by a low radial force. A preferred membrane is a polyurethane membrane, which might be extruded or blow moulded or ideally dip coated directly onto the frame. The membrane may be coated internally and externally with a low friction coating such as a hydrophobic silicone or a hydrophilic material. In one embodiment the membrane is a hydrophilic material itself, having a hydrogel with sufficient thickness and modulus to retain its structure under the force of aspiration. Other suitable materials for this cover include PTFE, ETFE and PFA. In one embodiment the sleeve 909 can be inserted through the inner lumen of the support structure, wrapped around the distal tip and drawn back over the exterior of the catheter to create a one piece internal and external sleeve covering. This would have many benefits within manufacturing stages and also benefit device durability as there would be no material joints at the distal tip to delaminate, it could also provide an atraumatic tip profile.
  • FIGS. 67a-67c illustrate a rapid exchange clot retrieval catheter 953 with an internal self-expanding feature to help expand the distal tip for improved aspiration and also provide strong clot grip. The device consists of a self-expanding element 950 connected proximally to a control wire 956 which is located inside the catheter Rx shaft 955. The catheter tip 952 is normally in the collapsed configuration as shown in FIG. 67a when the internal self-expanding element 950 is in the proximal position shown. The distal end of the self-expanding assembly 950 is kept proximal of the tapered catheter tip 952 during device advancement in the vasculature until the catheter 953 is at the target location adjacent to the clot 951. Once the catheter 953 is in position the element 950 is advanced distally into the expansile tip 952 via the control wire 956. This action expands the catheter tip 952 to create a large open mouth receptacle that is advantageous to clot 951 aspiration due to the increased contact area of the tip.
  • Once clot 951 has been drawn into the expanded catheter tip 952 with aspiration, the element 950 is pulled proximally using the control wire 956. In doing so the clot 951 is gripped further by the feature 952 and pulled proximally into the catheter 953. The self-expanding element 950 can be constructed from a super elastic material such as Nitinol and can be constructed from Nitinol wires or from an expanded laser cut tube. In this configuration the internal self-expanding element 950 does not protrude past the distal tip of the catheter 953 at any point in the procedure.
  • FIGS. 68a-68b illustrate a clot retrieval aspiration or intermediate catheter with mechanical and actuatable clot gripping features.
  • FIG. 68a illustrates a barbed tipped shaft 1001 attached to a proximal control shaft 1004, the device is delivered to the occlusion 1003 through the catheter 1000. Aspiration is applied to anchor/pull the clot 1003 into the catheter tip, once inside/anchored to the catheter tip a mechanical barbed device feature 1001 is advanced into the aspirated clot 1003 via the connected proximal control shaft 1004. Once mechanical grip is attained the clot 1003 is pulled further into the catheter 1000 or securely anchored within the catheter tip for retrieval with catheter. This device could be constructed so that the barbed device 1001 cannot protrude past the tip of the catheter and hence cannot contact the vessel wall.
  • FIG. 68b illustrates an actuated pinch/gripper mechanism 1002 attached to a proximal control shaft 1004, the device is delivered to the occlusion 1003 through the aspiration catheter 1000. Aspiration is applied to anchor/pull the clot 1003 into the catheter tip and once partially inside/anchored to the catheter tip an actuatable pinch/gripper device 1002 is advanced to the aspirated clot 1003 and actuated by the user to grip/pinch the clot via the connected proximal control shaft 1004. Once mechanical grip is attained the clot 1003 is pulled further into the catheter 1000 or securely anchored within the catheter tip for retrieval with the catheter.
  • FIGS. 69a-69c illustrate a rapid exchange catheter device 1050 and associated snare system integrated within. The snare consists of a distal loop 1054 located within the RX catheter 1055 tip and attached to actuator wires 1052. The distal loop 1054 is secured at two opposing points within the tip, on one side an internal feature 1056 that causes the snare to close down in diameter when pulled proximally and on the other side the snare loop is secured by a feature 1053 that holds the snare 1054 in position whilst the catheter 1055 is being pressed against the clot face. The feature 1053 allows the snare 1054 to break free once it is actuated using control wires 1052. The catheter 1050 shown is a rapid exchange (RX) catheter with an exit port 1058 that defines a transfer port for aspiration and provides a deliverability advantage of minimal frictional engagement with the guide catheter proximal of the exit port.
  • The Rx aspiration catheter can be forwarded using the proximal hypotube 1059 to contact the clot face. Upon contact with the clot, aspiration can be applied and the clot 1060 or a portion of the clot is drawn inside the RX catheter tip through the snare 1054 as shown in FIG. 69c . The snare is then actuated via the control wire 1052 that is housed within the catheter control hypotube 1059. Once adequate resistance or lock up is felt the RX catheter 1050 and integrated snare device 1054 can be extracted with the clot 1060 securely held as shown in FIG. 69d . In another embodiment the integrated snare 1054 can be removed from the RX catheter 1055 by simply retracting the snare device proximally using the control wires 1052 housed with the RX catheter hypotube 1059. This would allow the RX catheter 1055 to be used to deliver a microcatheter and/or stentriever device to a distal location.
  • FIGS. 70a-70b illustrate an actuated RX expansile tip catheter device that can be actuated to act as an expansile clot receptor during aspiration coupled with an integrated snare device. The expansile tip/integrated snare is actuated via a slider mechanism 1106 housed within a proximal control handle 1105. The catheter tip consists of two materials, a support material 1104 to give lateral strength, resist compression and sustain integrity during aspiration coupled with an expansile material 1100 to facilitate expansion whilst maintaining a closed wall structure at the tip that is capable of maintaining aspiration. The snare wire 1102 is integrated into a circumferential lumen 1101 within the expansile catheter tip where it is free to slide within the lumen 1101 when actuated via slider mechanism 1106. The wire 1102 is fixed to the end points 1103 of the circumferential lumen 1101 within the catheter tip. The circumferential lumen 1101 located within the catheter tip provides an added grip feature for clot. The actuator wire 1108 runs distally from the control handle assembly 1105 to the catheter tip via a separate lumen 1109 integrated within the main RX lumen 1110, this allows the main lumen 1110 to be used to deliver further catheters or thrombectomy devices to the occlusion site.
  • The expansile tip can be closed down to a taper using the control handle assembly 1105, this greatly improves catheter deliverability in tortuous anatomy along with lessening any traumatic effects on the vessel. Once in position at the clot face the catheter tip can be actuated to expand using the slider 1106 on the control handle assembly 1105. Aspiration can be applied to draw clot within the expanded catheter tip, and any clot that is too large to aspirate can be secured within the catheter tip by closing the tip down via the control handle assembly 1105 and extracting the RX Catheter system and clot together.
  • FIGS. 71a-71b illustrate an expansile tip intermediate or aspiration catheter with inner grip features located on the internal surface of the catheter tip. In one embodiment the internal grip features 1154 can be uni-directional features located upon the inner surface of the aspiration catheter 1151 that allow a low friction, low opposition entry of clot 1157 within the expansile catheter tip 1150 under aspiration. These uni-directional grip features 1154 serve to embed deeper, grip further and retain the clot when force is applied to them in an opposing direction during retrieval of catheter 1151. The expansile tip 1150 allows for accommodation of a larger clot volume during aspiration.
  • In one embodiment an atraumatic tip 1159 mounted on a control wire 1155 can be placed in position within the grip features 1154 of the catheter tip 1151. This tip 1159 consists of an inner lumen 1152 with a tapered atraumatic nose 1153. This tip 1159 is positioned within the distal tip of the catheter 1151 during advancement. It gives an atraumatic nose 1153 to the catheter 1151 which serves to aid catheter delivery and lessen vessel trauma. The tip 1159 also provides an atraumatic inner lumen 1152 in which further devices can be delivered without any interaction with the inner grip features 1154 located within the catheter tip 1150. Once any secondary devices have been delivered through the device 1159 to the occlusion site, the tip 1159 can be withdrawn proximally using the control wire 1155, this will serve to expose the uni-directional grip features 1154 within the catheter tip for use during clot 1157 retrieval.
  • FIGS. 72a-72b illustrate a multi-point aspiration catheter device 1210 in which sections of material constrained at one end are fixed into the catheter wall and act as a hinged tab. FIG. 72a illustrates a hinged tab 1200 in the closed position, which remains closed under aspiration until the catheter tip 1206 becomes occluded with clot 1205. FIG. 72b illustrates that when aspiration is applied through the lumen of the catheter 1201 via either a vacuum pump or syringe the catheter tip can become occluded with clot 1205. At this point the tab 1200 will bend at the hinge point 1204, thus opening up the aspiration lumen within the catheter 1201 to continue aspiration of emboli 1202. If the aspiration level drops below the specified level needed to bend the tab 1200 at the hinge point 1204 it will simply close and all aspiration will once again be directed to the catheter tip until it becomes occluded again with clot 1205, at which stage the tab 1200 will open once again. The tab 1200 material can be specified such that the vacuum level within the catheter lumen can be balanced at a pre-determined range. The tab 1200 can be formed from a variety of flexible materials with different properties such that they will bend at varying levels of aspirational force or alternatively they can be cut directly from the catheter material. Multiple tabs may be positioned at varying points around the catheter circumference and along the length to facilitate alternate aspiration points.
  • In another embodiment of the invention shown in FIGS. 73a and 73b , the clot engagement feature 1252 is an integral part of the intermediate catheter construction 1255. The intermediate catheter 1255 can be introduced into the vasculature and forwarded to a position proximal of the clot. The microcatheter 1251 can then be forwarded through the intermediate catheter 1255 as per standard interventional techniques and a stentriever device 1250 deployed at the target location within the clot (not shown). The clot engagement feature 1252 can be forwarded by advancing the push-wire 1256 until the engagement feature 1252 contacts the clot. This is facilitated by the handle construction 1265 attached to the proximal end of the catheter 1255. A slider button 1258 on the handle 1265 may be connected to the push-wire 1256 to enable the clot engagement feature to be advanced. Aspiration can be applied to the vessel via the catheter 1255 and the luer connection on the handle 1259. A seal may be maintained on the proximal end of the microcatheter 1262 during aspiration by the hemostasis valve 1261. The clot engager 1252, microcatheter 1251 and stentriever 1250 can then be held in a static position and the intermediate catheter 1255 advanced to cause the clot engagement feature 1252 to collapse down over the clot further enhancing grip on the clot, and partially resheathing the stentriever device 1250. This is facilitated by the slider button 1260 which is connected to catheter 1255 in the handle 1265. The handle and slider buttons make it easier for the user to control the advancement and retraction of the devices used in the procedure. The catheter 1255, stentriever 1250, microcatheter 1251 and clot can be removed from the vasculature as a single unit through the guide catheter or introducer sheath.
  • This device configuration may also be used without an additional stentriever and microcatheter. In this scenario, the clot engagement feature 1251 is forwarded into the proximal face of the clot. Aspiration is applied through the catheter and then the catheter 1255 is forwarded to cause the clot engagement feature 1251 to wrap down over the clot, gripping the clot securely. The clot engagement feature 1255 may be fully retracted into the catheter using the slider button 1258 to fully retrieve the clot, before the device is retracted. Alternatively, the clot engager 1255 and the clot may be held static and the catheter 1255 advanced over the clot engager 1255 and clot.
  • FIGS. 74a and 74b illustrate the distal tip 1305 of an intermediate or aspiration catheter that has an inner sleeve 1300 and an outer sleeve 1301. The sleeves are connected at the distal end by a flexible polymer sleeve 1302. The flexible sleeve 1302 is shown in its initial position in FIG. 74a . The catheter is advanced in the vasculature until the distal end of the catheter contacts the clot 1304. Aspiration is applied to the catheter to pull the clot 1304 into the catheter and remove it from the vasculature. If the clot is not fully removed the outer sleeve of the catheter 1301 may be advanced relative to the inner sleeve 1300 so that the flexible sleeve 1302 rolls over the clot providing enhanced grip and encapsulating the clot. The catheter and clot may then be removed as a single unit.
  • Alternatively the inner sleeve 1300 may be retracted proximally relative to the outer sleeve 1301 to help pull the clot 1304 into the catheter 1305 under aspiration. This may facilitate clot removal through the aspirate, or provide enhanced grip so that the catheter and clot may be removed as a single unit. The length of the flexible sleeve may vary from 2 mm to 30 mm but in the preferred embodiment varies from 5 to 15 mm. The sleeve may be formed from a flexible polymer such as polyurethane or may be constructed from a wire or polymer fibre braid. Nitinol wire braid is particularly suited to this construction due to its Superelastic and shape memory properties.
  • FIGS. 75a to 75d show a method of use to remove a clot 1351 from the vasculature 1355. FIG. 75a shows a microcatheter 1352 advanced across the clot 1351 using standard neuro-interventional techniques. The stentriever device 1350 is partially deployed to allow the fragment protection feature to expand and protect the distal vasculature from any emboli that may be released from the clot. The catheter 1354 is introduced into the vasculature and forwarded until the distal tip 1356 is in contact with the proximal face of the clot. Aspiration is applied through the catheter during advancement or when in contact with the clot to attempt to retrieve the clot fully. The catheter tip 1356 is shown in these images in a skive configuration but it may be any configuration described elsewhere in this patent.
  • If the clot 1351 has a large volume or has a high fibrin content, it might not be fully aspirated but may be partially aspirated in the catheter 1354 as shown in FIG. 75b . The microcatheter 1352 can then be retracted to deploy the remainder of the stentriever device 1350. The deployment of the device 1350 pins the partially retrieved clot 1353 against the inner surface of the catheter 1354 providing enhanced grip to the clot. The stentriever device 1350 may be further retrieved to pull the clot 1351 further into the catheter as shown in FIG. 75d . In this manner the clot 1351 may be fully retracted into the catheter 1354 and be removed or the clot 1351, catheter 1354 and stentriever device 1350 may be removed from the vasculature as a single unit.
  • FIGS. 76a and 76b show a partial cut-away view of a catheter tip construction 1410 suitable for use with a ‘rapid exchange’ (Rx) intermediate or aspiration catheter 1403. The Rx intermediate catheter is described elsewhere in this patent. This tip construction 1410 can be integrated into any access catheter such as a balloon guide catheter or introducer sheath 1402. The catheter tip 1410 is constructed so that it forms a seal 1400 between the sheath 1402 and the intermediate catheter 1403. Therefore when aspiration is applied to the proximal end of the sheath 1402 as per standard technique using a syringe or pump, this aspiration low pressure and flow rate is transmitted to the tip 1409 of the Rx intermediate catheter 1403 via the Rx port 1408 of the catheter. The seal 1400 between the sheath and the Rx intermediate catheter prevents blood flow into the tip of the sheath 1401; ensuring maximum aspiration effectiveness is transmitted to the tip of the Rx intermediate catheter 1409. The tip of the catheter 1401 may have a flared shape as shown to facilitate the retrieval of clot 1411 that may be exposed at the end of the Rx intermediate catheter 1409.
  • FIG. 76b shows an alternative embodiment of this invention where the catheter tip 1404 also forms a seal with the outer surface of the Rx intermediate catheter 1405 to ensure the maximum flow rate and pressure drop are transmitted through the Rx port 1408 of the Rx intermediate catheter 1405 during aspiration. Catheter tip 1404 may be constructed from an elastic polymer material such as polyurethane and has a necked down profile in its relaxed configuration. When the intermediate catheter 1405 is forwarded through the tip 1404, it stretches to accommodate the intermediate catheter and forms a seal. The inner surface of the tip 1404 can be lined with a low friction material such as HDPE or PTFE or may have a hydrophilic or low friction coating applied to minimise resistance to advancing the intermediate catheter 1405. This tip configuration 1404 may also act as an atraumatic tip for the introducer sheath 1402 during insertion and may improve trackability over a 0.035″ guidewire as the reduced tip diameter acts as a lead-in to the catheter.
  • FIG. 77 illustrates another configuration of an intermediate catheter 1450 where the tip 1451 is self-expandable so that when it is advanced distal to the guide catheter or sheath 1454, it can expand to a diameter greater than the inner diameter of the access catheter 1454. The expanded diameter of tip 1451 can vary from 1.times. to 3.times. the inner diameter of the guide catheter or sheath 1454 and in the preferred embodiment can range from 1× to 2×. The construction of this tip is described elsewhere in this patent. Proximal to the expanded tip 1451 is the catheter segment 1452 which has a reduced diameter compared to the body section of the catheter 1453. The reduced diameter section 1452 provides enhanced flexibility and trackability of the catheter allowing it to navigate through tortuous anatomy and reach the target location of the clot in the vasculature. The reduced diameter section can vary in length from 20 mm to 200 mm and in the preferred embodiment is approximately 100 mm long. The diameter of this section can vary from 30% to 80% of the body section 1453 diameter and in the preferred embodiment is approximately 50% to 60% of the body section diameter.
  • FIGS. 78a and 78b show another configuration of the invention and illustrate the distal section 1500 of a catheter. The tip of the catheter is configured so that there is a neck down region 1501 just proximal of the distal tip 1502. In this configuration the distal tip 1502 is the same diameter as the body section 1503. The neck down region 1501 provides a flare angle (a) to the distal tip 1502. This flare angle facilitates improved aspiration of clots as it improves the approach angle of the catheter to the clot as it is advanced in the vasculature. This is particularly relevant in bends and tortuous anatomy as shown in FIG. 78b . In this figure the catheter 1503 is advanced through the vessel 1505 until it is in contact with the clot 1506. The flare angle of tip 1502 ensures good contact with the clot 1506 and the necked down portion 1501 improves the flexibility of the tip and allows the tip 1502 to flex and align with the vessel facilitating improved aspiration of the clot.
  • It will be apparent from the foregoing description that while particular embodiments of the present invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. For example, while the embodiments described herein refer to particular features, the invention includes embodiments having different combinations of features. The invention also includes embodiments that do not include all of the specific features described.
  • The invention is not limited to the embodiments hereinbefore described which may be varied in construction and detail.

Claims (19)

What is claimed is:
1. An aspiration catheter comprising:
an elongate body;
an expansile distal tip continuous with the elongate body;
an expanding assembly alignable internal to the expansile distal tip and connected proximally to a control wire, the expanding assembly comprising:
a proximal position within the expansile distal tip proximal of a distal most end of the expansile distal tip; and
a distal position where the expanding assembly is distally moved, by the control wire, until being aligned with and contacting the distal most end of the expansile distal tip causing the expansile distal tip to form a funnel mouth to receive clot.
2. The catheter of claim 1, wherein the catheter is a rapid exchange catheter.
3. The catheter of claim 1, the expansile distal tip comprising a distal segment and a proximal segment, the distal segment comprising a diameter larger than a diameter of the proximal segment.
4. The catheter of claim 3, the control wire passing through both the distal and proximal segments of the expansile distal tip.
5. The catheter of claim 3, the proximal segment comprising a catheter Rx shaft with an inner lumen.
6. The catheter of claim 1, the distal end of the expanding assembly comprises a plurality of struts actuatable by the control wire that form the funnel mouth.
7. The catheter of claim 1, the expansile distal tip being distally tapered when the expanding assembly is in the proximal position.
8. The catheter of claim 7, wherein the expansile distal tip comprises a plurality of radially arranged folds configured to facilitate the expansile distal tip expanding to form the funnel mouth of the distal position.
9. The catheter of claim 1, the expanding assembly comprising a super elastic material and one or ore more wires comprising a memory alloy.
10. The catheter of claim 1, the expanding assembly being self expandable and comprising a memory alloy.
11. The catheter of claim 1, the expanding assembly being incapable of protruding distal of the expansile distal tip.
12. A method, comprising:
positioning an expanding assembly, in a proximal position internal to an expansile distal tip of a catheter;
connecting a control wire proximal to the expanding assembly; and
moving the expanding assembly, by the control wire, until being aligned with and contacting the distal most end of the expansile distal tip thereby causing the expansile distal tip to form a funnel mouth to receive clot.
13. The method of claim 12, the expansile distal tip comprising a distal segment and a proximal segment, the distal segment comprising a diameter larger than a diameter of the proximal segment.
14. The method of claim 13, further comprising:
passing the control wire through both the distal and proximal segments of the expansile distal tip.
15. The method of claim 13, the proximal segment comprising a catheter Rx a shaft with an inner lumen.
16. The method of claim 1 the expansile distal tip being distally tapered when the expanding assembly is in the proximal position.
17. The catheter of claim 1, the expanding assembly comprising a super elastic material and one or ore more wires comprising a memory alloy.
18. The catheter of claim 1, the expanding assembly being self expandable and comprising a memory alloy.
19. The method of claim 12, further comprising:
preventing, by the expansile distal tip, the expanding assembly from protruding distal of the expansile distal tip.
US17/038,301 2014-06-13 2020-09-30 Devices and methods for removal of acute blockages from blood vessels Abandoned US20210077134A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/038,301 US20210077134A1 (en) 2014-06-13 2020-09-30 Devices and methods for removal of acute blockages from blood vessels

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462011934P 2014-06-13 2014-06-13
US201462080724P 2014-11-17 2014-11-17
US14/737,249 US10441301B2 (en) 2014-06-13 2015-06-11 Devices and methods for removal of acute blockages from blood vessels
US201562266344P 2015-12-11 2015-12-11
US15/158,384 US10682152B2 (en) 2014-06-13 2016-05-18 Devices and methods for removal of acute blockages from blood vessels
US15/362,377 US10792056B2 (en) 2014-06-13 2016-11-28 Devices and methods for removal of acute blockages from blood vessels
US17/038,301 US20210077134A1 (en) 2014-06-13 2020-09-30 Devices and methods for removal of acute blockages from blood vessels

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/362,377 Division US10792056B2 (en) 2014-06-13 2016-11-28 Devices and methods for removal of acute blockages from blood vessels

Publications (1)

Publication Number Publication Date
US20210077134A1 true US20210077134A1 (en) 2021-03-18

Family

ID=58522684

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/362,377 Active 2035-10-06 US10792056B2 (en) 2014-06-13 2016-11-28 Devices and methods for removal of acute blockages from blood vessels
US17/038,301 Abandoned US20210077134A1 (en) 2014-06-13 2020-09-30 Devices and methods for removal of acute blockages from blood vessels

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/362,377 Active 2035-10-06 US10792056B2 (en) 2014-06-13 2016-11-28 Devices and methods for removal of acute blockages from blood vessels

Country Status (1)

Country Link
US (2) US10792056B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11534191B2 (en) 2019-01-11 2022-12-27 Anaconda Biomed, S.L. Loading device for loading a medical device into a catheter
US11679194B2 (en) 2021-04-27 2023-06-20 Contego Medical, Inc. Thrombus aspiration system and methods for controlling blood loss
US11771446B2 (en) 2020-10-19 2023-10-03 Anaconda Biomed, S.L. Thrombectomy system and method of use
US11986195B2 (en) 2018-10-16 2024-05-21 Anaconda Biomed, S.L. Device and a thrombectomy apparatus for extraction of thrombus from a blood vessel
US12161352B2 (en) 2015-01-13 2024-12-10 Anaconda Biomed, S.L. Thrombectomy device, system and method for extraction of vascular thrombi from a blood vessel
WO2024252274A1 (en) * 2023-06-04 2024-12-12 Ceretrieve Ltd. Embolus-retrieval device
US12285182B2 (en) 2018-10-10 2025-04-29 Innova Vascular, Inc. Devices and methods for removing an embolus
US12440231B2 (en) 2020-12-09 2025-10-14 Ceretrieve Ltd. Retrieval system and method
US12508042B2 (en) 2017-09-30 2025-12-30 Ceretrieve Ltd. Retrieval system
US12569264B2 (en) 2018-10-16 2026-03-10 Anaconda Biomed, S.L. Device and a thrombectomy apparatus for extraction of thrombus from a blood vessel
US12575845B2 (en) 2015-12-11 2026-03-17 Anaconda Biomed, S.L. Thrombectomy device, system and method for extraction of vascular thrombi from a blood vessel

Families Citing this family (203)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233085B4 (en) 2002-07-19 2014-02-20 Dendron Gmbh Stent with guide wire
WO2005094283A2 (en) 2004-03-25 2005-10-13 Hauser David L Vascular filter device
EP1986568B1 (en) 2006-02-03 2017-04-05 Covidien LP Methods and devices for restoring blood flow within blocked vasculature
US10076346B2 (en) 2007-04-17 2018-09-18 Covidien Lp Complex wire formed devices
US11202646B2 (en) 2007-04-17 2021-12-21 Covidien Lp Articulating retrieval devices
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US10517617B2 (en) 2007-12-20 2019-12-31 Angiodynamics, Inc. Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter
US11589880B2 (en) 2007-12-20 2023-02-28 Angiodynamics, Inc. System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure
US20170136158A1 (en) 2015-10-16 2017-05-18 Angiodynamics, Inc. Systems and Methods for Removing Undesirable Material Within a Circulatory System
JP5385302B2 (en) 2007-12-26 2014-01-08 ラザラス エフェクト, インコーポレイテッド Recovery system and method of use
KR101819554B1 (en) 2008-02-22 2018-01-17 마이크로 테라퓨틱스 인코포레이티드 Methods and apparatus for flow restoration
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
WO2012009675A2 (en) 2010-07-15 2012-01-19 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
EP2629684B1 (en) 2010-10-22 2018-07-25 Neuravi Limited Clot engagement and removal system
US12076037B2 (en) 2011-03-09 2024-09-03 Neuravi Limited Systems and methods to restore perfusion to a vessel
EP4566553A3 (en) 2011-03-09 2025-08-06 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
US9055964B2 (en) 2011-03-15 2015-06-16 Angio Dynamics, Inc. Device and method for removing material from a hollow anatomical structure
US12245788B2 (en) 2011-03-15 2025-03-11 Angiodynamics, Inc. Device and method for removing material from a hollow anatomical structure
CA2874586C (en) 2011-05-23 2019-07-09 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US8784434B2 (en) 2012-11-20 2014-07-22 Inceptus Medical, Inc. Methods and apparatus for treating embolism
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
PL2967610T3 (en) 2013-03-14 2019-07-31 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
WO2014140092A2 (en) 2013-03-14 2014-09-18 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
WO2014150288A2 (en) 2013-03-15 2014-09-25 Insera Therapeutics, Inc. Vascular treatment devices and methods
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US9592139B2 (en) 2013-10-04 2017-03-14 Covidien Lp Stents twisted prior to deployment and untwisted during deployment
US10238406B2 (en) 2013-10-21 2019-03-26 Inari Medical, Inc. Methods and apparatus for treating embolism
WO2015073704A1 (en) 2013-11-13 2015-05-21 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
US10226268B2 (en) * 2014-01-03 2019-03-12 Legacy Ventures LLC Clot retrieval system
US10285720B2 (en) 2014-03-11 2019-05-14 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
US10888346B2 (en) 2014-05-18 2021-01-12 Legacy Ventures LLC Clot retrieval system
US10441301B2 (en) 2014-06-13 2019-10-15 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US10265086B2 (en) 2014-06-30 2019-04-23 Neuravi Limited System for removing a clot from a blood vessel
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
WO2016083472A1 (en) 2014-11-26 2016-06-02 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
AU2016209354B2 (en) 2015-01-20 2020-11-05 Q'Apel Medical, Inc. Tubular structures with variable support
EP3256200A1 (en) 2015-02-11 2017-12-20 Covidien LP Expandable tip medical devices and methods
WO2016197036A1 (en) 2015-06-03 2016-12-08 Brian Martin Flexible intravascular treatment devices and associated systems and methods of use
US12082845B2 (en) 2015-09-04 2024-09-10 The Trustees Of The University Of Pennsylvania Systems and methods for percutaneous removal of objects from an internal body space
CN108135619B (en) 2015-09-25 2021-08-13 柯惠有限合伙公司 Medical Device Delivery System
CN111281482B (en) 2015-09-28 2023-03-28 斯瑞克公司 Mechanical embolectomy device
US10537344B2 (en) 2015-10-23 2020-01-21 Covidien Lp Rotatable connection between an intervention member and a manipulation member of an endovascular device
EP4233744B1 (en) 2015-10-23 2026-01-21 Inari Medical, Inc. Device for intravascular treatment of vascular occlusion
US10874410B2 (en) 2015-11-04 2020-12-29 Covidien Lp Clot removal by adhesion
US10265089B2 (en) 2016-02-12 2019-04-23 Covidien Lp Vascular device visibility
US10052185B2 (en) 2016-02-12 2018-08-21 Covidien Lp Vascular device marker attachment
EP3416568A4 (en) 2016-02-16 2019-10-16 Insera Therapeutics, Inc. Aspiration devices and anchored flow diverting devices
EP3419528B1 (en) 2016-02-24 2023-06-07 Incept, LLC Enhanced flexibility neurovascular catheter
CN109414272B (en) 2016-04-25 2021-09-28 斯瑞克公司 Reverse mechanical thrombectomy device and method for use in a vascular system
JP6924256B2 (en) 2016-04-25 2021-08-25 ストライカー コーポレイションStryker Corporation Pre-installed reversing tractor thrombectomy device and method
US11497512B2 (en) 2016-04-25 2022-11-15 Stryker Corporation Inverting thrombectomy apparatuses and methods
US11896247B2 (en) 2016-04-25 2024-02-13 Stryker Corporation Inverting mechanical thrombectomy apparatuses
ES2863415T3 (en) 2016-04-25 2021-10-11 Stryker Corp Thrombectomy equipment against obstruction and maceration
US10517624B2 (en) 2016-06-03 2019-12-31 Stryker Corporation Inverting thrombectomy apparatuses and methods
JP7082968B2 (en) 2016-07-27 2022-06-09 キューアペル メディカル, エルエルシー Tubular structure with variable support
JP7086935B2 (en) 2016-08-17 2022-06-20 ニューラヴィ・リミテッド Thrombus recovery system for removing thromboangiitis obliterans from blood vessels
CA3035706A1 (en) 2016-09-06 2018-03-15 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
JP2019526381A (en) 2016-09-12 2019-09-19 ストライカー コーポレイションStryker Corporation Self-rolling thrombectomy device and method
DK3528717T3 (en) 2016-10-24 2024-09-23 Inari Medical Inc Devices for treating vascular occlusion
EP3551095A1 (en) 2016-12-07 2019-10-16 Boston Scientific Scimed Inc. Medical device
CN110381855B (en) 2017-01-06 2023-07-04 因赛普特有限责任公司 Antithrombotic coating for aneurysm treatment devices
WO2018169959A1 (en) * 2017-03-13 2018-09-20 The Regents Of The University Of California Adjustable caliber catheter system
JP7332165B2 (en) 2017-04-10 2023-08-23 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン hydrodynamic vortex suction catheter
US11224458B2 (en) 2017-04-10 2022-01-18 The Regents Of The University Of Michigan Hydrodynamic vortex aspiration catheter
US11298145B2 (en) 2017-05-12 2022-04-12 Covidien Lp Retrieval of material from vessel lumens
US11129630B2 (en) 2017-05-12 2021-09-28 Covidien Lp Retrieval of material from vessel lumens
US10722257B2 (en) 2017-05-12 2020-07-28 Covidien Lp Retrieval of material from vessel lumens
US11191555B2 (en) 2017-05-12 2021-12-07 Covidien Lp Retrieval of material from vessel lumens
US10709464B2 (en) 2017-05-12 2020-07-14 Covidien Lp Retrieval of material from vessel lumens
US11006841B2 (en) 2017-06-07 2021-05-18 Covidien Lp Systems and methods for detecting strokes
US10945746B2 (en) 2017-06-12 2021-03-16 Covidien Lp Tools for sheathing treatment devices and associated systems and methods
US10478322B2 (en) 2017-06-19 2019-11-19 Covidien Lp Retractor device for transforming a retrieval device from a deployed position to a delivery position
US10575864B2 (en) 2017-06-22 2020-03-03 Covidien Lp Securing element for resheathing an intravascular device and associated systems and methods
US10342686B2 (en) 2017-08-10 2019-07-09 Covidien Lp Thin film mesh hybrid for treating vascular defects
WO2021072331A1 (en) 2019-10-09 2021-04-15 Nasser Rafiee Tissue excision, cutting, and removal systems and methods
US11000682B2 (en) 2017-09-06 2021-05-11 Inari Medical, Inc. Hemostasis valves and methods of use
EP3456379B1 (en) * 2017-09-15 2020-03-11 Sorin CRM SAS Explantation assembly for retrieving intracorporeal autonomous capsules
US11351346B2 (en) 2017-10-24 2022-06-07 Venkat Tummala Balloon sheath and associated methods
US10835398B2 (en) 2017-11-03 2020-11-17 Covidien Lp Meshes and devices for treating vascular defects
US10912576B2 (en) 2017-11-09 2021-02-09 Stryker Corporation Inverting thrombectomy apparatuses having enhanced tracking
CN107789100B (en) * 2017-12-08 2024-04-12 河北瑞鹤医疗器械有限公司 Fusion device pusher
US10709463B2 (en) 2017-12-11 2020-07-14 Covidien Lp Electrically enhanced retrieval of material from vessel lumens
US11974752B2 (en) 2019-12-12 2024-05-07 Covidien Lp Electrically enhanced retrieval of material from vessel lumens
US12318126B2 (en) 2021-06-25 2025-06-03 Covidien Lp Current generator for a medical treatment system
US11058444B2 (en) 2017-12-11 2021-07-13 Covidien Lp Electrically enhanced retrieval of material from vessel lumens
US12004803B2 (en) 2021-03-15 2024-06-11 Covidien Lp Thrombectomy treatment system
USD847864S1 (en) 2018-01-22 2019-05-07 Insera Therapeutics, Inc. Pump
CN118986471A (en) 2018-01-25 2024-11-22 伊思凯米克尔有限公司 Devices, systems, and methods for removing blood clots
US11154314B2 (en) 2018-01-26 2021-10-26 Inari Medical, Inc. Single insertion delivery system for treating embolism and associated systems and methods
US11395665B2 (en) 2018-05-01 2022-07-26 Incept, Llc Devices and methods for removing obstructive material, from an intravascular site
WO2019212984A1 (en) 2018-05-01 2019-11-07 Imperative Care, Inc. Devices and methods for removing obstructive material from an intravascular site
CN112423683B (en) 2018-05-14 2024-06-18 史赛克公司 Flip thrombectomy device and method of use
US11090071B2 (en) 2018-06-22 2021-08-17 Covidien Lp Electrically enhanced retrieval of material from vessel lumens
US11517335B2 (en) 2018-07-06 2022-12-06 Incept, Llc Sealed neurovascular extendable catheter
US11471582B2 (en) 2018-07-06 2022-10-18 Incept, Llc Vacuum transfer tool for extendable catheter
US10531883B1 (en) 2018-07-20 2020-01-14 Syntheon 2.0, LLC Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter
AU2019321256B2 (en) 2018-08-13 2023-06-22 Inari Medical, Inc. System for treating embolism and associated devices and methods
JP7440496B2 (en) * 2018-09-10 2024-02-28 ストライカー コーポレイション Inversion thrombectomy device and method of use
EP3849440A1 (en) 2018-09-10 2021-07-21 Stryker Corporation Laser slotted grabbing device
WO2020052355A1 (en) * 2018-09-13 2020-03-19 杭州唯强医疗科技有限公司 Intravascular foreign body extraction apparatus
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
CA3119221A1 (en) * 2018-11-13 2020-05-22 Anaconda Biomed, Sl A thrombectomy system and methods of extracting a thrombus from a thrombus site in a blood vessel of a patient
US11077288B2 (en) * 2018-11-15 2021-08-03 Biosense Webster (Israel) Ltd. Flushing balloon catheter for observation and removal of clots under vessel bifurcation conditions
WO2020132003A1 (en) 2018-12-19 2020-06-25 Marblehead Medical Llc Internal carotid artery thrombectomy devices and methods
EP3908213B1 (en) * 2019-01-07 2024-03-13 Legacy Ventures LLC Clot retrieval system
JP7483409B2 (en) 2019-03-04 2024-05-15 ニューラヴィ・リミテッド Actuated Clot Retrieval Catheter
US11612430B2 (en) 2019-03-19 2023-03-28 Covidien Lp Electrically enhanced retrieval of material from vessel lumens
US11766539B2 (en) 2019-03-29 2023-09-26 Incept, Llc Enhanced flexibility neurovascular catheter
US20200345904A1 (en) * 2019-05-01 2020-11-05 Neuravi Limited Aspiration control valve
US11191558B2 (en) 2019-06-12 2021-12-07 Covidien Lp Retrieval of material from corporeal lumens
US11523838B2 (en) 2019-06-12 2022-12-13 Covidien Lp Retrieval of material from corporeal lumens
JP7621990B2 (en) 2019-06-24 2025-01-27 オーバスネイチ・メディカル・プライベート・リミテッド Balloon fixation guide catheter extension
CN121489592A (en) 2019-07-09 2026-02-10 Amx技术有限责任公司 Methods and devices for the treatment of removing heart valves
EP4427686A3 (en) 2019-09-11 2024-11-06 Neuravi Limited Expandable mouth catheter
CN113347916B (en) 2019-10-15 2025-04-25 因普瑞缇夫护理公司 Systems and methods for multivariate stroke detection
JP7638273B2 (en) 2019-10-16 2025-03-03 イナリ メディカル, インコーポレイテッド Systems, devices and methods for treating vascular obstructions
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11839725B2 (en) 2019-11-27 2023-12-12 Neuravi Limited Clot retrieval device with outer sheath and inner catheter
US11779364B2 (en) 2019-11-27 2023-10-10 Neuravi Limited Actuated expandable mouth thrombectomy catheter
US12539130B2 (en) 2019-11-27 2026-02-03 Neuravi Limited Aspiration catheter, systems, and methods thereof
US11925745B1 (en) * 2019-11-27 2024-03-12 Clearflow, Inc. Clearance system for medical tubes such as surgical drains
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11395668B2 (en) 2019-12-12 2022-07-26 Covidien Lp Electrically enhanced retrieval of material from vessel lumens
JP2023507553A (en) 2019-12-18 2023-02-24 インパラティブ、ケア、インク. Methods and systems for treating venous thromboembolism
US20230248498A1 (en) 2019-12-18 2023-08-10 Imperative Care, Inc. Manually rotatable thrombus engagement tool
US11633272B2 (en) 2019-12-18 2023-04-25 Imperative Care, Inc. Manually rotatable thrombus engagement tool
US11259821B2 (en) 2019-12-18 2022-03-01 Imperative Care, Inc. Aspiration system with accelerated response
JP7649056B2 (en) 2020-01-30 2025-03-19 ユリア メディカル アーゲー Devices and methods for endoluminal neurovascular intervention - Patents.com
US11648020B2 (en) 2020-02-07 2023-05-16 Angiodynamics, Inc. Device and method for manual aspiration and removal of an undesirable material
EP4103076B1 (en) * 2020-02-11 2024-07-24 Stryker Corporation Anti-locking thrombectomy apparatuses
US12364397B2 (en) 2020-02-17 2025-07-22 Covidien Lp Systems and methods for detecting strokes
US12263020B2 (en) 2020-02-17 2025-04-01 Covidien Lp Systems and methods for detecting strokes
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11944327B2 (en) * 2020-03-05 2024-04-02 Neuravi Limited Expandable mouth aspirating clot retrieval catheter
US11633198B2 (en) * 2020-03-05 2023-04-25 Neuravi Limited Catheter proximal joint
CN113747934B (en) 2020-03-10 2024-07-09 因普瑞缇夫护理公司 Enhanced flexibility neurovascular catheter
US11883043B2 (en) * 2020-03-31 2024-01-30 DePuy Synthes Products, Inc. Catheter funnel extension
US11759217B2 (en) 2020-04-07 2023-09-19 Neuravi Limited Catheter tubular support
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
JP7655949B2 (en) 2020-06-05 2025-04-02 イナリ メディカル, インコーポレイテッド RECAPTUREABLE FUNNEL CATHETER AND ASSOCIATED SYSTEMS AND METHODS
US20210393277A1 (en) * 2020-06-18 2021-12-23 Neuravi Limited Catheter mouth designs
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11937836B2 (en) 2020-06-22 2024-03-26 Neuravi Limited Clot retrieval system with expandable clot engaging framework
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
CN116348047A (en) * 2020-07-20 2023-06-27 万能医药公司 Device and method for aspiration of thrombus
US11207497B1 (en) 2020-08-11 2021-12-28 Imperative Care, Inc. Catheter with enhanced tensile strength
WO2022047215A1 (en) 2020-08-28 2022-03-03 Covidien Lp Detection of patient conditions using signals sensed on or near the head
JP2023551755A (en) * 2020-09-22 2023-12-13 エーエムエックス テクノロジーズ,エルエルシー Heart valve treatment device removal method and device
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US20220110647A1 (en) * 2020-10-13 2022-04-14 Asahi Intecc Co., Ltd. Thrombus Aspiration Systems and Related Methods
US12433598B2 (en) * 2020-10-13 2025-10-07 Asahi Intecc Co., Ltd. Thrombus aspiration systems and related methods
US11937837B2 (en) 2020-12-29 2024-03-26 Neuravi Limited Fibrin rich / soft clot mechanical thrombectomy device
US12029442B2 (en) 2021-01-14 2024-07-09 Neuravi Limited Systems and methods for a dual elongated member clot retrieval apparatus
USD972720S1 (en) 2021-02-04 2022-12-13 Angiodynamics, Inc. Port for aspiration device
USD1048408S1 (en) 2021-02-04 2024-10-22 Angiodynamics, Inc. Handle for a manual mechanical aspiration device
USD1048407S1 (en) 2021-02-04 2024-10-22 Angiodynamics, Inc. Manual mechanical aspiration device
US11872354B2 (en) 2021-02-24 2024-01-16 Neuravi Limited Flexible catheter shaft frame with seam
EP4301250A1 (en) 2021-03-01 2024-01-10 Endovascular Engineering, Inc. Aspiration devices for treatment of thrombosis including expandable distal ends and systems and methods thereof
US11197684B1 (en) 2021-03-04 2021-12-14 Nventric Corporation Thrombectomy device and method
US12064130B2 (en) 2021-03-18 2024-08-20 Neuravi Limited Vascular obstruction retrieval device having sliding cages pinch mechanism
US20220339402A1 (en) * 2021-04-23 2022-10-27 Ohio State Innovation Foundation Tunneled Intravascular Catheters, Catheter Systems, and Related Methods
US11963713B2 (en) 2021-06-02 2024-04-23 Covidien Lp Medical treatment system
US11974764B2 (en) 2021-06-04 2024-05-07 Neuravi Limited Self-orienting rotating stentriever pinching cells
US20230012025A1 (en) * 2021-07-12 2023-01-12 Neuravi Limited Expansile frame assisted vascular obstruction retrieval
US12558175B2 (en) 2021-08-12 2026-02-24 Imperative Care, Inc. Multi catheter method of performing a robotic neurovascular procedure
US11944374B2 (en) 2021-08-30 2024-04-02 Covidien Lp Electrical signals for retrieval of material from vessel lumens
US11937839B2 (en) 2021-09-28 2024-03-26 Neuravi Limited Catheter with electrically actuated expandable mouth
USD1077996S1 (en) 2021-10-18 2025-06-03 Imperative Care, Inc. Inline fluid filter
US12011186B2 (en) * 2021-10-28 2024-06-18 Neuravi Limited Bevel tip expandable mouth catheter with reinforcing ring
US12076020B2 (en) 2021-11-18 2024-09-03 Covidien Lp Retrieval of material from corporeal lumens
USD1026212S1 (en) * 2021-12-13 2024-05-07 Yaniris R. Avellanet Cannula for removal of fat tissue
AU2023208030A1 (en) 2022-01-11 2024-07-18 Inari Medical, Inc. Devices for removing clot material from intravascularly implanted devices, and associated systems and methods
WO2023139516A1 (en) 2022-01-21 2023-07-27 Julier Medical AG Neurovascular catheter and method of use
EP4472532A4 (en) * 2022-02-03 2026-01-28 Shifamed Holdings Llc THROMBUS REMOVAL SYSTEMS AND ASSOCIATED PROCEDURES
EP4489830A1 (en) * 2022-03-07 2025-01-15 Edwards Lifesciences Corporation Introducer with dilation feature and expandable access sheaths
AU2023232116A1 (en) * 2022-03-10 2024-09-26 Scientia Vascular, Inc. Systems and methods for pulmonary emboli removal
US12220139B2 (en) 2022-03-20 2025-02-11 Von Vascular, Inc. System, devices and methods for removing obstructions in body lumens
EP4498944A4 (en) 2022-03-28 2026-03-11 Elixir Medical Corp ASPIRATION CATHETER WITH EXPANDABLE DISTAL TIP
US12201312B2 (en) * 2022-05-11 2025-01-21 Legacy Ventures LLC Self-adjusting catheter
CN115869520A (en) * 2022-08-19 2023-03-31 上海暖阳医疗器械有限公司 Catheter with releasable tip
US12053192B2 (en) 2022-09-01 2024-08-06 Endovascular Engineering, Inc. Systems, devices, and methods for aspiration, including expandable structures and rotatable shafts
US12496081B2 (en) 2023-01-09 2025-12-16 Inari Medical, Inc. Catheter for use with clot treatment systems
US12471937B2 (en) 2023-01-25 2025-11-18 Syntheon Pv, Llc Aspiration thrombectomy systems and methods for thrombus removal with aspiration catheter
US20240252335A1 (en) * 2023-01-31 2024-08-01 Thetrustees Of The University Of Pennsylvania Retrieval Devices
WO2024243114A1 (en) * 2023-05-19 2024-11-28 Legacy Ventures LLC Self-adjusting catheter
US12114880B1 (en) 2023-08-03 2024-10-15 Nventric Corporation Thrombectomy device having open frame cell ring
US20250057537A1 (en) * 2023-08-16 2025-02-20 Boston Scientific Scimed, Inc. Delivery device for occlusive implants
AU2024342716A1 (en) * 2023-09-14 2026-01-29 Inari Medical, Inc. Multi-lumen aspiration catheters, and associated systems and methods
WO2025072088A1 (en) * 2023-09-26 2025-04-03 Boston Scientific Scimed, Inc. Thrombectomy apparatus
WO2025106851A1 (en) 2023-11-16 2025-05-22 Inari Medical, Inc. Automatic locking and unlocking vacuum syringes, and associated systems and methods
US12171917B1 (en) 2024-01-08 2024-12-24 Imperative Care, Inc. Devices for blood capture and reintroduction during aspiration procedure
CN118340554B (en) * 2024-04-26 2025-03-28 万漉医疗科技(江苏)有限公司 Intracranial suction catheter and method of use thereof
WO2025235015A1 (en) 2024-05-10 2025-11-13 Inari Medical, Inc. Mechanical thrombectomy assemblies with relief features, and associated devices, systems, and methods

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592356A (en) * 1984-09-28 1986-06-03 Pedro Gutierrez Localizing device
US5106364A (en) * 1989-07-07 1992-04-21 Kabushiki Kaisha Topcon Surgical cutter
US5538008A (en) * 1993-01-18 1996-07-23 Crowe; John Forceps for endoscopes
US5846248A (en) * 1995-04-13 1998-12-08 Boston Scientific Corporation Method and apparatus for severing and capturing polyps
US6142957A (en) * 1993-09-20 2000-11-07 Boston Scientific Corporation Multiple biopsy sampling device
US6371963B1 (en) * 1998-11-17 2002-04-16 Scimed Life Systems, Inc. Device for controlled endoscopic penetration of injection needle
US20050119524A1 (en) * 2002-08-07 2005-06-02 Olympus Optical Co., Ltd. Endoscopic treatment system
US20050119668A1 (en) * 2003-09-18 2005-06-02 Boston Scientific Scimed, Inc. Medical retrieval devices and methods
US20060036271A1 (en) * 2004-07-29 2006-02-16 X-Sten, Inc. Spinal ligament modification devices
US20070179513A1 (en) * 2004-01-09 2007-08-02 Deutsch Harvey L Method and device for removing an occlusion
US20070239182A1 (en) * 2006-04-03 2007-10-11 Boston Scientific Scimed, Inc. Thrombus removal device
US20080269774A1 (en) * 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US20100036312A1 (en) * 2008-06-08 2010-02-11 Hotspur Technologies, Inc. Apparatus and methods for removing obstructive material from body lumens
US20100305566A1 (en) * 2007-11-30 2010-12-02 New England Assoication Of Gynecologic Laparoscopists, Llp Transcervical excision and removal of tissue
US20110071432A1 (en) * 2009-09-24 2011-03-24 Carrillo Jr Oscar R Fine Needle Aspiration Device with Distal Anchor
US20140276840A1 (en) * 2013-03-15 2014-09-18 DePuy Synthes Products, LLC Tools and methods for tissue removal
US20140277003A1 (en) * 2013-03-13 2014-09-18 The Spectranetics Corporation Material Capturing Guidewire

Family Cites Families (406)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243040A (en) 1979-09-17 1981-01-06 Beecher William H Extracting device for removing objects from human body passages
US4738666A (en) * 1985-06-11 1988-04-19 Genus Catheter Technologies, Inc. Variable diameter catheter
US4767404A (en) 1986-07-14 1988-08-30 R & S Associates Co. Surgical suction device having a perforated sleeve
US4793348A (en) 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
US4873978A (en) 1987-12-04 1989-10-17 Robert Ginsburg Device and method for emboli retrieval
US5011488A (en) 1988-12-07 1991-04-30 Robert Ginsburg Thrombus extraction system
US5092839A (en) 1989-09-29 1992-03-03 Kipperman Robert M Coronary thrombectomy
US5122136A (en) 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5171233A (en) 1990-04-25 1992-12-15 Microvena Corporation Snare-type probe
AU646666B2 (en) 1990-05-14 1994-03-03 Colin Nates Surgical apparatus
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
EP0555362A4 (en) 1990-10-29 1993-09-15 Scimed Life Systems, Inc. Guide catheter system for angioplasty balloon catheter
US6309379B1 (en) 1991-05-23 2001-10-30 Lloyd K. Willard Sheath for selective delivery of multiple intravascular devices and methods of use thereof
US5234437A (en) 1991-12-12 1993-08-10 Target Therapeutics, Inc. Detachable pusher-vasoocclusion coil assembly with threaded coupling
WO1994006357A1 (en) 1992-09-23 1994-03-31 Target Therapeutics, Inc. Medical retrieval device
US5538512A (en) 1993-02-25 1996-07-23 Zenzon; Wendy J. Lubricious flow directed catheter
GB9308893D0 (en) 1993-04-29 1993-06-16 Special Trustees For The Unite Apparatus for collecting data
US5897567A (en) 1993-04-29 1999-04-27 Scimed Life Systems, Inc. Expandable intravascular occlusion material removal devices and methods of use
US5855598A (en) 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5387226A (en) 1994-01-14 1995-02-07 Baxter International Inc. Rapid exchange catheter
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
EP1221307B1 (en) 1994-07-08 2010-02-17 ev3 Inc. System for performing an intravascular procedure
US5520651A (en) 1994-10-03 1996-05-28 Conmed Corporation Self releasing suction and irrigation apparatus and method of attachment
US5558652A (en) 1994-10-06 1996-09-24 B. Braun Medical, Inc. Introducer with radiopaque marked tip and method of manufacture therefor
US5658296A (en) 1994-11-21 1997-08-19 Boston Scientific Corporation Method for making surgical retrieval baskets
US5709704A (en) 1994-11-30 1998-01-20 Boston Scientific Corporation Blood clot filtering
US5549626A (en) 1994-12-23 1996-08-27 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Vena caval filter
CA2212084C (en) 1995-02-02 2008-11-18 Boston Scientific Corporation Surgical wire basket extractor
US6348056B1 (en) 1999-08-06 2002-02-19 Scimed Life Systems, Inc. Medical retrieval device with releasable retrieval basket
US5645558A (en) 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US5639277A (en) 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US5624461A (en) 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US5713853A (en) * 1995-06-07 1998-02-03 Interventional Innovations Corporation Methods for treating thrombosis
RU2157146C2 (en) 1995-06-13 2000-10-10 ВИЛЬЯМ КУК Европа, A/S Device for performing implantation in blood vessels and hollow organs
JPH0919438A (en) 1995-07-04 1997-01-21 Asahi Optical Co Ltd Basket-type grasping tool for endoscope
US6168604B1 (en) 1995-10-06 2001-01-02 Metamorphic Surgical Devices, Llc Guide wire device for removing solid objects from body canals
US5779716A (en) 1995-10-06 1998-07-14 Metamorphic Surgical Devices, Inc. Device for removing solid objects from body canals, cavities and organs
US6264663B1 (en) 1995-10-06 2001-07-24 Metamorphic Surgical Devices, Llc Device for removing solid objects from body canals, cavities and organs including an invertable basket
US5827304A (en) 1995-11-16 1998-10-27 Applied Medical Resources Corporation Intraluminal extraction catheter
US5769871A (en) 1995-11-17 1998-06-23 Louisville Laboratories, Inc. Embolectomy catheter
US5695519A (en) 1995-11-30 1997-12-09 American Biomed, Inc. Percutaneous filter for carotid angioplasty
US5895398A (en) 1996-02-02 1999-04-20 The Regents Of The University Of California Method of using a clot capture coil
JP2000504594A (en) 1996-02-02 2000-04-18 トランスバスキュラー インコーポレイテッド Method and apparatus for blocking flow in a blood vessel
NL1002423C2 (en) 1996-02-22 1997-08-25 Cordis Europ Temporary filter catheter.
US5728078A (en) 1996-03-19 1998-03-17 Powers Dental & Medical Technologies Inc. Medical suctioning bacteria valve and related method
WO1997038631A1 (en) 1996-04-18 1997-10-23 Applied Medical Resources Corporation Remote clot management
US6096053A (en) 1996-05-03 2000-08-01 Scimed Life Systems, Inc. Medical retrieval basket
US5935139A (en) 1996-05-03 1999-08-10 Boston Scientific Corporation System for immobilizing or manipulating an object in a tract
US6022336A (en) 1996-05-20 2000-02-08 Percusurge, Inc. Catheter system for emboli containment
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US6066158A (en) 1996-07-25 2000-05-23 Target Therapeutics, Inc. Mechanical clot encasing and removal wire
US6325819B1 (en) 1996-08-19 2001-12-04 Cook Incorporated Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm
US6520951B1 (en) 1996-09-13 2003-02-18 Scimed Life Systems, Inc. Rapid exchange catheter with detachable hood
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US5893869A (en) 1997-02-19 1999-04-13 University Of Iowa Research Foundation Retrievable inferior vena cava filter system and method for use thereof
WO1998038929A1 (en) 1997-03-06 1998-09-11 Percusurge, Inc. Intravascular aspiration system
US5814064A (en) 1997-03-06 1998-09-29 Scimed Life Systems, Inc. Distal protection device
US5947995A (en) 1997-06-06 1999-09-07 Samuels; Shaun Lawrence Wilkie Method and apparatus for removing blood clots and other objects
US5904698A (en) 1997-06-10 1999-05-18 Applied Medical Resources Corporation Surgical shaving device for use within body conduits
US5968057A (en) 1997-06-18 1999-10-19 Taheri; Syde A. Apparatus for removing a blood clot from a vessel
US5911725A (en) 1997-08-22 1999-06-15 Boury; Harb N. Intraluminal retrieval catheter
US6361545B1 (en) * 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US6395014B1 (en) 1997-09-26 2002-05-28 John A. Macoviak Cerebral embolic protection assembly and associated methods
US6066149A (en) 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6099534A (en) 1997-10-01 2000-08-08 Scimed Life Systems, Inc. Releasable basket
US5908435A (en) 1997-10-23 1999-06-01 Samuels; Shaun L. W. Expandable lumen device and method of use
BR9813935A (en) 1997-11-07 2000-09-19 Salviac Ltd Vascular filtration devices for removing embolic material from body fluids
US7491216B2 (en) 1997-11-07 2009-02-17 Salviac Limited Filter element with retractable guidewire tip
US20040260333A1 (en) * 1997-11-12 2004-12-23 Dubrul William R. Medical device and method
US6221006B1 (en) 1998-02-10 2001-04-24 Artemis Medical Inc. Entrapping apparatus and method for use
US20100030256A1 (en) 1997-11-12 2010-02-04 Genesis Technologies Llc Medical Devices and Methods
WO1999023952A1 (en) 1997-11-12 1999-05-20 William Dubrul Biological passageway occlusion removal
JP3075355B2 (en) 1998-02-05 2000-08-14 オリンパス光学工業株式会社 Basket type grasping forceps
US6602265B2 (en) 1998-02-10 2003-08-05 Artemis Medical, Inc. Tissue separation medical device and method
US6423032B2 (en) * 1998-03-13 2002-07-23 Arteria Medical Science, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6500182B2 (en) * 1998-03-27 2002-12-31 Cook Urological, Incorporated Minimally-invasive medical retrieval device
JP2002512072A (en) 1998-04-23 2002-04-23 サイムド ライフ システムズ, インコーポレイテッド Medical collection device with loop basket
US6511492B1 (en) 1998-05-01 2003-01-28 Microvention, Inc. Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders
IL124958A0 (en) 1998-06-16 1999-01-26 Yodfat Ofer Implantable blood filtering device
US6656218B1 (en) 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US6165194A (en) 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US6306163B1 (en) * 1998-08-04 2001-10-23 Advanced Cardiovascular Systems, Inc. Assembly for collecting emboli and method of use
US6093199A (en) 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
US6102932A (en) 1998-12-15 2000-08-15 Micrus Corporation Intravascular device push wire delivery system
US6165199A (en) 1999-01-12 2000-12-26 Coaxia, Inc. Medical device for removing thromboembolic material from cerebral arteries and methods of use
US6161547A (en) 1999-01-15 2000-12-19 Coaxia, Inc. Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US20020138094A1 (en) 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
US20020169474A1 (en) 1999-03-08 2002-11-14 Microvena Corporation Minimally invasive medical device deployment and retrieval system
US6673089B1 (en) 1999-03-11 2004-01-06 Mindguard Ltd. Implantable stroke treating device
US6632236B2 (en) * 1999-03-12 2003-10-14 Arteria Medical Science, Inc. Catheter having radially expandable main body
US6893450B2 (en) 1999-03-26 2005-05-17 Cook Urological Incorporated Minimally-invasive medical retrieval device
WO2000067666A1 (en) 1999-05-07 2000-11-16 Salviac Limited Improved filter element for embolic protection device
IL145979A0 (en) 1999-05-07 2002-07-25 Salviac Ltd An embolic protection device
US6964672B2 (en) 1999-05-07 2005-11-15 Salviac Limited Support frame for an embolic protection device
US6585756B1 (en) 1999-05-14 2003-07-01 Ernst P. Strecker Implantable lumen prosthesis
US6350271B1 (en) 1999-05-17 2002-02-26 Micrus Corporation Clot retrieval device
US6458139B1 (en) 1999-06-21 2002-10-01 Endovascular Technologies, Inc. Filter/emboli extractor for use in variable sized blood vessels
US6203561B1 (en) 1999-07-30 2001-03-20 Incept Llc Integrated vascular device having thrombectomy element and vascular filter and methods of use
US6530939B1 (en) 1999-07-30 2003-03-11 Incept, Llc Vascular device having articulation region and methods of use
US6544279B1 (en) 2000-08-09 2003-04-08 Incept, Llc Vascular device for emboli, thrombus and foreign body removal and methods of use
US6616679B1 (en) 1999-07-30 2003-09-09 Incept, Llc Rapid exchange vascular device for emboli and thrombus removal and methods of use
US6179861B1 (en) 1999-07-30 2001-01-30 Incept Llc Vascular device having one or more articulation regions and methods of use
US7306618B2 (en) 1999-07-30 2007-12-11 Incept Llc Vascular device for emboli and thrombi removal and methods of use
US6214026B1 (en) 1999-07-30 2001-04-10 Incept Llc Delivery system for a vascular device with articulation region
US20020026211A1 (en) 1999-12-23 2002-02-28 Farhad Khosravi Vascular device having emboli and thrombus removal element and methods of use
US6245087B1 (en) 1999-08-03 2001-06-12 Embol-X, Inc. Variable expansion frame system for deploying medical devices and methods of use
US6251122B1 (en) 1999-09-02 2001-06-26 Scimed Life Systems, Inc. Intravascular filter retrieval device and method
US6146404A (en) 1999-09-03 2000-11-14 Scimed Life Systems, Inc. Removable thrombus filter
US6454775B1 (en) 1999-12-06 2002-09-24 Bacchus Vascular Inc. Systems and methods for clot disruption and retrieval
US6660013B2 (en) 1999-10-05 2003-12-09 Omnisonics Medical Technologies, Inc. Apparatus for removing plaque from blood vessels using ultrasonic energy
US6652555B1 (en) * 1999-10-27 2003-11-25 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
US6425909B1 (en) 1999-11-04 2002-07-30 Concentric Medical, Inc. Methods and devices for filtering fluid flow through a body structure
US9113936B2 (en) 1999-12-23 2015-08-25 Abbott Laboratories Snare
US6402771B1 (en) 1999-12-23 2002-06-11 Guidant Endovascular Solutions Snare
US6575997B1 (en) 1999-12-23 2003-06-10 Endovascular Technologies, Inc. Embolic basket
US6660021B1 (en) 1999-12-23 2003-12-09 Advanced Cardiovascular Systems, Inc. Intravascular device and system
US6383206B1 (en) 1999-12-30 2002-05-07 Advanced Cardiovascular Systems, Inc. Embolic protection system and method including filtering elements
US6663613B1 (en) 2000-01-25 2003-12-16 Bacchus Vascular, Inc. System and methods for clot dissolution
US6692513B2 (en) 2000-06-30 2004-02-17 Viacor, Inc. Intravascular filter with debris entrapment mechanism
US6540768B1 (en) 2000-02-09 2003-04-01 Cordis Corporation Vascular filter system
US6485502B2 (en) 2000-03-10 2002-11-26 T. Anthony Don Michael Vascular embolism prevention device employing filters
US6695865B2 (en) 2000-03-20 2004-02-24 Advanced Bio Prosthetic Surfaces, Ltd. Embolic protection device
US6514273B1 (en) 2000-03-22 2003-02-04 Endovascular Technologies, Inc. Device for removal of thrombus through physiological adhesion
US6632241B1 (en) 2000-03-22 2003-10-14 Endovascular Technologies, Inc. Self-expanding, pseudo-braided intravascular device
GB2369575A (en) 2000-04-20 2002-06-05 Salviac Ltd An embolic protection system
US6592616B1 (en) 2000-04-28 2003-07-15 Advanced Cardiovascular Systems, Inc. System and device for minimizing embolic risk during an interventional procedure
US6602271B2 (en) 2000-05-24 2003-08-05 Medtronic Ave, Inc. Collapsible blood filter with optimal braid geometry
AUPQ831500A0 (en) 2000-06-22 2000-07-13 White, Geoffrey H. Method and apparatus for performing percutaneous thromboembolectomies
US6565591B2 (en) 2000-06-23 2003-05-20 Salviac Limited Medical device
US20040073243A1 (en) 2000-06-29 2004-04-15 Concentric Medical, Inc., A Delaware Corporation Systems, methods and devices for removing obstructions from a blood vessel
US20050288686A1 (en) 2000-06-29 2005-12-29 Concentric Medical, Inc., A Delaware Corporation Systems, methods and devices for removing obstructions from a blood vessel
CA2411699A1 (en) 2000-06-29 2002-01-10 Ivan Sepetka Systems, methods and devices for removing obstructions from a blood vessel
US6730104B1 (en) 2000-06-29 2004-05-04 Concentric Medical, Inc. Methods and devices for removing an obstruction from a blood vessel
US7285126B2 (en) 2000-06-29 2007-10-23 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US6824545B2 (en) 2000-06-29 2004-11-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7727243B2 (en) 2000-06-29 2010-06-01 Concentric Medical., Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7727242B2 (en) 2000-06-29 2010-06-01 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7766921B2 (en) 2000-06-29 2010-08-03 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US8298257B2 (en) 2000-06-29 2012-10-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US6663650B2 (en) 2000-06-29 2003-12-16 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US20070208371A1 (en) 2000-06-29 2007-09-06 Concentric Medical, Inc. Devices and methods for removing obstructions from a patient and methods for making obstruction removing devices
US6485501B1 (en) 2000-08-11 2002-11-26 Cordis Corporation Vascular filter system with guidewire and capture mechanism
US7381198B2 (en) * 2000-08-23 2008-06-03 Revascular Therapeutics, Inc. Steerable distal support system
SE517247C2 (en) 2000-09-13 2002-05-14 Dan Lundgren Strainer for suction tubes for surgical or dental use
US6589265B1 (en) 2000-10-31 2003-07-08 Endovascular Technologies, Inc. Intrasaccular embolic device
US6602272B2 (en) 2000-11-02 2003-08-05 Advanced Cardiovascular Systems, Inc. Devices configured from heat shaped, strain hardened nickel-titanium
US6740094B2 (en) 2000-11-06 2004-05-25 The Regents Of The University Of California Shape memory polymer actuator and catheter
US7229472B2 (en) 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
US6579308B1 (en) 2000-11-28 2003-06-17 Scimed Life Systems, Inc. Stent devices with detachable distal or proximal wires
US7927784B2 (en) 2000-12-20 2011-04-19 Ev3 Vascular lumen debulking catheters and methods
US6582448B1 (en) 2000-12-21 2003-06-24 Advanced Cardiovascular Systems, Inc. Vessel occlusion device for embolic protection system
WO2002094111A2 (en) 2001-01-16 2002-11-28 Incept Llc Vascular device for emboli and thrombi removal
US6936059B2 (en) 2001-01-16 2005-08-30 Scimed Life Systems, Inc. Endovascular guidewire filter and methods of use
US6610077B1 (en) 2001-01-23 2003-08-26 Endovascular Technologies, Inc. Expandable emboli filter and thrombectomy device
US6562066B1 (en) 2001-03-02 2003-05-13 Eric C. Martin Stent for arterialization of the coronary sinus and retrograde perfusion of the myocardium
US6579302B2 (en) 2001-03-06 2003-06-17 Cordis Corporation Total occlusion guidewire device
US7214237B2 (en) 2001-03-12 2007-05-08 Don Michael T Anthony Vascular filter with improved strength and flexibility
US6814739B2 (en) 2001-05-18 2004-11-09 U.S. Endoscopy Group, Inc. Retrieval device
US6635070B2 (en) 2001-05-21 2003-10-21 Bacchus Vascular, Inc. Apparatus and methods for capturing particulate material within blood vessels
US6551341B2 (en) 2001-06-14 2003-04-22 Advanced Cardiovascular Systems, Inc. Devices configured from strain hardened Ni Ti tubing
US6638245B2 (en) 2001-06-26 2003-10-28 Concentric Medical, Inc. Balloon catheter
US6702782B2 (en) 2001-06-26 2004-03-09 Concentric Medical, Inc. Large lumen balloon catheter
EP1404237B1 (en) 2001-06-28 2007-09-12 Lithotech Medical Ltd Foreign body retrieval device
US7338510B2 (en) 2001-06-29 2008-03-04 Advanced Cardiovascular Systems, Inc. Variable thickness embolic filtering devices and method of manufacturing the same
JP4567918B2 (en) 2001-07-02 2010-10-27 テルモ株式会社 Intravascular foreign matter removal wire and medical device
US6997939B2 (en) 2001-07-02 2006-02-14 Rubicon Medical, Inc. Methods, systems, and devices for deploying an embolic protection filter
US6533800B1 (en) 2001-07-25 2003-03-18 Coaxia, Inc. Devices and methods for preventing distal embolization using flow reversal in arteries having collateral blood flow
US6730107B2 (en) 2001-08-23 2004-05-04 Scimed Life Systems, Inc. Single lumen rapid-exchange catheter
US6551342B1 (en) 2001-08-24 2003-04-22 Endovascular Technologies, Inc. Embolic filter
US7175655B1 (en) 2001-09-17 2007-02-13 Endovascular Technologies, Inc. Avoiding stress-induced martensitic transformation in nickel titanium alloys used in medical devices
US7749243B2 (en) 2001-10-19 2010-07-06 Boston Scientific Scimed, Inc. Embolus extractor
US20040138692A1 (en) 2003-01-13 2004-07-15 Scimed Life Systems, Inc. Embolus extractor
US7594926B2 (en) 2001-11-09 2009-09-29 Boston Scientific Scimed, Inc. Methods, systems and devices for delivering stents
WO2003039405A2 (en) 2001-11-09 2003-05-15 Rubicon Medical, Inc. Stent delivery device with embolic protection
US6890340B2 (en) 2001-11-29 2005-05-10 Medtronic Vascular, Inc. Apparatus for temporary intraluminal protection
US7153320B2 (en) 2001-12-13 2006-12-26 Scimed Life Systems, Inc. Hydraulic controlled retractable tip filter retrieval catheter
US6790196B2 (en) 2001-12-18 2004-09-14 Scimed Life Systems, Inc. Aspirating devices for removal of thrombus/lipid from a body lumen
US7118539B2 (en) 2002-02-26 2006-10-10 Scimed Life Systems, Inc. Articulating guide wire for embolic protection and methods of use
US7063707B2 (en) 2002-03-06 2006-06-20 Scimed Life Systems, Inc. Medical retrieval device
US20030176884A1 (en) 2002-03-12 2003-09-18 Marwane Berrada Everted filter device
US20030199917A1 (en) 2002-04-22 2003-10-23 Knudson Mark B. Thrombus treatment with emboli management
US20030236533A1 (en) 2002-06-20 2003-12-25 The Regents Of The University Of California Shape memory polymer actuator and catheter
US7232452B2 (en) * 2002-07-12 2007-06-19 Ev3 Inc. Device to create proximal stasis
US7166120B2 (en) 2002-07-12 2007-01-23 Ev3 Inc. Catheter with occluding cuff
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7058456B2 (en) 2002-08-09 2006-06-06 Concentric Medical, Inc. Methods and devices for changing the shape of a medical device
DE10242444A1 (en) 2002-09-11 2004-04-01 pfm Produkte für die Medizin AG extractor
EP1549254A4 (en) 2002-09-27 2007-11-07 Medlogics Device Corp Implantable stent with modified ends
US8282678B2 (en) 2002-11-13 2012-10-09 Allium Medical Solutions Ltd. Endoluminal lining
US7766973B2 (en) 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
JP4335814B2 (en) 2002-12-23 2009-09-30 リソテック メディカル リミテッド Surgical apparatus for extracting foreign matter and method for manufacturing the same
US7220271B2 (en) 2003-01-30 2007-05-22 Ev3 Inc. Embolic filters having multiple layers and controlled pore size
US7323001B2 (en) 2003-01-30 2008-01-29 Ev3 Inc. Embolic filters with controlled pore size
EP1445001B1 (en) 2003-02-07 2006-11-22 Pierpont Family Limited Partnership Catheter system for performing angioplasty
US20040199201A1 (en) 2003-04-02 2004-10-07 Scimed Life Systems, Inc. Embolectomy devices
US7331976B2 (en) 2003-04-29 2008-02-19 Rex Medical, L.P. Distal protection device
US7604649B2 (en) 2003-04-29 2009-10-20 Rex Medical, L.P. Distal protection device
US7618434B2 (en) 2003-05-12 2009-11-17 University Of Florida Research Foundation, Inc. Devices and methods for disruption and removal of luminal occlusions
US7122043B2 (en) 2003-05-19 2006-10-17 Stout Medical Group, L.P. Tissue distention device and related methods for therapeutic intervention
EP1641401A4 (en) 2003-06-11 2010-03-31 Concentric Medical Inc Systems, methods and devices for removing obstructions from a blood vessel
US7722634B2 (en) 2003-07-03 2010-05-25 Regents Of The University Of Minnesota Medical device and method of intravenous filtration
US7316692B2 (en) 2003-08-12 2008-01-08 Boston Scientific Scimed, Inc. Laser-cut clot puller
US20050049670A1 (en) 2003-08-29 2005-03-03 Jones Donald K. Self-expanding stent and stent delivery system for treatment of vascular disease
US20050049669A1 (en) 2003-08-29 2005-03-03 Jones Donald K. Self-expanding stent and stent delivery system with distal protection
JP2007503918A (en) 2003-09-04 2007-03-01 セカント メディカル エルエルシー Intravascular snare for capturing and removing arterial emboli
US8535344B2 (en) 2003-09-12 2013-09-17 Rubicon Medical, Inc. Methods, systems, and devices for providing embolic protection and removing embolic material
US7344550B2 (en) 2003-10-21 2008-03-18 Boston Scientific Scimed, Inc. Clot removal device
US6994718B2 (en) 2003-10-29 2006-02-07 Medtronic Vascular, Inc. Distal protection device for filtering and occlusion
US7220269B1 (en) * 2003-11-06 2007-05-22 Possis Medical, Inc. Thrombectomy catheter system with occluder and method of using same
JP2005160648A (en) 2003-12-01 2005-06-23 Terumo Corp Wire and medical instrument for removing foreign body in blood vessel
US8002822B2 (en) 2004-01-22 2011-08-23 Isoflux, Inc. Radiopaque coating for biomedical devices
US20070118165A1 (en) 2004-03-08 2007-05-24 Demello Jonathan R System and method for removal of material from a blood vessel using a small diameter catheter
US20080228209A1 (en) 2004-03-08 2008-09-18 Demello Richard M System and method for removal of material from a blood vessel using a small diameter catheter
US20050228417A1 (en) 2004-03-26 2005-10-13 Teitelbaum George P Devices and methods for removing a matter from a body cavity of a patient
US20080045881A1 (en) 2004-03-26 2008-02-21 University Of Southern California Devices and methods for removing a matter from a body cavity of a patient
US7232462B2 (en) 2004-03-31 2007-06-19 Cook Incorporated Self centering delivery catheter
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
DE102004040868A1 (en) 2004-08-23 2006-03-09 Miloslavski, Elina Device for removing thrombi
US7931659B2 (en) 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
US20060058837A1 (en) 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US9655633B2 (en) * 2004-09-10 2017-05-23 Penumbra, Inc. System and method for treating ischemic stroke
EP2468349B1 (en) 2004-09-17 2019-03-06 Codman & Shurtleff, Inc. Thin film metallic devices for plugging aneurysms or vessels
EP1804719A2 (en) 2004-09-22 2007-07-11 Lee R. Guterman Cranial aneurysm treatment arrangement
US8109941B2 (en) 2005-02-28 2012-02-07 Boston Scientific Scimed, Inc. Distal release retrieval assembly and related methods of use
EP1863402B1 (en) 2005-03-24 2010-01-13 Cook Incorporated Exchangeable delivery system with distal protection
US20060229638A1 (en) 2005-03-29 2006-10-12 Abrams Robert M Articulating retrieval device
US8603122B2 (en) 2005-04-01 2013-12-10 Nexgen Medical Systems, Incorporated Thrombus removal system and process
US7955344B2 (en) 2005-04-01 2011-06-07 Nexgen Medical Systems, Inc. Thrombus removal system and process
US7955345B2 (en) 2005-04-01 2011-06-07 Nexgen Medical Systems, Inc. Thrombus removal system and process
WO2006135823A2 (en) 2005-06-09 2006-12-21 Baylor College Of Medicine Segmented embolectomy catheter
US7850708B2 (en) 2005-06-20 2010-12-14 Cook Incorporated Embolic protection device having a reticulated body with staggered struts
US8109962B2 (en) 2005-06-20 2012-02-07 Cook Medical Technologies Llc Retrievable device having a reticulation portion with staggered struts
US7771452B2 (en) 2005-07-12 2010-08-10 Cook Incorporated Embolic protection device with a filter bag that disengages from a basket
US7766934B2 (en) 2005-07-12 2010-08-03 Cook Incorporated Embolic protection device with an integral basket and bag
US8187298B2 (en) 2005-08-04 2012-05-29 Cook Medical Technologies Llc Embolic protection device having inflatable frame
US8123769B2 (en) 2005-08-12 2012-02-28 Cook Medical Technologies Llc Thrombus removal device
CA2619429A1 (en) 2005-08-22 2007-03-01 Incept, Llc Flared stents and apparatus and methods for making and using them
US20080188928A1 (en) * 2005-09-16 2008-08-07 Amr Salahieh Medical device delivery sheath
US8632562B2 (en) 2005-10-03 2014-01-21 Cook Medical Technologies Llc Embolic protection device
US8182508B2 (en) 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US8252017B2 (en) 2005-10-18 2012-08-28 Cook Medical Technologies Llc Invertible filter for embolic protection
CN101355909B (en) 2005-11-09 2013-02-20 菲诺克斯有限公司 Device for eliminating thromboses
DE102005059670A1 (en) 2005-12-12 2007-06-14 Phenox Gmbh Device for removing thrombi from blood vessels
WO2007076480A2 (en) 2005-12-23 2007-07-05 Levy Elad I Bifurcated aneurysm treatment arrangement
JP5301080B2 (en) 2005-12-26 2013-09-25 株式会社ジャパンディスプレイ Liquid crystal display
US7691124B2 (en) 2006-01-31 2010-04-06 Codman & Shurtleff, Inc. Delivery of therapeutic devices
JP5164861B2 (en) 2006-02-01 2013-03-21 ザ クリーブランド クリニック ファウンデーション Method and apparatus for increasing blood flow through a blocked blood vessel
EP1986568B1 (en) 2006-02-03 2017-04-05 Covidien LP Methods and devices for restoring blood flow within blocked vasculature
US7846175B2 (en) 2006-04-03 2010-12-07 Medrad, Inc. Guidewire and collapsable filter system
US20070239254A1 (en) 2006-04-07 2007-10-11 Chris Chia System for percutaneous delivery and removal of a prosthetic valve
US20120150147A1 (en) 2010-12-08 2012-06-14 Penumbra, Inc. System and method for treating ischemic stroke
GB0700560D0 (en) 2007-01-11 2007-02-21 Emcision Ltd Device and method for the treatment of diseased tissue such as tumours
US20070288038A1 (en) 2006-06-13 2007-12-13 Frank Bimbo Medical Retrieval Devices and Methods
US20100004607A1 (en) 2006-07-21 2010-01-07 Scott Wilson Devices and methods for accessing a cerebral vessel
US20080082107A1 (en) 2006-07-21 2008-04-03 John Miller Devices and methods for removing obstructions from a cerebral vessel
US7708704B2 (en) * 2006-07-31 2010-05-04 Codman & Shurtleff, Pc Interventional medical device component having an interrupted spiral section and method of making the same
JP2010500915A (en) 2006-08-17 2010-01-14 エヌフォーカス ニューロメディカル, インコーポレイテッド Aneurysm isolation device
US8834554B2 (en) 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
DE102006044831A1 (en) 2006-09-20 2008-04-03 Phenox Gmbh Device for removing thrombi from blood vessels
US20080088928A1 (en) * 2006-10-13 2008-04-17 Kaiser Optical Systems Optical configurations for achieving uniform channel spacing in wdm telecommunications applications
US9149609B2 (en) 2006-10-16 2015-10-06 Embolitech, Llc Catheter for removal of an organized embolic thrombus
US8246641B2 (en) 2006-11-08 2012-08-21 Cook Medical Technolgies, LLC Thrombus removal device
DE602007009915D1 (en) 2006-11-20 2010-12-02 Septrx Inc Device for preventing unwanted flow of emboli from the veins into the arteries
US7914549B2 (en) 2007-01-05 2011-03-29 Hesham Morsi Mechanical embolectomy and suction catheter
JP5385155B2 (en) 2007-02-05 2014-01-08 ボストン サイエンティフィック リミテッド Thrombus removal device
US8333783B2 (en) 2007-02-16 2012-12-18 Reverse Medical Corporation Occlusion device and method of use
US8814925B2 (en) 2007-03-20 2014-08-26 Minvasys Apparatus and methods for stent delivery with embolic protection
US20080243170A1 (en) 2007-03-30 2008-10-02 Boston Scientific Scimed, Inc. Embolic capturing devices and methods
US10064635B2 (en) 2007-04-17 2018-09-04 Covidien Lp Articulating retrieval devices
US8512352B2 (en) 2007-04-17 2013-08-20 Lazarus Effect, Inc. Complex wire formed devices
US20080275488A1 (en) 2007-05-01 2008-11-06 Fleming James A Extended duration removable medical filter
US20080275493A1 (en) 2007-05-01 2008-11-06 Victor Farmiga Extended duration medical filter system with caged filter
US20110022149A1 (en) 2007-06-04 2011-01-27 Cox Brian J Methods and devices for treatment of vascular defects
US20090024157A1 (en) 2007-07-18 2009-01-22 Abbott Laboratories Embolic protection device with open cell design
JP2010268818A (en) 2007-09-06 2010-12-02 Will Fine:Kk Intravascular clot recovering device
US9138307B2 (en) 2007-09-14 2015-09-22 Cook Medical Technologies Llc Expandable device for treatment of a stricture in a body vessel
US8252018B2 (en) 2007-09-14 2012-08-28 Cook Medical Technologies Llc Helical embolic protection device
US8419748B2 (en) 2007-09-14 2013-04-16 Cook Medical Technologies Llc Helical thrombus removal device
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
EP2211972B1 (en) 2007-10-26 2015-12-23 Embolitech, LLC Intravascular guidewire filter system for pulmonary embolism protection and embolism removal or maceration
DE102007056946A1 (en) * 2007-11-27 2009-05-28 Gunnar Pah Device for filtering blood
US9492263B2 (en) 2007-12-10 2016-11-15 Incept, Llc Retrieval apparatus and methods for use
US8734374B2 (en) 2007-12-20 2014-05-27 Angiodynamics, Inc. Systems and methods for removing undesirable material within a circulatory system during a surgical procedure
US20110213290A1 (en) 2007-12-20 2011-09-01 Vortex Medical Systems and Methods for Removing Undesirable Material Within a Circulatory System
JP5385302B2 (en) 2007-12-26 2014-01-08 ラザラス エフェクト, インコーポレイテッド Recovery system and method of use
US8246672B2 (en) 2007-12-27 2012-08-21 Cook Medical Technologies Llc Endovascular graft with separately positionable and removable frame units
US8021380B2 (en) 2008-01-11 2011-09-20 Dustin Thompson Obstruction removal system
US8021379B2 (en) 2008-01-11 2011-09-20 Medtronic Vascular, Inc. Obstruction removal system
KR101819554B1 (en) 2008-02-22 2018-01-17 마이크로 테라퓨틱스 인코포레이티드 Methods and apparatus for flow restoration
US20090270815A1 (en) 2008-04-29 2009-10-29 Infraredx, Inc. Catheter Priming System
US20090292307A1 (en) 2008-05-22 2009-11-26 Nasser Razack Mechanical embolectomy device and method
WO2011135556A1 (en) 2010-04-28 2011-11-03 Neuravi Limited Clot engagement and removal systems
EP2341845B1 (en) 2008-07-22 2016-01-06 Neuravi Limited Clot capture systems
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US8465456B2 (en) 2008-07-31 2013-06-18 Boston Scientific Scimed, Inc. Extendable aspiration catheter
DE102008038195A1 (en) 2008-08-19 2010-02-25 Phenox Gmbh Device for opening occluded blood vessels
EP2288300A2 (en) 2008-08-29 2011-03-02 Rapid Medical Ltd. Embolectomy device
US9005237B2 (en) 2008-08-29 2015-04-14 Rapid Medical Ltd. Device and method for clot capture
US9034008B2 (en) 2008-08-29 2015-05-19 Rapid Medical Ltd. Device and method involving stabilization during clot removal
US8864792B2 (en) 2008-08-29 2014-10-21 Rapid Medical, Ltd. Device and method for clot engagement
US8758364B2 (en) 2008-08-29 2014-06-24 Rapid Medical Ltd. Device and method for clot engagement and capture
DE202009001951U1 (en) 2008-10-02 2010-03-04 M T W - Endoskopie Inhaber Wolfgang Haag E.K. Medical instrument
WO2010046897A1 (en) 2008-10-24 2010-04-29 Rapid Medical Ltd. Embolectomy device containing a distal and proximal effecter
US20100125326A1 (en) 2008-11-20 2010-05-20 Medtronic Vascular, Inc. Braided Stent With a Shortenable Tether
US20110152920A1 (en) 2008-12-02 2011-06-23 Rapid Medical Ltd. Embolectomy device
US20100191272A1 (en) 2009-01-23 2010-07-29 Salviac Limited Distal access embolic protection system and methods of using the same
US8361095B2 (en) 2009-02-17 2013-01-29 Cook Medical Technologies Llc Loop thrombectomy device
US20100211094A1 (en) 2009-02-18 2010-08-19 Cook Incorporated Umbrella distal embolic protection device
US9011511B2 (en) * 2009-02-20 2015-04-21 Boston Scientific Scimed, Inc. Balloon catheter
WO2010102307A1 (en) 2009-03-06 2010-09-10 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US20100249815A1 (en) 2009-03-25 2010-09-30 Cook Incorporated Everted sheath thrombectomy device
GB2470716B (en) 2009-05-18 2013-10-23 Cook Medical Technologies Llc Thrombus retrieval device
DK2442860T3 (en) 2009-06-15 2019-06-24 Perflow Medical Ltd APPARATUS FOR POSSIBLE BLOOD FLOWING THROUGH AN UNCLUDED CAR
US8529596B2 (en) 2009-07-08 2013-09-10 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8795317B2 (en) 2009-07-08 2014-08-05 Concentric Medical, Inc. Embolic obstruction retrieval devices and methods
US8357179B2 (en) 2009-07-08 2013-01-22 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8795345B2 (en) 2009-07-08 2014-08-05 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8357178B2 (en) 2009-07-08 2013-01-22 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8057497B1 (en) 2009-07-28 2011-11-15 Seshadri Raju Thrombectomy removal device kit
JP5537081B2 (en) 2009-07-28 2014-07-02 浜松ホトニクス株式会社 Processing object cutting method
US9452040B2 (en) 2009-08-27 2016-09-27 Boston Scientific Scimed Inc. Embolic protection devices with an improved filter membrane
WO2011025966A1 (en) 2009-08-31 2011-03-03 Boston Scientific Scimed, Inc. Recanalization device with expandable cage
US20110077620A1 (en) * 2009-09-30 2011-03-31 Debeer Nicholas C Guide Catheters
US8372133B2 (en) 2009-10-05 2013-02-12 480 Biomedical, Inc. Polymeric implant delivery system
DE102009056448B4 (en) 2009-12-01 2011-11-10 Acandis Gmbh & Co. Kg Delivery system for a medical functional element
DE102009056450A1 (en) 2009-12-01 2011-06-09 Acandis Gmbh & Co. Kg Medical device for introduction into a hollow organ and method for producing such a device
US9539081B2 (en) 2009-12-02 2017-01-10 Surefire Medical, Inc. Method of operating a microvalve protection device
DE102010025661A1 (en) 2010-02-05 2011-08-11 Acandis GmbH & Co. KG, 76327 Medical device for the release of concrements, method for producing such a device, treatment system with such a device and method for producing a treatment system
US20110196414A1 (en) 2010-02-05 2011-08-11 Stephen Porter Multimode occlusion and stenosis treatment apparatus and method of use
US9211396B2 (en) 2010-02-23 2015-12-15 Covidien Lp Devices and methods for vascular recanalization
DE102010010848A1 (en) 2010-03-10 2011-09-15 Acandis Gmbh & Co. Kg Medical device for removing concretions from hollow organs of the body
DE102010010849B4 (en) 2010-03-10 2024-10-02 Acandis Gmbh Medical device for removing concretions from hollow body organs and method for producing such a device
DE102010014778A1 (en) 2010-04-13 2011-10-13 Acandis Gmbh & Co. Kg Medical device for e.g. removing thrombus from curved blood vessel, has suction opening turnable towards calculus such that calculus is connected with suction element over low pressure laterally transferable from line and suction element
DE102010024085B4 (en) 2010-06-17 2012-10-18 Acandis Gmbh & Co. Kg Delivery system for a medical functional element
US8858497B2 (en) 2010-09-07 2014-10-14 Angio Dynamics, Inc. Device and method for removing material from a hollow anatomical structure
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
EP2629684B1 (en) 2010-10-22 2018-07-25 Neuravi Limited Clot engagement and removal system
US20120123466A1 (en) 2010-11-12 2012-05-17 Stryker Nv Operations, Ltd. Axially variable radial pressure cages for clot capture
EP2648658B1 (en) 2010-12-06 2018-10-24 Covidien LP Vascular remodeling device
WO2012081020A1 (en) 2010-12-12 2012-06-21 Perflow Medical Ltd. Method and apparatus for occlusion retrieval
RU2599592C2 (en) 2011-02-04 2016-10-10 Концентрик Медикал, Инк. Device for embolic occlusion extraction
DE102011011510B4 (en) 2011-02-17 2022-12-29 Acandis Gmbh Medical device for removing calculus and system with such a medical device
EP4566553A3 (en) 2011-03-09 2025-08-06 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
DE102011014586B3 (en) 2011-03-21 2012-09-13 Acandis Gmbh & Co. Kg Medical device for treatment of hollow organs of the body, system with such a device and method for producing such a device
WO2012156924A1 (en) 2011-05-17 2012-11-22 Cardioflow Ltd. Vascular occlusion and aspiration device
WO2012158883A1 (en) 2011-05-19 2012-11-22 Tyco Healthcare Group Lp Vascular remodeling device
CA2874586C (en) 2011-05-23 2019-07-09 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US11026708B2 (en) 2011-07-26 2021-06-08 Thrombx Medical, Inc. Intravascular thromboembolectomy device and method using the same
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US8617200B2 (en) 2011-08-17 2013-12-31 Cook Medical Technologies Llc Multi-layer filtration device
US20130046334A1 (en) 2011-08-19 2013-02-21 Donald K. Jones Intralumenal retrieval system
US20130046333A1 (en) 2011-08-19 2013-02-21 Donald K. Jones Intralumenal retrieval system
JP5998147B2 (en) 2011-09-27 2016-09-28 寛治 井上 Vascular free substance capture device
EP2770914A4 (en) 2011-10-24 2015-09-16 Rapid Medical Ltd Clot removal devices and methods
US8771341B2 (en) 2011-11-04 2014-07-08 Reverse Medical Corporation Protuberant aneurysm bridging device and method of use
WO2013071173A1 (en) 2011-11-11 2013-05-16 Dacuycuy Nathan John Devices for removing vessel occlusions
US20130144328A1 (en) * 2011-12-06 2013-06-06 Boston Scientific Scimed, Inc. Expanding distal sheath with combined embolic protection
ES2633347T3 (en) 2011-12-16 2017-09-20 Stryker Corporation Embolectomy cage
EP2804547B1 (en) 2012-01-15 2018-04-04 Triticum Ltd. Device for removing occlusions in a biological vessel
CN107432760A (en) 2012-01-17 2017-12-05 珀弗娄医疗有限公司 Method and apparatus for removing tamper
DE102012101284A1 (en) 2012-02-17 2013-09-05 Acandis Gmbh & Co. Kg Medical device with a grid structure and treatment system with such a medical device
US9522258B2 (en) 2012-02-24 2016-12-20 Cook Medical Technologies Llc Clot removal system and method
JP5238088B1 (en) 2012-06-29 2013-07-17 ハリマ化成株式会社 Solder alloy, solder paste and electronic circuit board
JP2015525653A (en) 2012-08-13 2015-09-07 マイクロベンション インコーポレイテッド Mold removal device
US9204887B2 (en) 2012-08-14 2015-12-08 W. L. Gore & Associates, Inc. Devices and systems for thrombus treatment
US9456834B2 (en) 2012-10-31 2016-10-04 Covidien Lp Thrombectomy device with distal protection
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US8784434B2 (en) 2012-11-20 2014-07-22 Inceptus Medical, Inc. Methods and apparatus for treating embolism
US20140180377A1 (en) 2012-12-20 2014-06-26 Penumbra, Inc. Aneurysm occlusion system and method
US9439661B2 (en) 2013-01-09 2016-09-13 Covidien Lp Connection of a manipulation member, including a bend without substantial surface cracks, to an endovascular intervention device
US20140257362A1 (en) 2013-03-07 2014-09-11 St. Jude Medical, Cardiology Division, Inc. Filtering and removing particulates from bloodstream
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
WO2014140092A2 (en) 2013-03-14 2014-09-18 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
PL2967610T3 (en) 2013-03-14 2019-07-31 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US9724112B2 (en) 2013-03-15 2017-08-08 Cook Medical Technologies Llc Shape memory metal emboli trap
US9393035B2 (en) 2013-04-12 2016-07-19 Yongyi Alan Yu Systems and methods for restoring blood flow to a vessel
US10111676B2 (en) 2013-05-01 2018-10-30 Cook Medical Technologies Llc Looped clot retriever wire
WO2014178198A1 (en) 2013-05-02 2014-11-06 テルモ株式会社 Blood clot removal device
US20140364896A1 (en) * 2013-06-07 2014-12-11 Abott Cardiovascular Systems, Inc. Device, system, and method for thrombus retrieval
US20150018860A1 (en) 2013-07-12 2015-01-15 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US10383644B2 (en) 2013-10-17 2019-08-20 Covidien Lp Mechanical thrombectomy with proximal occlusion
US10238406B2 (en) 2013-10-21 2019-03-26 Inari Medical, Inc. Methods and apparatus for treating embolism
WO2015073704A1 (en) 2013-11-13 2015-05-21 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
US9155552B2 (en) 2014-01-03 2015-10-13 Legacy Ventures LLC Clot retrieval system
US9962177B2 (en) 2014-01-03 2018-05-08 Legacy Ventures LLC Clot retrieval system
US8900265B1 (en) 2014-01-03 2014-12-02 Legacy Ventures LLC Clot retrieval system
US20160066921A1 (en) 2014-02-21 2016-03-10 Neuravi Limited DEVICE AND METHOD FOR ENDOVASCULAR TREATMENT OF ANEURYSMS USING EMBOLIC ePTFE
EP3113697B8 (en) 2014-03-04 2019-09-18 ThrombX Medical, Inc. Intravascular thromboembolectomy device having a plurality of clot engaging elements
US20150374391A1 (en) 2014-03-07 2015-12-31 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
US10285720B2 (en) 2014-03-11 2019-05-14 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
CA2947201C (en) 2014-05-18 2019-09-24 Legacy Ventures LLC Clot retrieval system
EP3094363A4 (en) 2014-06-09 2017-10-04 Inceptus Medical, LLC Retraction and aspiration device for treating embolism and associated systems and methods
US10441301B2 (en) 2014-06-13 2019-10-15 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US10265086B2 (en) 2014-06-30 2019-04-23 Neuravi Limited System for removing a clot from a blood vessel
US20160015403A1 (en) 2014-07-15 2016-01-21 Boston Scientific Scimed, Inc. Medical retrieval devices and methods
EP4008389B1 (en) * 2014-11-04 2025-07-02 OrbusNeich Medical Pte. Ltd. Progressive flexibility catheter support frame
WO2016083472A1 (en) 2014-11-26 2016-06-02 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592356A (en) * 1984-09-28 1986-06-03 Pedro Gutierrez Localizing device
US5106364A (en) * 1989-07-07 1992-04-21 Kabushiki Kaisha Topcon Surgical cutter
US5538008A (en) * 1993-01-18 1996-07-23 Crowe; John Forceps for endoscopes
US6142957A (en) * 1993-09-20 2000-11-07 Boston Scientific Corporation Multiple biopsy sampling device
US5846248A (en) * 1995-04-13 1998-12-08 Boston Scientific Corporation Method and apparatus for severing and capturing polyps
US6371963B1 (en) * 1998-11-17 2002-04-16 Scimed Life Systems, Inc. Device for controlled endoscopic penetration of injection needle
US20050119524A1 (en) * 2002-08-07 2005-06-02 Olympus Optical Co., Ltd. Endoscopic treatment system
US20050119668A1 (en) * 2003-09-18 2005-06-02 Boston Scientific Scimed, Inc. Medical retrieval devices and methods
US20070179513A1 (en) * 2004-01-09 2007-08-02 Deutsch Harvey L Method and device for removing an occlusion
US20060036271A1 (en) * 2004-07-29 2006-02-16 X-Sten, Inc. Spinal ligament modification devices
US20070239182A1 (en) * 2006-04-03 2007-10-11 Boston Scientific Scimed, Inc. Thrombus removal device
US20080269774A1 (en) * 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US20100305566A1 (en) * 2007-11-30 2010-12-02 New England Assoication Of Gynecologic Laparoscopists, Llp Transcervical excision and removal of tissue
US20100036312A1 (en) * 2008-06-08 2010-02-11 Hotspur Technologies, Inc. Apparatus and methods for removing obstructive material from body lumens
US20110071432A1 (en) * 2009-09-24 2011-03-24 Carrillo Jr Oscar R Fine Needle Aspiration Device with Distal Anchor
US20140277003A1 (en) * 2013-03-13 2014-09-18 The Spectranetics Corporation Material Capturing Guidewire
US20140276840A1 (en) * 2013-03-15 2014-09-18 DePuy Synthes Products, LLC Tools and methods for tissue removal

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12161352B2 (en) 2015-01-13 2024-12-10 Anaconda Biomed, S.L. Thrombectomy device, system and method for extraction of vascular thrombi from a blood vessel
US12575845B2 (en) 2015-12-11 2026-03-17 Anaconda Biomed, S.L. Thrombectomy device, system and method for extraction of vascular thrombi from a blood vessel
US12508042B2 (en) 2017-09-30 2025-12-30 Ceretrieve Ltd. Retrieval system
US12285182B2 (en) 2018-10-10 2025-04-29 Innova Vascular, Inc. Devices and methods for removing an embolus
US11986195B2 (en) 2018-10-16 2024-05-21 Anaconda Biomed, S.L. Device and a thrombectomy apparatus for extraction of thrombus from a blood vessel
US12569264B2 (en) 2018-10-16 2026-03-10 Anaconda Biomed, S.L. Device and a thrombectomy apparatus for extraction of thrombus from a blood vessel
US11534191B2 (en) 2019-01-11 2022-12-27 Anaconda Biomed, S.L. Loading device for loading a medical device into a catheter
US11771446B2 (en) 2020-10-19 2023-10-03 Anaconda Biomed, S.L. Thrombectomy system and method of use
US12364492B2 (en) 2020-10-19 2025-07-22 Anaconda Biomed, S.L. Thrombectomy system and method of use
US12440231B2 (en) 2020-12-09 2025-10-14 Ceretrieve Ltd. Retrieval system and method
US11931502B2 (en) 2021-04-27 2024-03-19 Contego Medical, Inc. Thrombus aspiration system and methods for controlling blood loss
US11717603B2 (en) 2021-04-27 2023-08-08 Contego Medical, Inc. Thrombus aspiration system and methods for controlling blood loss
US11679195B2 (en) 2021-04-27 2023-06-20 Contego Medical, Inc. Thrombus aspiration system and methods for controlling blood loss
US11679194B2 (en) 2021-04-27 2023-06-20 Contego Medical, Inc. Thrombus aspiration system and methods for controlling blood loss
WO2024252274A1 (en) * 2023-06-04 2024-12-12 Ceretrieve Ltd. Embolus-retrieval device

Also Published As

Publication number Publication date
US20170105743A1 (en) 2017-04-20
US10792056B2 (en) 2020-10-06

Similar Documents

Publication Publication Date Title
US12539129B2 (en) Devices and methods for removal of acute blockages from blood vessels
US20210077134A1 (en) Devices and methods for removal of acute blockages from blood vessels
EP3335647B1 (en) Devices for removal of acute blockages from blood vessels
JP7271614B2 (en) Pre-installed inverted tractor thrombectomy apparatus and method
WO2017097616A1 (en) Devices and methods for removal of acute blockages from blood vessels
US20230149035A1 (en) Devices and methods for aspiration of thrombus
US20240188972A1 (en) Expandable mouth aspirating clot retrieval catheter
CN112842464A (en) Actuated expandable open thrombectomy catheter
US20230014731A1 (en) Clot retrieval device for removing clot from a blood vessel
CN112842456B (en) Aspiration catheters, systems and methods
CN112842456A (en) Aspiration catheters, systems, and methods thereof

Legal Events

Date Code Title Description
AS Assignment

Owner name: NEURAVI LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VALE, DAVID;CASEY, BRENDAN;GILVARRY, MICHAEL;AND OTHERS;SIGNING DATES FROM 20170217 TO 20170504;REEL/FRAME:053931/0569

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION